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ABSTRACT 
 
 
There is mounting evidence in support of the view that skeletal muscle hypertrophy 
results from the complex and coordinated interaction of numerous signalling 
pathways. Well characterised components integral to skeletal muscle adaptation 
include the transcriptional activity of the members of the myogenic regulatory factors, 
numerous secreted peptide growth factors, and the regenerative potential of satellite 
cells. Whilst studies investigating isolated components or pathways have enhanced 
our current understanding of skeletal muscle hypertrophy, our knowledge of how all of 
these components react in concert to a common stimulus remains limited. The broad 
aim of this thesis was to identify and characterise novel genes involved in skeletal 
muscle hypertrophy. We have created a customised human skeletal muscle specific 
microarray which contains ~11,000 cDNA clones derived from a normalised human 
skeletal muscle cDNA library as well as 270 genes with known functional roles in 
human skeletal muscle. The first aspect of this thesis describes the production of the 
microarray and evaluates the robustness and reproducibility of this analytical 
technique.  
 
Study one aimed to use this microarray in the identification of genes that are 
differentially expressed during the forced differentiation of human rhabdomyosarcoma 
cells, an in vitro model of skeletal muscle development. Firstly using this unique model 
of aberrant myogenic differentiation we aimed to identify genes with previously 
unidentified roles in myogenesis. Secondly, the data from this study permitted the 
examination of the performance of the microarray in detecting differential gene 
expression in a biological system. We identified several new genes with potential roles 
in the myogenic arrest of rhabdomyosarcoma and further characterised the expression 
of muscle specific genes in rhabdomyosarcoma differentiation. 
 
In study two, the molecular responses of cell cycle regulators, muscle regulatory 
factors, and atrophy related genes were mapped in response to a single bout of 
resistance exercise in human skeletal muscle. We demonstrated an increased 
expression of MyoD, myogenin and p21, whilst the expression of myostatin was 
decreased. The results of this study contribute to the existing body of knowledge on 
the molecular regulation skeletal muscle to a hypertrophic stimulus. 
 
 x 
In study three, the muscle samples collected in study two were analysed using the 
human skeletal muscle specific microarray for the identification of novel genes with 
potential roles in the hypertrophic process. The analysis uncovered four interesting 
genes (TXNIP, MLP, ASB5, FLJ 38973) that have not previously been examined in 
human skeletal muscle in response to resistance exercise. The functions of these 
genes and their potential roles in skeletal muscle are discussed. 
 
In study four, the four genes identified in study three were examined in human primary 
skeletal muscle cell cultures during myogenic differentiation. Human primary skeletal 
muscle cells were derived from the vastus lateralis muscle of 8 healthy volunteers (6 
males and 2 females). Cell cultures were differentiated using serum withdrawal and 
serum withdrawal combined with IGF-1 supplementation. Markers of the cell 
proliferation, cell cycle arrest and myogenic differentiation were examined to assess 
the effectiveness of the differentiation stimulus. Additionally, the expressions of 
TXNIP, MLP, ASB5 and FLJ 38973 measured in an attempt to characterise further 
their roles in skeletal muscle. The expression of TXNIP changed markedly in response 
to both differentiation stimuli, whilst the expression of the remaining genes were not 
altered. Therefore it was suggested that expression of these genes might be 
responsive to the mechanical strain or contraction induced by the resistance exercise. 
In order to examine whether these novel genes responded specifically to resistance 
type exercise, their expression was examined following a single bout of endurance 
exercise. The expression of TXNIP, MLP, and FLJ 38973 remained unchanged whilst 
ASB5 increased 30 min following the cessation of the exercise.  
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1.1 Overview of the main events during resistance exercise leading to skeletal 
muscle hypertrophy. (1) Muscular overload is detected by the muscle 
through numerous perturbations in the cellular environment. Via receptor 
binding and other cellular signals, a network of signal transduction 
pathways (2) results in the activation of transcription factors. Active nuclear 
transcription factors alter the expression of numerous genes (3) which 
ultimately result in increased synthesis and assembly of myofibrillar 
proteins (4). Simultaneously, growth factors, cytokines released from 
injured cells, and other unknown mechanisms mediate the activation of 
satellite cells (5). The activated satellite cells subsequently proliferate, 
differentiate and then fuse to existing myofibres to promote muscle repair 
and enlargement via increased production of myofibrillar proteins (6).  
 
3 
1.2 Overview of overload induced myotrauma and satellite cell activation. (A) 
Myofibre damage occurs. (B) inflammatory response releases cytokines 
and muscle derived growth factors which in turn activate satellite cells to 
(C) proliferate, differentiate and fuse to existing myofibres, resulting in (D) 
myofibre  hypertrophy.  
 
10 
2.1 Overview of microarray production and analysis. Initially selected cDNA 
clones are PCR amplified, purified and then spotted onto glass sides by 
microarray printing robots. RNA from samples of interest and a reference 
are extracted, reverse transcribed and are labelled with Cy3 (usually red) 
and Cy5 (usually green) fluorescent dyes. The two samples are then 
combined and competitively hybridised to the prepared microarray slides. 
Laser excitation of the incorporated fluorescent dyes yields an emission 
with a characteristic spectrum, which is measured using a scanning 
confocal laser microscope. Thus from the fluorescence intensities and 
colours from each spot, the relative expression of that particular RNA 
species in the experimental sample can be estimated. 
 
23 
2.2 Representative agarose gel of amplified clones. PCR amplified cDNA 
clones were run on a 1% agarose gel to verify amplification and the 
presence of a single product. 
 
29 
2.3 A representative section of a SYBRGold stained microarray slide. 
Representative microarrays from each manufactured batch were stained for 
DNA using SYBRGold. The resulting image demonstrated a high degree of 
DNA retention on the surface of the array, good spot morphology and a 
uniform printing pattern. 
 
29 
2.4 A false colour image of the muscle:muscle hybridisation (A) and an 
enlarged view of a single 20 × 20 grid (B). The array consists of PCR-
amplified random cDNA clones spotted onto a glass slide. Equal quantities 
of skeletal muscle RNA was labelled with Cy3 and Cy5 fluorophores and 
competitively hybridised to the array. Yellow dots represent genes that 
show no difference in expression between the two sample RNAs. 
 
31 
2.5 Homotypic Hybridisations. (A) Scatter plot of the calibrated Cy5 versus Cy3 
fluorescence response from a skeletal muscle/skeletal muscle 
hybridisation. Virtually all gene elements lie close to the diagonal line 
corresponding to the theoretical differential expression ratio of 1. (B) Data 
points from the homotypic hybridisations were used to construct a 
histogram, which shows the distribution of gene elements around the 
expected log ratio of 0.0. 
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2.6 Hierarchical clustering dendrogram of six identical hybridisations, two 
conducted on one day (repeat 1a and 1b), two conducted one week later 
(repeat 2a and 2b) and two conducted 4 weeks later. The closest 
correlations are indicated by low branches on the dendrogram. The overall 
high correlation (top branch on the dendrogram) across the six arrays 
indicated very good reproducibility of the microarray. 
 
34 
3.1 Western blot analysis of MHC protein expression over 10 days of 
differentiation with TPA containing medium. A representative blot from one 
replicate experiment is shown above the histogram. The order of samples 
on the blot corresponds with the order of bars in the histogram below. The 
cell extracts were electrophoresed through a 12% SDS-polyacrylamide gel, 
transferred to nitrocellulose membranes and probed with the myosin 
antibody (MY-35). The density of the bands was analysed using Kodak 1D 
3.5 image analysis software and the average of three independent replicate 
experiments is presented. 
 
44 
3.2 Immunofluorescence analysis of RMS cells over the 10 days of TPA 
induced differentiation. Cells were reacted to the MHC antibody MY-35 
(green). Nuclei were counterstained using the DNA binding dye 
Bisbenzimide Hoechst 33285 (blue). (A), Control; (B), Day 1; (C), Day 3; 
(D), Day 6; (E), Day 8; (F), Day10. Bar represents 100µM. 
 
45 
3.3 Hierarchical clustering analysis of expression profiles. Hierarchical 
clustering was used to group genes based on their expression profiles. 
Each gene element is represented on the vertical axis, and the time points 
are shown on the horizontal axis. The expression ratios for each gene at 
each time point are colour coded: red indicates increased expression while 
green indicated reduced expression relative to the reference expression 
level. Two distinct clusters are evident, an up regulated pattern of 
expression (highlighted in blue) and a down regulated pattern of 
expression. The averages of three independent replicate experiments are 
presented. 
 
47 
3.4 Microarray expression profiles of selected differentially expressed genes. 
Each bar represents the mean ± SEM of three independent, replicate 
experiments. 
 
49 
3.5 Real-time PCR validation of the genes identified from the microarray 
analysis. Data is presented as arbitrary units normalized to the control 
value. Bars show the mean ± SEM of six replicate experiments.  
 
51 
3.6 Expression of the myogenic basic helix-loop-helix transcription factors. 
A. mRNA expression of the MRFs over 10 days of differentiation. Data is 
presented as arbitrary units normalized to the control value. Bars show the 
mean ± SEM of six replicate experiments. 
B. Western blot analysis of myogenin protein expression over 10 days of 
differentiation. A representative blot from one replicate experiment is shown 
above the histogram. The order of samples on the blot corresponds with 
the order of bars in the histogram below. The cell extracts were 
electrophoresed through a 12% SDS-polyacrylamide gel, transferred to 
nitrocellulose membranes and probed with the myogenin antibody (F5D). 
The average of three independent replicate experiments is presented. 
 
52 
4.1 Examination of the mRNA expression of the endogenous control β-actin 
following an acute bout of resistance exercise. Statistical analysis revealed 
no change in the expression of this gene at any time point following the 
exercise intervention. Therefore, this was considered an appropriate 
endogenous control for this study. 
 
62 
4.2 Average concentric (white bars) and eccentric (black bars) torque across 
the three exercise sets. The data represented is the average of 12 
contractions from 10 subjects, ± SEM. 
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4.3 The effects of a single bout of heavy resistance exercise on the expression 
of cell cycle regulatory factors. Real-time PCR analysis was performed on, 
Cyclin D1, PCNA, p21, and p27. Values are means ± SEM. 
 
65 
4.4 The effects of a single bout of heavy resistance exercise on the expression 
of the Muscle Regulatory Factors. Real-time PCR analysis was performed 
on, Myf5, MyoD, myogenin, and Myf6. Values are means ± SEM.  
 
66 
4.5 The effects of a single bout of heavy resistance exercise on the expression 
of myostatin mRNA. Values are means ± SEM. 
 
67 
4.6 The effects of a single bout of heavy resistance exercise on the expression 
of atrogin-1 and MuRF-1 mRNA. Values are means ± SEM. 
 
68 
5.1 3 × 2 self organising map representation of the patterns of gene expression 
observed following a single bout of endurance exercise. Subjects 
completed an acute bout of resistance exercise consisting of 3 sets of 12 
repetitions of maximal leg extension. Biopsies were taken before exercise 
(pre), at 30 min, 4 h, and 24 h post exercise. Self organising map was used 
to group genes based on their expression profiles. Each gene element is 
represented vertically, and the time points are shown horizontally. The 
expression ratios for each gene at each time point are colour coded: red, 
increased expression compared to reference RNA; green reduced 
expression compared to reference RNA.  
 
82 
5.2 Real-time PCR results for selected genes. Subjects completed an acute 
bout of resistance exercise consisting of 3 sets of 12 repetitions of maximal 
leg extension. Biopsies were taken before exercise (pre), at 30 min, 4 h, 
and 24 h post exercise. Bars represent mean ± SEM, average of 10 
subjects.  
 
87 
6.1 Differentiation of primary human skeletal muscle cell lines. The 
differentiation potential of our cell lines was examined using 
immunocytochemical staining of MHC protein in proliferating cells (A) and 
following 7 days of serum withdrawal mediated differentiation (B). Cells 
were reacted to the MHC antibody MY-35 (green). Nuclei were 
counterstained using the DNA binding dye Bisbenzimide Hoechst 33285 
(blue). 
 
102 
6.2 mRNA expression analysis of markers of proliferation (PCNA), cell cycle 
arrest (p21, Myostatin) and differentiation (MHC IIx, MHC I, CKM) during 
serum withdrawal (DM; solid bars) or serum withdrawal combined with 
30ng/ml R3IGF-1 (DM+IGF-1;white bars). Each bar represents the mean ± 
SEM of eight independent, replicate experiments. 
 
104 
6.3 CK activity increases with time in differentiating conditions. Human primary 
skeletal myoblasts were differentiated with serum withdrawal (DM) or 
serum withdrawal combined with 30ng/ml R3IGF-1 (DM+IGF-1). CK assay 
was performed on cell lysates and is expressed as mU/mg of total protein 
normalised to the 0h time-point. The average of eight independent primary 
cell cultures is presented, ± SEM.  
 
105 
6.4 Western blot analysis of MHC protein expression over time in differentiating 
conditions. The cell extracts were electrophoresed through a 6% SDS-
polyacrylamide gel, transferred to nitrocellulose membranes and reacted to 
the myosin antibody (MY-35). (A) MHC expression analysed using 
densitometry. The average of four independent primary cell culture 
experiments is presented (B) Representative blots from DM and DM+IGF-1 
treated cells. 
 
106 
6.5 mRNA expression analysis of the myogenic regulatory factors (MyoD, 
Myf5, myogenin, Myf6) during serum withdrawal (DM; solid bars) or serum 
withdrawal combined with 30ng/ml R3IGF-1 (DM+IGF-1;white bars). Each 
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bar represents the mean ± SEM of eight independent, replicate 
experiments. 
 
6.6 mRNA expression analysis of the FLJ38973, ASB5, MLP, and TXNIP 
during serum withdrawal (DM; solid bars) or serum withdrawal combined 
with 30ng/ml R3IGF-1 (DM+IGF-1;white bars). Each bar represents the 
mean ± SEM of eight independent, replicate experiments. 
 
110 
7.1 Examination of the mRNA expression of the endogenous control β-actin (A) 
and cyclophilin (B) following an acute bout of resistance exercise. 
Statistical analysis revealed no change in the expression of this gene at 
any time point following the exercise intervention. Therefore, this was 
considered an appropriate endogenous control for this study. 
 
120 
7.2 The effects of a single of bout of endurance exercise on the expression of 
resistance exercise sensitive genes. Real-time PCR analysis was 
performed on, TXNIP, MLP, ASB5 and FLJ38973. Values are means ± 
SEM of 8 subjects. 
 
124 
7.3 The effects of a single of bout of endurance exercise on the expression of 
the Muscle Regulatory Factors. Real-time PCR analysis was performed on, 
Myf5, MyoD, myogenin, and Myf6. Values are means ± SEM of 8 subjects. 
 
125 
7.4 The effects of a single bout of endurance exercise on the expression of 
PDK4. Values are means ± SEM of 8 subjects. 
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CHAPTER ONE 
REVIEW OF THE LITERATURE 
I. INTRODUCTION 
Skeletal muscle comprises 50-60% of total body mass and is one of the major tissues 
involved in regulating metabolism, locomotion and strength. Skeletal muscle mass and 
contractile characteristics are readily modified by increased loading (e.g. resistance 
exercise). Similarly, conditions of disuse (e.g. bed rest, microgravity), starvation, 
aging, and some disease states (e.g. cancer cachexia, AIDS) results in protein 
breakdown and considerable skeletal muscle atrophy. Significant loss of muscle mass 
results in numerous deleterious consequences including muscle weakness and frailty, 
increased risk of falls and associated morbidity, reduction in or prevention of 
ambulation, and in severe cases, mortality. Recent developments in molecular biology 
have begun to provide some insights into the subtle interactions and complex events 
which control these adaptations. Understanding the fundamental mechanisms 
underlying hypertrophy has the potential to provide new therapies to treat muscle 
disease. Importantly, the molecules and signalling pathways that induce hypertrophy 
might be manipulated or mimicked to directly arrest the atrophic process, or indeed 
augment the growth of skeletal muscle in these populations. In this review, current 
understandings of the cellular and molecular mechanisms of skeletal muscle 
hypertrophy are presented. 
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II. CELLULAR & MOLECULAR REGULATION OF 
SKELETAL MUSCLE HYPERTROPHY 
Skeletal muscle hypertrophy results from a set of complex and highly orchestrated 
signalling events which result in increased protein synthesis and the addition of new 
contractile filaments to pre-existing fibres, ultimately enabling greater force production. 
It has become evident that there are two primary processes mediating hypertrophy. 
The first is increased protein synthesis within the myofibre leading to appropriate 
cellular adaptations. The second involves the proliferation, differentiation and fusion of 
satellite cells, providing additional myonuclei for the enlarging fibre. Equally as 
important are the many critical mechanisms by which the cell senses increased 
loading and transduces this information into intracellular adaptations (Figure 1.1).  
A. Signalling Pathways Mediating Myofibre Adaptation 
Strenuous, growth-inducing muscle activity is associated with changes in one or more 
variables including myofibre integrity or damage, calcium concentrations, energy 
demand, growth factors and cytokines, intramuscular temperature and oxygen 
concentrations, as well as mechanical stretch and contraction of the muscle itself 
(Rennie et al. 2004). Alterations of an appropriate magnitude in these variables have 
the capacity to activate numerous parallel signalling pathways. The involvement of 
these signalling pathways in the sensation and transduction of cellular environmental 
stimuli is widely recognised as critical in the activation of specific gene expression and 
cellular reprogramming (Martineau and Gardiner 2001; Nader and Esser 2001). 
Several signalling pathways involving cytoplasmic protein kinases and nuclear 
encoded transcription factors have been identified as possible master regulators of 
skeletal muscle adaptation. These pathways encompass both the sensing of 
mechanical and environmental perturbations as well as the transduction of these 
signals into intracellular responses. 
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Figure 1.1. Overview of the main events during resistance exercise leading to 
skeletal muscle hypertrophy. (1) Muscular overload is detected by the muscle 
through numerous perturbations in the cellular environment. Via receptor binding 
and other cellular signals, a network of signal transduction pathways (2) results in 
the activation of transcription factors. Active nuclear transcription factors alter the 
expression of numerous genes (3) which ultimately result in increased synthesis 
and assembly of myofibrillar proteins (4). Simultaneously, growth factors, 
cytokines released from injured cells, and other unknown mechanisms mediate 
the activation of satellite cells (5). The activated satellite cells subsequently 
proliferate, differentiate and then fuse to existing myofibres to promote muscle 
repair and enlargement via increased production of myofibrillar proteins (6).  
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 1. Mechanotransduction & the Integrin Signalling Pathway 
Mechanotransduction is the mechanism by which mechanical stress initiates 
intracellular signalling. Striated muscle cells are particularly responsive to mechanical 
stress as evidenced by the fact that cellular size is in large part dictated by physical 
forces. A fundamental unanswered question concerns how skeletal muscle cells 
sense mechanical loading and transduce this information into cellular level 
adaptations.  
 
One potential candidate for influencing load-induced changes in skeletal muscle 
protein synthesis through the regulation of gene transcription is the integrin-mediated 
signalling pathway. Initially, integrins were considered solely as membrane-associated 
proteins necessary for maintaining adhesive interactions with the extracellular matrix, 
cell growth and cell motility (Carson and Wei 2000). More recently however, it is 
believed that integrins constitute a critical component of the signalling pathways by 
which the cell integrates physical or mechanical signals from the surrounding 
environment (Carson and Wei 2000). Activation of cellular signalling through 
extracellular matrix-integrin interactions initially occurs by the formation of focal 
adhesion complexes (FACs). Within the FACs, signalling proteins are brought into 
close proximity - thereby facilitating signal transduction.  
 
Importantly, the formation of FACs appears sensitive to mechanical forces. The focal 
adhesion protein focal adhesion kinase (FAK) is activated by the mechanical stretch of 
muscle and both FAK and paxillin (a down-stream target of FAK) protein 
concentrations are increased in hypertrophied skeletal muscle (Flück et al. 1999; 
Gordon et al. 2001). Equally, the expression of a down stream effector molecule of 
integrins, RhoA, is increased following functional overload and during the recovery 
from disuse atrophy (McClung et al. 2003; McClung et al. 2004). Indeed, RhoA can 
regulate the expression of the muscle specific transcription factors, MyoD and 
myogenin and is critical for skeletal muscle differentiation (Carnac et al. 1998; Takano 
et al. 1998; Wei et al. 1998). 
1.1. Signal Integration 
Whilst integrins may be important for transducing mechanical stimuli into cellular level 
signalling, there is some suggestion that integrins may also be excellent candidates 
for integrating many of the signalling cascades activated during hypertrophy (Carson 
and Wei 2000). Muscle overload and contraction alter innumerable variables which, in 
turn activate many signalling pathways simultaneously. It appears to be that the 
combinatorial activation of these signal transduction pathways as well as the relative 
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magnitude of the signals ultimately result in the specific adaptations of the cell. 
Integrins may provide a mechanism by which all of these signalling pathways work 
together to give a unified response resulting in appropriate cellular adaptations. 
Signalling pathways that have been shown to be connected to integrin signalling 
include phosphatidylinositol-3 kinase (P13k), mitogen-activated protein kinase 
(MAPK), and calcium signalling pathways (Clarke and Brugge 1995; Goel and Dey 
2002; Zhang et al. 2003; Kim et al. 2004; Velling et al. 2004).  
2. PI(3)k/Akt Signalling Pathway 
Numerous studies have identified critical roles for the PI3k/Akt pathway in modulating 
the intracellular response to resistance exercise. Most notably, the growth factor 
insulin-like growth factor I (IGF-1), a powerful stimulator of muscle hypertrophy 
(Vandenburgh et al. 1991; Coleman et al. 1995), has recently been shown to act via 
the PI3k/Akt signalling pathway (Bodine et al. 2001b; Rommel et al. 2001). IGF-1 
binding to the IGF-1 receptor stimulates a cascade of events which ultimately result in 
the activation of P13k and further downstream, Akt. Akt in turn phosphorylates an ever 
increasing set of substrates amongst which are proteins that induce protein synthesis, 
block apoptosis, activate cell proliferation, and mediate gene transcription, steps 
essential for the development of skeletal muscle hypertrophy (Glass 2003; Matsui et 
al. 2003). Targeted activation of PI3k has been shown to induce skeletal muscle 
hypertrophy (Murgia et al. 2000). Indeed, pharmacological inhibition of PI3k is 
sufficient to block IGF-1 stimulated hypertrophy (Rommel et al. 1999). Equally, the 
over-expression of a constitutively active form of Akt plays critical roles in both the 
promotion of muscle hypertrophy and the inhibition of muscle atrophy in vivo (Bodine 
et al. 2001b). Furthermore, specific inhibition of mTOR, a downstream target of Akt, 
with rapamycin leads to a 95% inhibition of hypertrophy. Conversely, another 
downstream target of Akt, glycogen synthase kinase-3β (GSK-3β) appears to be a 
negative regulator of skeletal muscle hypertrophy. GSK-3β phosporylation and 
inactivation by Akt has been observed during hypertrophy in animals (Bodine et al. 
2001b) and in culture (Rommel et al. 2001; Vyas et al. 2002). Collectively, these 
studies identify a crucial role for the P13k-Akt signalling pathway in regulating the 
development of skeletal muscle hypertrophy. 
3. MAPK Signalling Pathway 
The involvement of the MAPK cascades in mechanically induced signalling from the 
cytosol to the nucleus is receiving increasing attention. This function is compatible with 
the well known role of the MAPKs as points of convergence for various signalling 
cascades regulating gene expression (Martineau and Gardiner 2001). The MAPK 
superfamily can be separated into distinct parallel pathways including the extracellular 
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signal-related kinase (ERK) 1/2, the stress activated protein kinase cascades 
(SAPK1/JNK and SAPK2/p38) and ERK5. Cellular stresses can elicit signal 
transduction of the MAPK signalling pathways through protein phosphorylation on 
serine, threonine, and tyrosine residues. Many factors associated with exercise, 
including growth factors and their cell surface receptors, cytokines, hypoxia, changes 
in intracellular calcium and mechanical stresses have been shown to stimulate MAPK 
signal cascades (Widegren et al. 2001). Thus MAPK signal cascades are a likely 
candidate system that may convert the mechanical and biochemical stimuli associated 
with muscle contraction into appropriate intracellular responses (Widegren et al. 
2001). Importantly, recent evidence suggests that exercise and muscle contraction 
can induce phosphorylation and activation of components of the ERK, JNK and p38 
MAPK cascades in both human and rat skeletal muscle (Aronson et al. 1997a; 
Aronson et al. 1997b; Aronson et al. 1998; Boppart et al. 1999; Boppart et al. 2000; 
Osman et al. 2000; Ryder et al. 2000; Wretman et al. 2000; Carlson et al. 2001; 
Martineau and Gardiner 2001; Thompson et al. 2003). Furthermore, several of these 
studies (Aronson et al. 1997a; Aronson et al. 1998) demonstrated a rapid and 
concurrent induction of c-jun and c-fos mRNA levels, early response genes which 
have been implicated in the activation of genetic events leading to the differential 
regulation of muscle specific genes (Williams and Neufer 1996). Thus muscular 
contraction activates MAPK signalling cascades that ultimately lead to the activation of 
different transcription factors responsible for initiating muscle specific gene and protein 
expression.  
4. Intracellular Calcium Signalling 
Changes in intracellular calcium regulate many important cellular processes, including 
motility, neurotransmitter release, proliferation and gene expression (Bading et al. 
1997). Calcium has been shown to regulate gene expression via multiple signalling 
pathways by activating calcium sensitive kinases such as calmodulin kinases, and 
mitogen-activated protein kinases. Although the essential role of intracellular calcium 
concentrations in the regulation of skeletal muscle contraction has been established, 
its role in the regulation of muscle growth is less well understood.   
 
Changes in intracellular calcium have been implicated in regulating diverse processes 
in skeletal muscle, including differentiation, hypertrophy and fibre type determination. 
The calcium/calmodulin-dependant protein phosphatase, calcineurin plays an 
important role in mediating downstream calcium-dependant signalling. Calcineurin is a 
serine/threonine phosphatase that is activated in response to sustained increases in 
intracellular calcium (Dolmetsch et al. 1997). In skeletal muscle, calcineurin activation 
has been shown to be necessary for hypertrophic growth in response to insulin-like 
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growth factor-1 (Musarò et al. 1999), or during compensatory overload (Dunn et al. 
1999). Considerable controversy exists however as to the relative importance of 
calcineurin in this process. Whereas some groups have reported that cyclosporin A, 
an inhibitor of calcineurin, blocks hypertrophy (Dunn et al. 1999), others have seen no 
effect (Bodine et al. 2001b; Musarò et al. 2001; Rommel et al. 2001; Dupont-
Versteegden et al. 2002). Calcineurin dependant pathways have also been implicated 
in myoblast differentiation (Delling et al. 2000; Friday et al. 2000) through the 
activation of MyoD and MEF2 (Friday et al. 2003) as well as skeletal muscle 
regeneration (Sakuma et al. 2003). More recently, the hypothesised roles of 
calcineurin have been extended to include the regulation of skeletal muscle fibre type 
switching (Mitchell et al. 2002; Parsons et al. 2004). Indeed, calcineurin has been 
shown to selectively activate the expression of the slow MHC isoform (Delling et al. 
2000).  
B. Contribution of Satellite Cells to Muscle Adaptation 
Each myonucleus controls the production of mRNA and proteins over a finite volume 
of cytoplasm, known as the myonuclear domain. mRNA encoding proteins do not 
freely mix along the fibre length but remain concentrated around their myonuclei of 
origin (Hall and Ralston 1989; Pavlath et al. 1989). Therefore, any increase in the size 
of a muscle fibre, in response to increased mechanical load for example, would 
necessitate the incorporation of additional myonuclei (Yan 2000). Yet, mature 
myofibres within adult skeletal muscle are terminally differentiated and therefore 
incapable of mitotic division to produce additional myonuclei in times of increased 
protein synthesis and muscle growth. Satellite cells, myogenic precursor cells located 
between the basal lamina and sarcolemma of multinucleated myofibres, provide the 
additional pool of myonuclei necessary for muscle growth (Hawke and Garry 2001). In 
normal mature fibres, satellite cells are quiescent. Rates of RNA and protein synthesis 
are low but the cell retains the ability to divide. Upon activation, they re-enter the cell 
cycle, proliferate, and differentiate to form myofibres by fusing with themselves or 
existing fibres (Hawke and Garry 2001). 
 
There is very strong evidence to suggest that skeletal muscle remodelling and 
regeneration is dependent, to a large extent upon the activity of satellite cells 
(Rosenblatt and Parry 1992; Rosenblatt and Parry 1993). Such that, upon mild γ-
radiation induced inhibition of satellite cell proliferation, overload induced hypertrophy 
was obliterated (Rosenblatt and Parry 1992; Rosenblatt and Parry 1993). The exact 
contribution of satellite cells to the hypertrophic response remains unclear however, as 
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the induction of hypertrophy has been observed despite the elimination of satellite cell 
activity (Lowe and Alway 1999). Similarly, studies have reported an enlargement of 
myofibre size before an increase in satellite derived myonuclear number had occurred 
(Allen et al. 1995a; Roy et al. 1999). Collectively, these observations indicate that 
although the activity of satellite cells are an integral component of skeletal muscle 
hypertrophy, existing myonuclei must also act in concert with satellite cells to regulate 
the adaptation of the entire myofibre. 
 
Mechanical loading, has been shown to induce augmented activation and proliferation 
of satellite cells in the muscle of humans (Kadi and Thornell 2000; Crameri et al. 2004; 
Kadi et al. 2004b) and adult rats (Darr and Schultz 1987; Rosenblatt et al. 1994; Smith 
et al. 2001). Increased myonuclei numbers have been reported in high-level 
resistance trained subjects as the result of years of intensive training (Kadi et al. 1999) 
and more recently in response to 10 weeks of strength training in women (Kadi and 
Thornell 2000). Since the importance of satellite cells to the remodelling and 
regenerative potential of skeletal muscle was described, much research has focused 
on understanding the molecular and cellular mechanisms regulating their functions in 
muscle.   
1. Overload Induced Activation of Satellite Cells  
In mature muscle, satellite cells are normally quiescent and require appropriate 
signals to become activated, proliferate and differentiate as required. As mentioned 
previously, resistance exercise has the capacity to generate numerous, parallel 
signalling pathways within skeletal muscle that ultimately result in cellular level 
adaptations. A variety of extracellular signalling pathways have been found to govern 
satellite cell activities, most prominently, cytokines from inflammatory cells and growth 
factors released from muscle and surrounding tissues (Vierck et al. 2000). Initially, 
strenuous or unaccustomed resistance exercise may result in muscle damage ranging 
from micro-tears to large tears in the sarcolemma and basal lamina as well as within 
the contractile proteins of the myofibre (Vierck et al. 2000). Whether muscle damage 
is causally linked to the hypertrophic process remains unclear. However, eccentric 
muscular contractions induce more muscle damage than concentric exercise and the 
hypertrophic response is blunted when the eccentric phase is omitted from resistance 
training (Hather et al. 1991).  
 
One proposed theory suggests that resistance exercise resulting in myotrauma may 
initiate the release of signalling factors that stimulate and attract immune cells to the 
injury site. Cytokines from the activated immune cells, along with muscle-derived 
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growth factors, initiate a sequence of events that ultimately results in satellite cell 
proliferation and differentiation (Vierck et al. 2000), see Figure 1.2.  
 
Integral to the proliferative response are the growth factors insulin-like growth factor 
(IGF-1), hepatocyte growth factor, basic fibroblast growth factor (bFGF) , transforming 
growth factor β (TGF-β) and growth hormone as well as interlukin-6 (IL-6), and 
leukaemia inhibitory factor (LIF) (Vierck et al. 2000). Such factors differ in their effects 
on myogenesis: IL-6 and LIF only stimulate myoblast proliferation (Austin and Burgess 
1991), whereas bFGF stimulates myoblast proliferation but also inhibits muscle 
differentiation (Gospodarowicz et al. 1976) and TGF-β inhibits proliferation. IGF-1 is 
unique amongst growth factors in that it is capable of stimulating both proliferation and 
differentiation of satellite cells (Allen and Boxhorn 1987).  
 
Although there is no general consensus on the exact contribution of cytokines and 
muscle derived growth factors in overload induced hypertrophy, it is generally 
accepted that some, if not all of these factors contribute to the regulation of satellite 
cell activity within muscle. 
 
 10 
Overload Induced Muscle Damage 
 
A
Myofibre damage
Basal Lamina Satellite cell
Macrophage 
Neutrophil
Immune 
Response
LIF 
IL-6 
Growth Factors 
IGF-I 
IGF-II 
MGF 
FGF 
HGF 
TGF-β 
Satellite cell proliferation Differentiation & Fusion of 
Satellite Cells 
& 
Myofibre hypertrophy 
D
C
B
 
Figure 1.2. Overview of overload induced myotrauma and satellite cell activation. 
(A) Myofibre damage occurs. (B) inflammatory response releases cytokines and 
muscle derived growth factors which in turn activate satellite cells to (C) 
proliferate, differentiate and fuse to existing myofibres, resulting in (D) myofibre  
hypertrophy.  
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2. Proliferation & Differentiation of Satellite Cells 
The effective capacity for regeneration and remodelling of muscle via satellite cell 
activity is remarkable considering that satellite cells constitute an estimated 2.5-6% of 
myofibre nuclei (Zammit et al. 2002). Once activated, satellite cells re-enter the cell 
cycle and proliferate until signalled to withdraw from the cell cycle and differentiate or 
return to a state of quiescence. Much research has focused on delineating the 
molecular mechanisms necessary for entire process of myogenesis including the 
regulation of the satellite cell cycle, myoblast determination, differentiation and 
subsequent fusion and maturation.  
2.1. Cell Cycle Regulation 
The decision of an activated satellite cell to progress through a new division appears 
primarily regulated late in the first gap phase (G1), before the initiation of DNA 
synthesis (S phase). Critical to this process is the activity of positive cell cycle 
regulators, the G1 cyclins (D1, D2, D3, A and E) and the regulatory subunits for the G1 
cyclin-dependant kinases (Cdks) (Cdk4, Cdk6 and Cdk2) which together, promote 
progression into successive phases of the cell cycle (Sherr 1994). Conversely, 
permanent cell cycle withdrawal, necessary for the terminal differentiation and 
maturation of satellite cells, requires that the major positive cell cycle regulators are 
inhibited. The major negative regulators comprise the Cdk-inhibitors (p21cip, p27kip, 
p57kip), the product of the retinoblastoma susceptibility gene (Rb protein) and the two 
related Rb family proteins p107 and p130 (Guo et al. 1995; Halevy et al. 1995; Parker 
et al. 1995; Novitch et al. 1996).  
 
Central to cell cycle regulation is the activity of the Rb protein. Active Cdk4/6-cyclin D1 
phosphorylates Rb during early G1; this leads to the up-regulation of cyclin E, its 
assembly with Cdk2, activation of the Cdk2-cyclin E complex and subsequent 
hyperphosphorylation of Rb. Hyperphosphorylated Rb releases, and subsequently 
activates the transcription factor E2F-1, allowing expression of genes necessary for 
G1/S progression, and mitosis (Ishida et al. 2001). Conversely, dephosphorylation of 
Rb protein by Cdk-inhibitors results in Rb binding and inactivating E2F-1, contributing 
to permanent cell cycle withdrawal (Sherr and Roberts 1999; Mal et al. 2000).  
2.2. Myogenic Regulatory Factors 
Whilst the activity of the Cdks and Cdk-inhibitors are important in the proliferative 
response in many cell types, the specification of the skeletal muscle phenotype is 
dependent on the activity of the basic-loop-helix family of muscle regulatory factors 
(MRFs). The MRFs comprise four members: MyoD, Myf5, myogenin and Myf6 (MRF4, 
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Herculin) that bind to specific consensus sites that are functionally important in the 
transcription of muscle-specific genes. Despite potentially overlapping roles of the 
MRFs, current understanding suggests specification of muscle cell fate is reliant on 
the activation of the core network of myogenic regulatory factors, rather than on the 
independent action of a single myogenic factor. In all known skeletal muscle lineages, 
MRF expression follows essentially the same pattern. MyoD and Myf5 are expressed 
in actively proliferating cells prior to differentiation, followed, at the beginning of 
differentiation by increased myogenin expression (Montarras et al. 1991; Lassar et al. 
1994). Lastly, Myf6 is transiently expressed during myofibre maturation (Montarras et 
al. 1991). 
 
It is well known that the MRFs are functionally important in regulating the expression 
of muscle specific genes (Piette et al. 1990; Lin et al. 1991; Wentworth et al. 1991; 
Muscat et al. 1992; Lassar et al. 1994; Li and Capetanaki 1994). More recently 
however, it has been suggested that the MRFs (in particular MyoD) interact with cell 
cycle regulators to promote cell cycle arrest and thus differentiation of myogenic cells. 
MyoD is capable of inducing the expression of p21, p27, p57, and Rb (Martelli et al. 
1994; Guo et al. 1995; Halevy et al. 1995; Parker et al. 1995; Reynaud et al. 2000). As 
mentioned previously, the induction of these Cdk-inhibitors activate Rb protein and 
contribute to permanent cell cycle arrest.  
 
Numerous studies have indicated that cells must exit the cell cycle to terminally 
differentiate. Central to the differentiation of skeletal myoblasts is myogenin, the 
absence of which results in the failure of myoblasts to attain the differentiated 
phenotype (Hasty et al. 1993). Myogenin, in conjunction with MyoD and the myocyte 
enhancer family protein, MEF-2C subsequently regulate the late phase of myogenesis 
by inducing the expression of myofibrillar and muscle specific proteins (Gu et al. 1993; 
Olson and Klein 1994).  
 
3. Satellite Cell Fusion 
The last critical step in terminal differentiation of satellite cells is the fusion of the 
differentiated myoblasts, either to themselves to form syncytial muscle fibres or to 
existing myofibres to promote repair and/or hypertrophy. Cell-surface molecules such 
as cadherins, ADAMs, EMC receptors, and the Ig superfamily molecules N-CAM and 
VCAM, have all been implicated in the regulation of myoblast fusion (Mege et al. 1992; 
Charlton et al. 2000; Cooper 2001; Fischer-Lougheed et al. 2001; Kang et al. 2003). 
Additionally, β1 integrins have been implicated in myoblast fusion and sarcomere 
incorporation (Li et al. 1999). Furthermore, the inactivation of Rho/ROCK signalling 
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and subsequent nuclear translocation of the transcription factor FKHR is required for 
myoblast fusion (Bois and Grosveld 2003; Nishiyama et al. 2004).  
  
4. Satellite Cell Self-Renewal 
Central to the continued regenerative and adaptive potential of muscle is the self-
renewal of satellite cells without which recurrent demands for increased myonuclei 
would rapidly deplete the satellite cell pool. Several scenarios have been proposed to 
explain how the satellite cell pool is replenished. Firstly, it has been suggested that 
two populations of satellite cells exist; one rapidly dividing population responsible for 
the provision of myonuclei and a slowly dividing pool of ‘reserve cells’, thought 
responsible for the replenishment of the quiescent satellite cell population (Rantanen 
et al. 1995; Yoshida et al. 1998; Zammit et al. 2004). Alternatively, satellite cells might 
represent an intrinsically homogenous pool of cells, capable of rapid proliferation and 
yet able, as required, to withdraw from the differentiation program and return to 
quiescence. Furthermore, renewal of the satellite cell pool may not rely exclusively on 
the satellite cell compartment. Indeed, several recent studies have shown that other 
cells, isolated both from muscle (side population cells) and a diverse range of tissues 
(bone marrow in particular) are capable of adopting a myogenic phenotype, albeit at a 
reduced frequency (Ferrari et al. 1999; Asakura et al. 2002; LaBarge and Blau 2002; 
Camargo et al. 2003; Corbel et al. 2003). The relative importance of these cell types to 
normal muscle repair and remodelling is unknown. 
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III. TRANSCRIPTIONAL REGULATION OF MUSCLE 
HYPERTROPHY 
Skeletal muscle adaptation involves the modification of cellular (myofibrils, 
mitochondria etc.) and extracellular compartments (capillaries, connective tissue etc.) 
such that the muscle is appropriately modified to suit its functional demands. 
Alterations in the molecular components of muscle tissue during adaptation are largely 
dependant on modulations in the protein make-up of the myofibres. The change in 
protein content and protein constituents can potentially be controlled at many steps, 
from RNA synthesis (transcription) to the synthesis of new proteins (translation) and 
post translational modifications. Translational regulation has been identified as a 
critical modulator of increased protein synthesis during skeletal muscle hypertrophy, 
however it is beyond the scope of this review and the reader is directed to several 
excellent reviews in the area (Jefferson and Kimball 2001; Nader et al. 2002; Bolster 
et al. 2003). Equally, it has long been recognised that increased transcription is 
essential for skeletal muscle hypertrophy (Goldberg and Goodman 1969; Sobel and 
Kkaufman 1970), although the genes and regulatory mechanisms responsible are only 
just beginning to be elucidated.  
A. Muscle Derived Growth Factors  
Changes in the availability of muscle derived growth factors appears to be a central 
regulatory process in muscle hypertrophy. These factors are produced locally within 
the muscle and act both in an autocrine and paracrine fashion. Muscle contraction or 
damage activates signal transduction pathways, ultimately stimulating the production 
of these growth factors most likely via increased transcription. In vitro, numerous 
growth factors have been implicated in muscle proliferation and differentiation 
including members of the FGF and TGF-β families, IGF-1, and HGF. However, 
physiological functions in vivo have only been described for relatively few of these 
factors, most notably IGF-1 and myostatin. 
1. IGF-1/MGF 
The role of IGF-1 in regulating growth and development in many tissues is widely 
acknowledged. More recently, the autocrine/paracrine regulation of IGF-1 within 
muscle tissue has become apparent with numerous studies identifying increased 
production and release of this factor following exercise or overload (Adams et al. 
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1999; Bamman et al. 2001; Psilander et al. 2003). Moreover, an alternate splice 
variant of IGF-1, called mechano-growth factor (MGF) or IGF-IEc, has been identified 
as being expressed exclusively in muscle in response to contraction or stretch (Yang 
et al. 1996; McKoy et al. 1999; Owino et al. 2001; Bickel et al. 2003; Hameed et al. 
2003). Whilst the mechanisms by which IGF-1 and MGF promote muscle hypertrophy 
are not entirely clear, it is evident that they act by signalling to both satellite cells 
(promoting both proliferation and differentiation) and the mature myofibre (activating 
signalling pathways and ultimately increasing protein synthesis).  
 1. Myostatin 
Myostatin (growth/differentiation factor 8), a member of the TGB-β family (McPherron 
et al. 1997) is a powerful endogenous negative regulator of muscle hypertrophy 
(Sharma et al. 2001). Myostatin is synthesised and secreted as an inactive complex of 
the N-terminus propeptide and active C-terminus. The latent form of myostatin 
circulates bound to and inhibited by follistatin. Mature myostatin exerts its effects via 
interaction with the activin/TGF-β ActIIb receptor and subsequent activation of the 
Smad family to control gene transcription (Rebbapragada et al. 2003; Rios et al. 
2004). Further studies have confirmed that myostatin signals satellite cell quiescence 
by up-regulating p21 thus reducing the differentiation potential of satellite cells, and 
subsequent capacity for hypertrophy (Carlson et al. 1999; Joulia et al. 2003). Mice, 
cattle and humans with inactive or absent myostatin proteins exhibit a gross 
hypermuscular phenotype (Grobet et al. 1997; Kambadur et al. 1997; McPherron and 
Lee 1997; Schuelke et al. 2004). Furthermore, reductions in circulating myostatin 
(Walker et al. 2004), and myostatin gene expression (Roth et al. 2003) have been 
observed following resistance exercise training in humans. Collectively, these studies 
suggest a model in which myostatin expression is responsive to muscle loading and 
plays a key role in regulating muscles adaptation to this increased load.  
1. HGF & FGFs 
Both HGF and FGF family members have been described as potent regulators of 
satellite cell activity (Allen et al. 1995b; Bischoff 1997; Sheehan and Allen 1999; 
Yablonka-Reuveni et al. 1999), however the importance of their expression in vivo 
during muscle overload is not well understood. To date only one study has 
investigated the expression of these growth factors following increased muscle 
loading. FGF family members, and HGF mRNAs were increased following 
compensatory overload of rat plantaris muscle, suggesting prominent roles in the early 
proliferative response of satellite cells during muscle adaptation (Sheehan and Allen 
1999). 
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B. Expression of structural/contractile/enzymatic genes   
Resistance or strength exercise, characterised by ‘low repetition, high load’ muscular 
contractions, induces specific and distinct structural and functional modifications in 
muscle fibres. Increases in structural and contractile proteins (e.g. desmin, troponin I) 
as well as muscle specific enzymes (e.g. muscle creatine kinase) are necessary for 
muscle to hypertrophy and remain functional. Numerous studies have observed 
increased structural, contractile and enzymatic gene expression following acute and 
chronic resistance exercise in humans as well as overload models of hypertrophy in 
animals. Both acute (1 session) and chronic (12 weeks) heavy resistance exercise 
results in an increased expression of  myosin heavy chain isoforms, type I, type IIa 
and type IIx (Willoughby and Rosene 2001; Willoughby and Nelson 2002). In rats, 
compensatory overload has been associated with increased expressions of β-tubulin, 
cardiac troponin T and atrial myosin light chain 1 (Carson et al. 2002). Similarly, 
increased desmin and creatine kinase expression has been observed during quail 
muscle hypertrophy (Lowe et al. 1998).  
C. Myogenic Regulatory Factors 
The altered contractile characteristics and increased myofibre size is a generally 
excepted adaptation of skeletal muscle to increased loading. Importantly, research is 
beginning to elucidate the molecular mechanisms required for these cellular 
adaptations. The MRFs are likely candidates as regulators of this process considering 
the importance of their expression during myogenesis, and because of their regulation 
of the transcription of muscle specific genes including α-actin (Muscat et al. 1992), 
desmin (Li and Capetanaki 1994), nicotinic Ach receptor (Piette et al. 1990), muscle 
creatine kinase (Lassar et al. 1994), troponin I (Lin et al. 1991) and myosin light chain 
(Wentworth et al. 1991). Load mediated increases in the expression of the MRFs have 
been observed in animals models of hypertrophy (Carson and Booth 1998; Lowe et al. 
1998; Lowe and Alway 1999; Adams et al. 2002; Carson et al. 2002; Haddad and 
Adams 2002). Similarly, alterations in MRF expression patterns have been 
demonstrated in response to resistance exercise training (Willoughby and Rosene 
2003) as well as acute resistance exercise bouts (Willoughby and Nelson 2002; Bickel 
et al. 2003; Psilander et al. 2003; Bamman et al. 2004; Bickel et al. 2004). Importantly, 
the exact roles the MRFs play in mature muscle adaptation are yet to be established. 
Whilst their temporal patterns of expression and driving roles in myogenesis have 
been well described in vitro, it is yet to be determined whether these expression 
patterns and functions are mimicked in vivo. Equally, the relative contributions of the 
 17
MRFs to adaptation within the mature myofibre compared with their roles in satellite 
cell activity are yet to be fully characterised.  
IV. PERSPECTIVES 
Much progress has been made in recent years into understanding the molecular 
mechanisms by which skeletal muscle adapts to changes in physiological stimuli. 
Substantial information about the interrelationships between signalling pathways and 
the impact on transcriptional and translational processes has been accrued. Similarly, 
the importance of satellite cells and their mechanisms of action during skeletal muscle 
hypertrophy and remodelling are being established. Nevertheless, there are 
considerable gaps in our understanding. We still have no clear idea of the 
commonality of, or indeed distinct nature of the pathways governing satellite cell 
activity versus pathways necessary for mature myofibre adaptation. The common 
thread in all of these processes is that they rely on transcriptional reprogramming. 
Importantly, only a handful of genes have been isolated to date that have been shown 
to be uniquely responsive to resistance exercise and increased loading. The recent 
advancement in molecular biological techniques, particularly the use of high-
throughput transcriptional profiling should enable the identification of previously 
unknown molecules. Similarly, the use of more sophisticated in vitro tools such as 
human primary skeletal muscle cell cultures provide a more physiologically revellent 
model to examine novel gene expression and function. 
A. cDNA Microarray Technology in Studies of Skeletal Muscle 
The complete identification of coding sequences in the human genome and advances 
in molecular biology have preceded the development of methods such as cDNA 
microarrays which allow the investigation of the transcriptional activity of thousands of 
genes or indeed the entire transcriptome simultaneously. cDNA microarrays can be 
used to compare the gene expression in two different cell types or tissue samples for 
example cancerous versus normal tissue. They can also be used to examine changes 
in transcriptional activity over time and following any number of potential interventions. 
  
The use of microarray technology on human skeletal muscle samples following 
different exercise paradigms provides a new and exciting avenue for investigation. 
Microarrays have been used to characterise gene expression patterns in skeletal 
muscle in a variety of contexts including atrophy (Gomes et al. 2001; Jagoe et al. 
2002; Lecker et al. 2004), treatment with thyroid hormone (Clement et al. 2002), 
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during a  hyperinsulinemic clamp (Rome et al. 2003), in disease states such as 
diabetes (Yang et al. 2002; Hansen et al. 2004) and muscular dystrophy (Chen et al. 
2000; Bakay et al. 2002; Noguchi et al. 2003),  as well as the comparison of fast 
versus slow muscle tissue (Campbell et al. 2001).  
 
The complex nature of the molecular processes regulating skeletal muscle 
development, adaptation and regeneration make it an ideal candidate for the 
development of a tissue specific microarray. Microarray analysis has also been used 
to examine the transcriptional response of skeletal muscle to various exercise 
interventions. Barash (Barash et al. 2003) observed the up-regulation of 36 known 
genes in eccentric exercised mouse muscle compared to contralateral and 
isometrically exercised controls. Similarly, Carson (Carson et al. 2002) used 
microarray analysis to identify 112 mRNAs differentially expressed in overload versus 
control rat muscle. To date, only three studies have employed microarray technology 
to examine global gene expression in skeletal muscle following exercise interventions. 
Roth (Roth et al. 2002) studied the role of age, sex and strength training on human 
muscle gene expression with 69 genes identified as differentially regulated by strength 
training, 200 genes differentially expressed between the sexes and 50 genes 
differentially expressed in relation to age. Zambon (Zambon et al. 2003) used 
microarrays to determine the effects of resistance exercise on gene regulation in 
biopsy samples of human quadriceps muscle obtained 6 and 18 hours after an acute 
bout of isotonic exercise with one leg. Diurnal gene regulation was also profiled at the 
same time points in the non-exercised leg. The results suggested that resistance 
exercise may directly modulate circadian rhythms in human skeletal muscle. Finally, 
Chen and colleagues (Chen et al. 2003) examined the effect of eccentric exercise on 
gene expression in human skeletal muscle Volunteers performed 300 concentric 
contractions with one leg and 300 eccentric contractions with the opposite leg. 
Pronounced increases in inflammatory and vascular remodelling gene responses were 
observed following eccentric exercise.  
 
B. Primary Human Skeletal Muscle Cell Culture 
Both primary skeletal muscle cell cultures and established muscle cell lines have 
become important tools as model systems for skeletal muscle development. The 
dividing myoblasts provided by these systems provide great flexibility in studies of 
myogenesis as cultures are readily manipulated allowing the examination of distinct 
aspects of muscle development. Although many studies have been carried out on the 
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growth and differentiation of muscle cells, the vast majority use immortalised rat and 
mouse muscle cell lines. Considerable differences exist however, in the expression 
profiles (James et al. 1993; McCusker and Clemmons 1998; Crown et al. 2000), and 
physiological responses of these cell culture systems (Florini et al. 1991; Foulstone et 
al. 2003). Human primary skeletal muscle cell cultures are a more physiologically 
relevant in vitro model of adult skeletal muscle because the cells retain the 
characteristics of the donor. For example, cells cultured from type 2 diabetic patients 
retain their characteristic insulin resistant skeletal muscle phenotype (reduced insulin-
stimulated glucose uptake and glycogen synthesis) (Henry et al. 1995; Henry et al. 
1996). Human primary skeletal muscle cultures have been used previously to examine 
the mechanisms of type 2 diabetes (Henry et al. 1995; Henry et al. 1996; Hansen et 
al. 2004), myoblast differentiation (Chazaud et al. 1998; Konig et al. 2004), the effect 
of IGF-1 treatment  (Crown et al. 2000; Foulstone et al. 2003), mechanisms of 
muscular dystrophy (Merickel et al. 1981), and susceptibility to malignant 
hyperthermia (Girard et al. 2002).  
 
Despite the complexity of the mechanisms governing skeletal muscle hypertrophy, 
advances in powerful molecular biological tools should begin to provide considerable 
insights into the regulation of this process, ultimately paving the way for the 
development of interventions and treatments for the myriad of diseases affecting 
skeletal muscle.  
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V. AIMS 
The broad aims of the thesis are to examine the molecular regulation of skeletal 
muscle hypertrophy with a focus on the identification of novel genes involved in this 
process. This series of studies is critical to further elucidate the transcriptional events 
that contribute to the development of skeletal muscle hypertrophy.  
 
The specific aims of this thesis are: 
 
• To develop and test a human skeletal muscle specific cDNA microarray for 
global transcriptional profiling and the identification of novel gene transcripts. 
 
• To further enhance current understanding of the process of myogenesis by 
examining the expression profile of rhabdomyosarcoma cells undergoing forced 
differentiation using the human skeletal muscle specific microarray.  
 
• To further test the sensitivity and reliability of the microarray in identifying 
changes in gene expression in a biological system. Thus ensuring reliable and 
reproducible results would be attainable from the microarray in subsequent 
studies using less readily available human skeletal muscle samples.  
 
• To investigate the expression of myogenic and atrogenic genes in human 
skeletal muscle following an acute bout of resistance exercise. 
 
• To use the human skeletal muscle specific microarray to study the time-course 
of transcriptional changes and identify novel genes expressed following an 
acute bout of resistance exercise. 
 
• To use human primary skeletal muscle cell cultures o identify whether the 
expression of the novel genes were (1) activated at any time during 
proliferation, cell cycle arrest or differentiation or (2) activated by the additional 
mitogenic and myogenic stimulation provided by exogenous IGF-1 peptide 
supplementation.   
 
• To examine whether the novel genes are a unique response to resistance 
exercise or if they were responsive to skeletal muscle contraction or exercise in 
general.   
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VI. HYPOTHESES 
It is hypothesised that: 
 
• cDNA microarray analysis of the transcriptional profile of differentiating 
rhabdomyosarcoma cells will result in the identification of novel differentially 
expressed genes. 
 
• An acute bout of resistance exercise will increase the expression of the MRFs 
and cell cycle regulators whilst reducing the expression of genes involved in 
skeletal muscle atrophy. 
 
• The transcriptional analysis of human skeletal muscle following an acute bout of 
resistance exercise using a human skeletal muscle specific cDNA microarray 
will identify novel differentially expressed genes. 
 
• The expression of ASB5, TXNIP, MLP, FLJ38973 and the MRFs will be altered 
during the differentiation of human skeletal muscle primary cell cultures. 
 
• The expression of ASB5, TXNIP, MLP, FLJ38973 and the MRFs will not be 
altered following an acute bout of resistance exercise. 
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CHAPTER TWO 
DEVELOPMENT AND VALIDATION OF A HUMAN 
SKELETAL MUSCLE SPECIFIC MICROARRAY 
I. INTRODUCTION 
New methods for the simultaneous assessment of the levels of expression of 
hundreds or thousands of mRNA levels in individual tissue samples are an attractive 
means by which biological processes can be studied. The analysis of gene transcript 
abundance is an important step in the determination of the functional roles of genes, 
how these genes and gene products interact as well as the comparison of gene 
expression patterns under different experimental conditions. Although mRNA is not 
the ultimate product of a gene, transcription is the first regulatory step in gene 
expression, and information about the mRNA levels is important for the understanding 
of gene regulatory networks.  
 
The ability to monitor global gene expression at the transcript level has become 
possible due to the advent of cDNA microarray technologies. The power of microarray 
lies in its ability to simultaneously estimate the comparative level of gene expression 
of a large number of genes (up to 20,000 per array) in a single sample. Microarrays 
have been developed that allow a high throughput and provide identity and expression 
of both selected known genes and cDNAs representing uncharacterised genes 
between numerous biological samples. 
 
Microarrays are constructed by “spotting” PCR-amplified cDNA clones at high density 
onto optically flat glass microscope slides in an orderly array (Hegde et al. 2000). RNA 
extracted from experimental samples can be fluorescently labelled and competitively 
hybridised to the microarray against a reference RNA sample, which is labelled with a 
different fluorophore (Figure 2.1).  
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Figure 2.1. Overview of microarray production and analysis. Initially cDNA clones are PCR amplified, 
purified and then spotted onto glass sides by microarray printing robots. RNA from samples of 
interest and a reference are extracted, reverse transcribed, and labelled with Cy3 (usually red) and 
Cy5 (usually green) fluorescent dyes. The two samples are then combined and competitively 
hybridised to the prepared microarray slides. Laser excitation of the incorporated fluorescent dyes 
yields an emission with a characteristic spectrum, which is measured using a scanning confocal laser 
microscope. Thus from the fluorescence intensities and colours from each spot, the relative 
expression of that particular RNA species in the experimental sample can be estimated. Laser 
excitation of the incorporated targets yields an emission with a characteristic spectrum which is 
measured using a scanning confocal laser microscope. Thus from the fluorescence intensities and 
colours for each spot, the relative expression level of that particular RNA species in the experimental 
sample can be estimated.  
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The complex nature of the molecular processes regulating skeletal muscle 
development, adaptation and regeneration make it an ideal candidate for the 
development of a tissue specific microarray. To this end we have created a 
customised microarray containing up to 11,000 uncharacterised cDNAs derived from a 
human skeletal muscle cDNA library as well as 270 genes with known functional roles 
in skeletal muscle. The genes chosen represent key regulatory steps in signal 
transduction pathways, various biochemical pathways including glycolysis and fatty 
acid oxidation, as well as a number of transcription factors, cytoskeletal and proteolytic 
proteins. The cDNA library used to construct the microarray was a human skeletal 
muscle 5’-STRETCH PLUS cDNA library. The mRNA source for this library was 
pooled from the quadriceps, iliopsoas and pectoralis major muscles from 8 male and 
female Caucasians, aged 29-60, who died following trauma. Furthermore, the cDNA 
library underwent extensive normalisation, a complex process where the cDNA copies 
of a primary library are equalized, so that each original mRNA transcript is 
represented in the normalized library to the same extent as all the rest of the clones. 
Subsequently, by increasing the frequency of occurrence of rare cDNAs whilst 
simultaneously decreasing the percentage of abundant genes, normalisation can 
expedite the discovery of novel transcripts. 
 
The extraction of reliable information from the massive amounts of data generated by 
microarrays however, is dependant on optimal study design, array fabrication, data 
acquisition, data quality and data analysis. There are many process variables that will 
impact on the quality of the data generated by microarray platforms. Thus the 
parameters required for the effective manufacture of cDNA microarrays with highly 
reproducible performance characteristics, the quality and quantity of sample mRNA’s 
used to create the dye-labelled cDNA probes and the effects of these optimised 
procedures on the overall performance, accuracy, and precision are needed to be 
extensively tested to guarantee the reliability of generated expression data.  
Therefore, the aims of this study were firstly to describe the fabrication of the 
microarray and secondly, evaluate the robustness and reproducibility of this analytical 
technique.  
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II. METHODS 
A. Microarray Fabrication 
cDNA clones corresponding to the 270 known skeletal muscle genes were purchased 
from Incyte Genomics (Palo Alto, CA). The clones were grown overnight and inserts 
were PCR amplified using vector specific primers. Products were visualized by 
agarose gel electrophoresis, then excised and sequence verified using a BigDye 
Terminator Cycle Sequencing Ready Reaction Kit (Applied Biosystems, Foster City, 
CA). For the gene discovery aspect of the microarray, the Human Skeletal Muscle 5'-
STRETCH PLUS cDNA Library was purchased from Clontech (Palo Alto, CA). The 
clones were grown overnight and picked by the Australian Genome Research Facility 
(Melbourne, Victoria, Australia) using a BioPick automated colony picker (BioRobotics 
Woburn, MA). The inserts were PCR amplified and the products visualized by agarose 
gel electrophoresis to confirm amplification of a single PCR product. Amplified cDNAs 
were then purified using an ArrayIT PCR Purification Kit (Telechem, Sunnyvale, CA) 
and resuspended in Spotting Solution Plus (Telechem) in preparation for arraying onto 
SuperAmine Microarray Substrates (TeleChem) using a ChipWriter Pro microarrayer 
(Virtek, Toronto, Canada). DNA adhesion to the glass was achieved by firstly baking 
the printed arrays for 1h at 80°C, followed by rehydration at 37°C and  irradiation in a 
Stratalinker® UV Crosslinker (Stratagene, La Jolla, CA) at an energy output of 60mJ. 
To minimise any potential non-specific probe interactions with the glass the 
microarrays were washed for 2 min in 0.2% SDS (Invitrogen), followed by three rinses 
in H2O for 2 minutes each with the last wash conducted at 95°C. They were washed 
again for 2 min in 0.2% SDS, and rinsed a further two times in H2O for 2 min each. 
Finally, the arrayed slides were dried by brief centrifugation and stored in opaque 
plastic slide boxes at room temperature. 
B. RNA Extraction 
The RNA used for the homotypic hybridisations was a commercially available human 
skeletal muscle RNA (Ambion, Austin, TX)  
 
RNA for the repeatability and reliability analysis was derived from differentiating 
rhabdomyosarcoma cells and formed part of a larger study (see chapter 3). Total RNA 
was extracted using the RNA-bee (Tel-Test, Friendswood, TX) reagent and purified 
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using RNeasy Columns (Qiagen, Mannhiem, Germany) as per the manufactures 
instructions (Qiagen 2001). Briefly, an appropriate volume of Trizol Reagent (Life 
Technologies, Invitrogen, Carlsbad, CA) was used to ensure complete cellular 
disruption and release of genetic material. Chloroform was added to the solution, 
thoroughly mixed, incubated on ice for 5 mins followed by centrifugation at 4°C for 15 
min. The upper aqueous layer was removed and mixed with an equal volume of 70% 
ethanol before being added to the RNeasy spin column. After washing the column, the 
RNA was eluted as described in the manufacture’s protocol. RNA quality and 
concentration was determined using the Agilent 2100 Bioanalyzer (Agilent 
Technologies, Inc., Palo Alto, CA). 
C. Indirect labelling of cDNA 
Fluorescently labelled cDNA was prepared from total RNA using an indirect labelling 
method. cDNA synthesis was performed in a 20µl reaction containing 5µg oligo-dT 
primer, 400U SuperscriptII (Invitrogen), 1X first strand buffer, 0.01M DTT, 0.5mM of 
each dATP, dCTP and dGTP, 0.150mM dTTP (Amersham, Buckinghamshire, UK) and 
0.2mM aminoallyl-dUTP (Sigma, St Louis, MO). Synthesis was conducted in a 
GeneAmp PCR System 9700 (Applied Biosystems) at 42°C for 2 h. The reaction was 
stopped by addition of 5µl of 0.5M EDTA and RNA was hydrolysed by addition of 20µl 
of 1M NaOH at 70°C for 20 minutes. The reaction was neutralised with 25µl of 1M 
HEPES and the cDNA was purified using Qiaquick PCR purification kits (Qiagen) 
according to manufacturer’s instructions and eluted in nuclease-free water. The cDNA 
was concentrated using Microcon30 spin columns (Millipore, Bedford, MA). Following 
the addition of 0.09M sodium bicarbonate, the cDNA was coupled to Cy3 or Cy5 
monofunctional N-hydroxysuccinimyl ester reactive dyes (Amersham). The coupling 
reaction was conducted in the dark for 1 h. 
 
The fluorescently labelled cDNA was purified using Qiaquick PCR purification kits 
(Qiagen), combined and added to 10µg Human Cot1 DNA (Invitrogen). The cDNAs 
were again concentrated to the required volume with Microcon30 spin columns 
(Millpore). The cDNA were hybridised in a 40µl volume, containing the labelled cDNA, 
5X SSC, 0.3% SDS, 4µg yeast tRNA, 8µg polydA, 2.5X Denhart’s solution. The cDNA 
was denatured at 98°C for 2 minutes and maintained at 60°C until required. 38µl of 
the hybridisation solution was applied to cover slips and then mounted onto the array 
slide. Hybridisation was conducted in humid hybridisation chambers in a hybridisation 
oven at 65°C for 16-20 hours.  
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D. Image Acquisition and Normalisation  
Fluorescent images of the microarrays were acquired using the GenePix 4000B laser 
scanner (Axon Instruments, Inc., Union City, CA) and the images processed using 
Genepix Pro 3 software (Axon Instruments). Data files were entered into Acuity 4.0 
software (Axon Instruments) where a global normalisation strategy was applied to 
normalise signal intensities across all arrays. Normalisation of signal intensities across 
all arrays is necessary in order to eliminate the effects of array-to-array variations in 
target preparation, hybridisation and scanning. 
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III. RESULTS & DISCUSSION 
A. Microarray Validation 
1. Quality of cDNA clones and Microarray Printing 
The manufacture of high quality, reproducible arrays with 10,000 or more unique PCR 
products is an expensive and time consuming process. It requires considerable 
attention to the details and necessary procedures in each step to ensure the quality 
and reproducibility of the end product. Yue (Yue et al. 2001) state in their evaluation of 
the performance of cDNA arrays that low concentrations of DNA in the input printing 
solutions results in reduced amounts of arrayed DNA and this, in turn, reduces the 
dynamic signal range and produces an apparent underestimation of differential 
expression. Prior to being spotted onto optically flat microscope slides, the cDNA 
clones for both the known and discovery aspects of the microarray were PCR 
amplified, purified and visualised on agarose gels to verify amplification and presence 
of a single PCR product (Figure 2.2). Plates containing greater than 15% PCR failure 
or multiple products were not included in the array printing. Additionally, PCR products 
corresponding to the known genes were sequence verified as previous findings have 
identified incorrect sequences as a significant source of error (Knight 2001).  
 
Representative microarrays from each manufactured batch were stained for DNA 
using SYBRGold (Molecular Probes) and scanned on a GenePix 4000A scanner 
(Axon Instruments) at 535 nm. The resulting image (Figure 2.3) demonstrated a high 
degree of DNA retention on the surface of the array, good spot morphology and a 
uniform printing pattern. The median diameter of the features on the array was 100 
µm, with a preset spacing between the centres of adjacent features of 200 µm.  
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Figure 2.2. Representative agarose gel of amplified clones. PCR amplified cDNA 
clones were run on a 1% agarose gel to verify amplification and the presence of a 
single product. 
 
1kb Ladder 
No insert
Figure 2.3. A representative section of a SYBRGold stained microarray slide. 
Representative microarrays from each manufactured batch were stained for DNA 
using SYBRGold. The resulting image demonstrated a high degree of DNA 
retention on the surface of the array, good spot morphology and a uniform 
printing pattern. 
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2. Homotypic Response 
An estimate of the accuracy and precision of microarray expression data was first 
made by performing a homotypic hybridisation. A competitive hybridisation of 
fluorescently labelled Cy3 and Cy5 cDNA, both prepared from the same mRNA, 
should theoretically give a ratio of 1 (i.e. Cy3 fluorescence divided by Cy5 
fluorescence). Replicate hybridisations provide valuable information on the overall 
precision of the data by examining any deviations from the theoretical value (Yue et al. 
2001). 
 
Twenty µg of human skeletal muscle RNA was coupled to both Cy3 and Cy5 
fluorophores and competitively hybridised to the skeletal muscle microarray. Figure 
2.4 shows a false colour image of the hybridised microarray (A) with one 20 × 20 grid 
enlarged (B). Typically, an array composed of disparate RNA samples, each labelled 
with a different fluorophore, will exhibit varying degrees of expression typically 
represented as red and green spots on an array. Elements showing no difference in 
expression between the two samples are represented by yellow spots. As expected, a 
homotypic hybridisation such as the one shown in Figure 2.4 is composed almost 
exclusively of yellow spots.  
 
A scatter plot of the Cy3 versus Cy5 fluorescent response and a histogram of intensity 
ratios from the skeletal muscle/skeletal muscle hybridisation is shown in Figure 2.5. 
Virtually all gene elements lie close to the diagonal line corresponding to the 
theoretical differential expression ratio of 1 (Log ratio of 0, r2 = 0.99) The average 
calculated relative fluorescence ratios for all elements was 1.057 with the 99.5% 
confidence interval falling between 0.054 (lower bound) and 1.061 (upper bound). The 
average coefficient of variation for ‘differential expression’ of any element in this 
homotypic experiment is 11% over the entire signal range. These results demonstrate 
equal incorporation of Cy3 and Cy5 to the RNA and equal hybridisation to the 
microarray. 
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Figure 2.4. A false colour image of 
the muscle:muscle hybridisation (A)
and an enlarged view of a single 20 
× 20 grid (B). The array consists of 
PCR-amplified random cDNA clones 
spotted onto a glass slide. Equal 
quantities of skeletal muscle RNA 
was labelled with Cy3 and Cy5 
fluorophores and competitively 
hybridised to the array. Yellow dots 
represent genes that show no 
difference in expression between 
the two sample RNAs. 
B
A
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Figure 2.5. Homotypic Hybridisations. (A) Scatter plot of the calibrated Cy5 
versus Cy3 fluorescence response from a skeletal muscle/skeletal muscle 
hybridisation. Virtually all gene elements lie close to the diagonal line 
corresponding to the theoretical differential expression ratio of 1. (B) Data points 
from the homotypic hybridisations were used to construct a histogram, which 
shows the distribution of gene elements around the expected log ratio of 0.0. 
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3. Repeatability and Reliability 
3.1 Within-array reproducibility 
To examine the spot to spot reproducibility and reliability within arrays, a total of 155 
genes printed in duplicate on each array were examined across 18 microarrays. The 
printing of replicate spots on the arrays allowed us to examine whether identical spots 
on the array produced comparable results. From the 18 arrays in this data set we 
calculated a coefficient of variation (CV) for each of the 155 duplicated genes. The 
average CV was observed to be 15% across the entire signal range, although there 
was slightly greater variation at low signal levels. Consequently, replicate genes 
showing large variation in expression were excluded from subsequent analysis.  
3.2 Between-array reproducibility 
To examine the influence on hybridisations conducted on different days, six identical 
hybridisations were performed: two performed on one day (repeat 1a and 1b), two 
performed one week later (repeat 2a and 2b) and two performed 4 weeks later (repeat 
3a and 3b). Skeletal muscle RNA was coupled to Cy3 dye and RNA extracted from 
differentiated rhabdomyosarcoma cells was coupled to Cy5 dye. Disparate samples 
were chosen for this analysis to examine the reproducibility and reliability of the data 
over a range of expression values. Following normalisation and log transformation, 
clustering methods were utilised to examine the similarity between the replicate 
hybridisations. Algorithms utilized in clustering result in genes or groups whose 
members resemble each other, and thus provide a convenient way to illustrate the 
data. In this context, hierarchical clustering was performed to examine how similar or 
different the overall arrays were across the six replicate hybridizations. Hierarchical 
clustering partitions the data into a tree, so that substances that are not grouped 
together on one branch of the tree are grouped together at a higher branch. 
Substances occur only once in the tree. The distance between clusters was 
determined by the distance between 'average neighbours'. Figure 2.6 shows the 
hierarchical clustering dendrogram of the six replicate hybridisations. Pearson’s 
Correlation Coefficient was used to examine the similarities between clusters. The 
replicate hybridisations conducted on the same days showed a very high degree of 
similarity (r2 = 0.97, 0.91 and 0.99 for replicates 1, 2, and 3 respectively) indicating a 
very high degree of reproducibility. Greater variance was observed between arrays 
conducted on different days, however the highly positive correlation (r2 =0.84) 
indicated very good overall precision and reproducibility for the microarray. 
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Figure 2.6. Hierarchical clustering dendrogram of six identical hybridisations, two 
conducted on one day (repeat 1a and 1b), two conducted one week later (repeat 
2a and 2b) and two conducted 4 weeks later. The closest correlations are 
indicated by low branches on the dendrogram. The overall high correlation (top 
branch on the dendrogram) across the six arrays indicated very good 
reproducibility of the microarray.  
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cDNA microarrays are a very attractive and powerful means of examining global gene 
expression. The extraction of reliable information from the massive amounts of data 
generated by microarrays however, is dependant on optimal study design, array 
fabrication, data acquisition, data quality and data analysis. An important first step in 
developing cDNA microarrays is the validation of the experimental and analytical 
techniques. It is critical to establish whether repeated hybridisations with identical RNA 
deliver comparable results before any attempt is made to quantitate biological 
variability. We have developed a skeletal muscle specific cDNA microarray from a 
normalised human skeletal muscle cDNA library which will allow expression analysis 
and identification of novel genes in a range of different experimental systems. The 
results presented demonstrate the robustness of the microarray in producing accurate 
and reliable data. 
 
  
 36 
CHAPTER THREE 
IDENTIFICATION OF NOVEL GENES IN 
DIFFERENTIATING RHABDOMYOSARCOMA 
CELLS 
I. INTRODUCTION 
Skeletal muscle differentiation is characterised by terminal withdrawal from the cell 
cycle, muscle-specific gene activation and subsequent fusion of myoblasts into 
multinucleated myotubes. It has been well documented that myogenic differentiation is 
under the control of a family of regulatory genes which belong to the basic helix-loop-
helix family of transcription factors, also referred to as the myogenic regulatory factors 
(MRFs). The MRFs encode a family of transcription factors comprising four members, 
MyoD, Myf5, myogenin and Myf6 (MRF4, herculin) that bind to specific consensus 
sites that are functionally important in the transcription of muscle-specific genes 
(Megeney and Rudnicki 1995; Yun and Wold 1996). These factors are characterised 
by the ability, upon transfection, to convert nonmyogenic cells to the muscle 
phenotype. Although these transcription factors play a major role in the myogenic 
differentiation process, it is becoming evident that although their activity is necessary, 
multiple signalling pathways are required to act in concert for the execution of the 
differentiation program of muscle cells (Puri and Sartorelli 2000; Wei and Paterson 
2001).  
 
Rhabdomyosarcoma (RMS) are highly aggressive, malignant soft tissue sarcomas 
that primarily affect children and young adults. These tumours resemble primitive 
skeletal muscle-forming cells in appearance, suggesting that RMS may arise as a 
consequence of regulatory disruption of the growth and differentiation of skeletal 
muscle progenitor cells. Normal myogenesis is characterised by the expression of the 
MRFs (MyoD and Myf5 and then myogenin and Myf6), followed by the differentiation 
of myoblasts and formation of multinucleated myotubes. RMS cells however, are 
blocked on their way to terminal muscle differentiation. Paradoxically, this abortive 
myogenic differentiation occurs despite the expression of the MRFs, MyoD and 
myogenin, (Aguanno et al. 1990; Bouche et al. 1993). Most RMS cell lines of human 
and animal origin retain the ability to differentiate despite limited differentiation in vivo. 
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Treatment of RMS cells with phorbol esters such as 12-O-tetradecanoylphorbol-13-
acetate (TPA) has been widely shown to induce growth arrest and myogenic 
differentiation, without affecting the expression of the myogenic transcription factors 
(Garvin et al. 1986; Mayer et al. 1988; Aguanno et al. 1990; Lollini et al. 1991; Bouche 
et al. 1993; Bouche et al. 1995; Bouche et al. 2000). Suggesting that the differentiation 
arrest is due to mechanisms that interfere with the MRFs; downstream of their 
expression (Bouche et al. 1995). However, the precise molecular mechanisms 
responsible for the disruption of the myogenic characteristics of RMS is not well 
understood.  
 
The genetic regulation of RMS tumours is of great interest as the differentiation 
potential strongly influences metastic ability and therefore prognosis of these tumours 
(Lollini et al. 1991). Furthermore, the aberrant myogenic differentiation program in 
RMS tumours provides a unique model for the identification of genes with previously 
unidentified roles in myogenesis. An extensive body of work has demonstrated the 
temporal and spatial roles of specific genes during myogenesis, however, limited 
knowledge exists about how broad the transcriptional control of this process may be or 
even which specific processes are the critical regulators of differentiation, 
determination and fusion of muscle cells. Given the complexity of myogenesis, clearly 
there are a host of genes, some known and some novel, involved in this process. 
Thus, identifying known molecules with unknown functions or novel molecules that 
play critical roles in the cascade of molecular events will help provide an essential 
foundation for our understanding of myogenesis.  
 
Because of the wide spectrum of genes likely to be involved in myogenesis, cDNA 
microarray technology is well suited for the examination of genes expressed at key 
time points during proliferation and differentiation. Microarray technology is a very 
valuable tool, not only for the simultaneous examination of thousands of genes but 
also in its ability to examine the expression of novel genes. The aims of this study 
were two-fold. In chapter 2, the development of a skeletal muscle specific cDNA was 
discussed. The first aim of this study was to further enhance current understanding of 
the process of myogenesis by examining the expression profile of rhabdomyosarcoma 
cells undergoing forced differentiation using the human skeletal muscle specific 
microarray. The second aim was to further test the sensitivity and reliability of the 
microarray in identifying changes in gene expression in a biological system. Thus 
ensuring reliable and reproducible results would be attainable from the microarray in 
subsequent studies using less readily available human skeletal muscle samples.  
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II. METHODS 
A. Cell culture 
The rhabdomyosarcoma cell line RD-A was a kind gift from Dr. Bruce Thorley at the 
Victorian Infectious Diseases Reference Laboratory (North Melbourne, Australia). The 
cells were maintained in high glucose Dulbecco’s Modified Eagle Medium (Gibco, 
Invitrogen Corporation, Carlsbad, CA) containing 10% foetal bovine serum (Gibco) in 
a humidified atmosphere of 5% CO2 in air at 37°C. 
B. Study Design  
RD-A cells were seeded at a density of 3000 cells/cm2 in complete medium on the day 
prior to experimentation. After 24 h the medium was replaced with fresh medium 
containing 2% horse serum (Gibco) to reduce proliferative factors. At the same time 
100nM of TPA (Sigma, St Louis, MO) in DMSO (Sigma) was added to the medium to 
induce differentiation. Cells were cultured for up to 10 days, with RNA and protein 
extracted for analysis at day 1, day 3, day 6, day 8 and day 10. The control condition 
for this experiment consisted of actively proliferating cells collected immediately before 
the addition of the differentiation medium. At least 3 independent replicate 
experiments were conducted. 
C. Microarray Fabrication 
The human skeletal muscle specific microarray was constructed as previously 
described. 
D. RNA extraction 
Total RNA was extracted using the RNA-bee (Tel-Test, Friendswood, TX) reagent and 
purified using RNeasy columns (Qiagen, Mannhiem, Germany) as per the 
manufacturer’s instructions (Qiagen 2001). Briefly, an appropriate volume of Trizol 
Reagent was used to ensure complete cellular disruption and release of genetic 
material. Chloroform was added to the solution, thoroughly mixed, incubated on ice for 
5 min followed by centrifugation at 4°C for 15 min. The upper aqueous layer was 
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removed and mixed with an equal volume of 70% ethanol before being added to the 
RNeasy spin column. After washing the column, the RNA was eluted as described in 
the manufacture’s protocol. RNA quality and concentration was determined using the 
RNA Nano 6000 kit (Agilent Technologies, Inc., Palo Alto, CA).on the Agilent 2100 
Bioanalyzer (Agilent Technologies).  
E. Indirect labelling of cDNA and hybridisation 
Fluorescently labelled cDNA was prepared from 40µg of total RNA using an indirect 
labelling method. The reference RNA for this study was pooled from both 
undifferentiated and differentiated rhabdomyosarcoma cells. Indirect labelling of the 
RNA and subsequent hybridisation was prepared as previously described. In all 
hybridisations, the reference RNA was labelled with Cy5 dye, whilst the experimental 
samples were labelled with Cy3 dye.  
F. Image Acquisition and Data Analysis  
Fluorescent images of the microarrays were acquired using the GenePix 4000B laser 
scanner (Axon Instruments, Inc., Union City, CA) and the images processed using 
GenePix Pro4 software (Axon Instruments). Data files were entered into Acuity 4.0 
software (Axon Instruments) for subsequent data analysis. The microarrays were 
normalized using a linear, ratio-based normalization strategy. The normalization factor 
was calculated from the average ratio of all features with expression ratios between 
0.1 and 10. Flagged spots and spots with less than 55% of feature pixels with 
intensities more than two standard deviations above the background pixel intensity 
were not retained for further analysis. Furthermore, genes had to be present in at least 
70% of arrays to be considered in the analysis. The elements and time-points were 
averaged across replicate experiments and then organized by hierarchical clustering 
with the Pearson correlation metric and average linkage clustering (Eisen et al. 1998). 
Paired t-tests were used to identify ten elements with the greatest evidence of 
differential expression during the differentiation process. 
G. Clone Identification 
Selected cDNA clones were grown overnight and plasmid isolation was conducted 
using the QIAprep Spin Miniprep Kit (Qiagen) according to the manufacturer’s 
instructions. Inserts were PCR amplified using vector specific primers. Products were 
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visualized by agarose gel electrophoresis then excised and the sequence was 
determined using a BigDye Terminator Cycle Sequencing Ready Reaction Kit (Applied 
Biosystems). The basic local alignment search tool (BLAST, 
http://www.ncbi.nlm.nih.gov/BLAST/) was used to compare the cDNA clone 
sequences with previously characterized genes (Altschul et al. 1990) 
H. Real-time PCR Analysis 
1. RNA Extraction 
Total RNA was extracted as previously described (Chapter 3, section II, part D). The 
RNA used for the real-time PCR analysis was derived from the same original stock 
used in the microarray analysis. 
2. Reverse Transcription 
Prior to reverse transcription, the diluted RNA was heated to 65° C for 10 mins, then 
quenched on ice for 5 mins. 1 µg of RNA was reverse transcribed to synthesise first 
strand cDNA using the AMV reverse transcriptase kit (A3500; Promega, Madison, WI). 
The RNA was added to a master mix containing a final concentration of 5 mM MgCl2, 
10 mM Tris-HCl (pH 8.8), 50 mM KCl, 1% Triton X-100, 1 mM of each dNTP, 20 U 
Recombinant Rnasin Ribonuclease Inhibitor (40 U/µl) and 1 µg oligo (dT)15 Primer 
per 1 µg RNA. Following the addition of 15 U AMV Reverse Transcriptase (20 U/µl) 
(Promega, Madison, WI), the mixture was incubated at 42° C for 60 mins, before the 
reaction was terminated by incubation at 99° C for 5 mins followed by 5 mins at 4° C 
using the PCR Express Thermal Cycler (Hybaid, Middlesex, UK). The cDNA was 
stored at -20° C for subsequent analysis. A reverse transcription (RT) negative was 
obtained by not adding any RNA to an aliquot of the RT mix. 
3. Primer Design 
To perform PCR, specific primers were designed for all genes using Primer Express 
software (Applied Biosystems, Foster City, CA) on sequences obtained from GenBank 
(see Table 3.1 for details). Where possible, primers were designed spanning intron-
exon boundaries to prevent amplification of the target region from any contaminating 
DNA. Sequence information, including the positions of intron-exon boundaries was 
obtained from the Ensemble Genome Project (www.ensembl.org) (Hubbard et al. 
2002). Primer specificity was confirmed using BLAST (www.ncbi.nlm.nih.gov/BLAST/). 
Primers were purchased from GeneWorks (Adelaide, SA, Australia). 
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4. Real-time PCR Reaction 
For the PCR step, reaction volumes of 20µl contained SYBR Green 1 Buffer (Applied 
Biosystems, Foster City, CA), forward and reverse primers (see Table 3.1) and cDNA 
template (diluted 1:40). All samples were run in duplicate. Real-time PCR was run for 
1 cycle (50ºC 2 min, 95ºC 10 min) followed by 40 cycles (95ºC 15 s, 60ºC 60 s) and 
fluorescence was measured after each of the repetitive cycles. A melting point 
dissociation curve generated by the instrument was used to confirm that only a single 
product was amplified. The expression of the gene of interest in a given sample was 
calculated by subtracting the CT of the target gene for a given sample, from the CT of 
the control sample. The relative expression of the gene of interest compared with 
control was then calculated using the expression 2-∆CT. 
5. PCR Efficiency 
For each gene, the PCR efficiency of the primer pairs was determined using a dilution 
series of cDNA input into the PCR reaction. Linear regression was used to analyse the 
response of CT vs. the logarithm of the cDNA concentration. Using the slopes of the 
lines, we calculated the efficiency (E) of the target amplification with the equation E = 
(10-1/slope)-1 (Lekanne Deprez et al. 2002). PCR efficiencies indicated a linear 
detection of the cDNA for all genes (Table 3.1).  
I. Western Blot Analysis 
Rhabdomyosarcoma cells were cultured as described above. Control cells and cells 
collected at day 1, day 3, day 6, day 8 and day 10 were resuspended in lysis buffer 
(50mM Tris, pH7.6, 250mM NaCl, 5mM EDTA, 0.1% IGEPAL, Complete Protease 
Inhibitor Cocktail (Sigma) and passed through a syringe. The cell extracts were 
centrifuged to pellet cell debris, supernatants removed and analysed for total protein 
(BCA protein assay kit, Pierce, Rockford, IL) (Langley et al. 2002). Equal amounts of 
denatured total proteins from each sample were separated by electrophoresis on 
either a 10% (myogenin) or 6% (total myosin heavy chain (MHC)) SDS-polyacrylamide 
gel and transferred to nitrocellulose membrane by electroblotting. Membranes were 
blocked for 2 h with 5% skim milk in Tris-buffered saline (50 mM Tris-HCl, 750 mM 
NaCl, 0.25% Tween), and were incubated overnight at 4°C with a polyclonal anti-MHC 
(MY-32, Zymed, San Francisco, CA) or anti-myogenin antibody (F5D, Developmental 
Studies Hybridoma Bank, University of Iowa). Membranes were washed (4 x 5 min), 
followed by a 60 min incubation with anti-rabbit IgG (MHC) or anti-mouse IgG 
(myogenin) conjugated to horse-radish peroxidase (1 in 10,000 dilution) (Santa Cruz 
Biotechnology, Santa Cruz, CA), then washed again. Immunoreactive bands were 
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detected using enhanced chemiluminescence (Western Lightning Chemiluminescent 
Reagent, Perkin-Elmer, Boston, MA). An internal control was used in each gel to 
normalize for variation in signal observed across the membranes. The density of the 
bands was analysed using Kodak 1D 3.5 image analysis software (Kodak Digital 
Science, Rochester, NY). 
 
J. Immunocytochemistry 
Myosin heavy chain expression was evaluated on cells grown on cover slips under the 
conditions described above. At different time points, the cells were fixed in cold 100% 
methanol at -20°C for 10min. Non-specific binding sites were blocked with 1% BSA in 
PBS followed by incubation in the primary antibody reactive to skeletal myosin heavy 
chain (MY-32, Zymed, San Francisco, CA). Subsequently, the cells were incubated 
with the fluorescent secondary antibody, anti-mouse AlexaFluor 488 (Molecular 
Probes, Oregon, USA). Nuclei were stained by incubating the cells in the DNA binding 
dye Bisbenzimide Hoechst 33285 (Sigma). Immunostained cells were visualised with 
an Olympus IX70 fluorescent microscope (Olympus, Australia) and digital images 
collected (Spot RT slider camera: Image-Pro® Plus Software).  
K. Statistical Analysis 
Statistical analysis was performed using GraphPad Prism 4.1 (GraphPad Software, 
San Diego, CA). Unless stated, means were compared using a one-way ANOVA (for 
normally distributed data) and any significant differences analysed using a Dunnet’s 
Multiple Comparison and using a Kruskal-Wallis test (for non-Gaussian distributions) 
and any significant differences analysed using a Dunn’s post test. Data is presented 
as mean ± standard error of the mean (SEM) unless otherwise stated. P<0.05 was 
considered statistically significant. 
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Table 3.1. Real-Time PCR Primer Details. 
 
Gene 
GenBank 
Accession 
Number 
Forward Primer (5’-3’) Conc, µM Reverse Primer (5’-3’) 
Conc, 
µM 
Exon 
Span 
Amplicon 
Size, bp 
PCR 
Efficiency 
CCT7 NM_006429 AGAGATTGCTGTGACCGTGAAG 2 CGGTCATGGCACACTTTTCC 2 4 & 5 74 0.8 
CKM NM_001824 GGCATCTGGCACAATGACAA 2 GATGACCCGGAGGTGATCCT 2 4 & 5 69 0.8 
MYF5         NM_005593 TTCTACGACGGCTCCTGCATA 2 CCACTCGCGGCACAAACT 2 --- 67 1.2
MYF6         NM_002469 CACCCTGCGCGAAAG 2 CACAGTTCGCCGCTTCAGT 2 --- 70 1.1
MYL1 NM_079420 TGCTGAACTCCGCCATGTT 2 CCATCAGGGCTTCCACTTCTT 2 4 & 5 71 0.9 
MYOD         NM_002478 CCGCCTGAGCAAAGTAAATGA 4 GCAACCGCTGGTTTGGATT 4 --- 74 1.0
myogenin NM_002479 GGTGCCCAGCGAATGC 2 TGATGCTGTCCACGATGGA 2 2 & 3 155 0.9 
PTMA NM_002823 CTCAGACGCAGCCGTAGACA 2 CTGCCTCTTCCACAACTTCCTT 2 1 & 2 80 0.9 
Tim10         NM_012456 TCCTCTCAGGGCCCAACAG 2 GTTGATCATATCGGCCATCATCTC 2 --- 64 0.9
 
Primer sequences were designed using Primer Express Version 2 software (Applied Biosystems) using sequences accessed through GenBank and checked for specificity using 
Nucleotide-Nucleotide Blast search (http://www.ncbi.nlm.gov/BLAST/). Exon information was obtained from the Ensembl Genome Database (http://www.ensembl.org/). The 
concentrations of forward and reverse primers are indicated along with the intron-exon divide the primers were designed around (if possible) and amplicon size in base pairs. PTMA, 
Prothymosin alpha; CCT7, chaperonin containing t polypeptide 1 eta; CKM, creatine kinase, muscle; MYL1, myosin, light polypeptide 1; Tim10, translocase of inner mitochondrial 
membrane 10 homolog;. 
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III. RESULTS 
A human skeletal muscle specific microarray was used to examine the gene 
expression of rhabdomyosarcoma cells undergoing a forced differentiation. TPA was 
used to induce growth arrest and myogenic differentiation of a derivative of the 
embryonal rhabdomyosarcoma cell line RD, RD-A. As expected, differentiation of the 
cells was accompanied by a significantly increased expression (p<0.01) of myosin 
heavy chain protein (Figure 3.1) and an increased appearance of some multinuclear, 
myotube-like structures (Figure 3.2).  
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Figure 3.1. Western blot analysis of MHC protein expression over 10 days of 
differentiation with TPA containing medium. A representative blot from one 
replicate experiment is shown above the histogram. The order of samples on the 
blot corresponds with the order of bars in the histogram below. The cell extracts 
were electrophoresed through a 6% SDS-polyacrylamide gel, transferred to 
nitrocellulose membranes and probed with the myosin antibody (MY-35). The 
arbitrary density of the bands was analysed using Kodak 1D 3.5 image analysis 
software and the average of three independent replicate experiments is 
presented. 
* Significantly different from control (p<0.05) 
** Significantly different from control (p<0.01) 
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igure 3.2. Immunofluorescence analysis of RMS cells over the 10 days of TPA 
B
C D
E F
A 
 
F
induced differentiation. Cells were reacted to the MHC antibody MY-35 (green). 
Nuclei were counterstained using the DNA binding dye Bisbenzimide Hoechst 
33285 (blue). (A), Control; (B), Day 1; (C), Day 3; (D), Day 6; (E), Day 8; (F), 
Day10. Bar represents 100µM. 
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The microarray used for the experiments was fabricated from a human skeletal 
muscle cDNA library and contained approximately 11,000 elements. Due to the 
marked differences in gene expression between normal human skeletal muscle and 
rhabdomyosarcoma tissue, hybridization of rhabdomyosarcoma RNA to the 
microarray resulted in only 4042 elements showing adequate expression levels 
following normalization. Using hierarchical clustering and paired t-tests, genes were 
grouped according to common patterns of expression over the time-course of 
differentiation (Figure 3.3). Analysis was focused on the identification of genes with 
evidence for either increased or decreased expression during the differentiation 
process. 105 elements demonstrated consistent up-regulation of expression 
throughout the differentiation in all three of the replicate experiments. Conversely, 190 
elements showed a reproducible reduction in expression. 
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Figure 3.3. Hierarchical clustering analysis of expression profiles. Hierarchical 
clustering was used to group genes based on their expression profiles. Each 
gene element is represented on the vertical axis, and the time points are shown 
on the horizontal axis. The expression ratios for each gene at each time point are 
colour coded: red indicates increased expression while green indicated reduced 
expression relative to the reference expression level. Two distinct clusters are 
evident, an up regulated pattern of expression (highlighted in blue) and a down 
regulated pattern of expression. The averages of three independent replicate 
experiments are presented. 
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Ten elements showing the greatest evidence of altered expression during 
differentiation were selected for sequencing and further analysis (Table 3.3). These 
ten elements were found to consist of seven genes that were differentially expressed 
during the differentiation of RMS cells. Muscle creatine kinase (CKM) and several 
cytoskeletal proteins including myosin light chain 1 (MLY1) and myosin light chain 2 
(MLY2) were markedly up-regulated during differentiation (Figure 3.4). In contrast 
prothymosin alpha (PTMA), chaperonin containing t-complex polypeptide 1, eta 
subunit (CCT7) and translocase of inner mitochondrial membrane 10 (Tim10) showed 
reduced expression during differentiation. 
 
 
 
Table 3.3. List of genes identified following clone sequencing. 
 
 
Up-Regulated Genes Down-Regulated Genes 
Clone ID Gene Clone ID Gene 
M15n5 Creatine kinase, muscle M17c4 Prothymosin, alpha 
M11a3 Creatine kinase, muscle M34l16 Translocase of inner mitochondrial membrane 10 
M12l14 Creatine kinase, muscle M07d22 
Chaperonin containing t-
complex polypeptide 1, eta 
subunit 
M52e6 
Myosin, light polypeptide 
2, regulatory, cardiac, 
slow 
  
M52f20 Myosin, light polypeptide 1, alkali; skeletal, fast   
M02i7 
Myosin, light polypeptide 
3, alkali; ventricular, 
skeletal, slow 
  
M06e16 Creatine kinase, muscle   
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Figure 3.4. Microarray expression profiles of 
selected differentially expressed genes. Each 
bar represents the mean ± SEM of three 
independent, replicate experiments.  
* Significantly different from control (p<0.05) 
** Significantly different from control (p<0.01) 
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To confirm the results of the microarray experiments, the changes in mRNA levels of 5 
genes were quantified using real-time RT-PCR (Figure 3.5). The changes measured 
by real-time PCR were very similar to that of the microarray with the exception of one 
gene, CCT7, whose expression was not changed over the time course of 
differentiation as measured by real-time PCR. CKM and MYL1 demonstrated a 
significant ~12-fold (p<0.01) and ~16-fold (p<0.01) increase in gene expression 
respectively following 3 days of differentiation which continued to increase after 6 days 
(although not significantly) and then slowly decreased. Tim10 mRNA tended to 
decrease during differentiation, but this did not reach statistical significance (p=0.09). 
PTMA expression was significantly reduced (p<0.01) following 3 days (2.5-fold), 6 
days (2.5 fold), 8 days (4.7 fold) and 10 days (5.4 fold) of TPA induced differentiation 
of rhabdomyosarcoma cells. 
 
Since the muscle regulatory factors are considered critical in the process of normal 
myogenic differentiation, we examined their expression over the time course of RMS 
differentiation. MyoD and Myf5 are expressed early on in the differentiation cascade, 
showing a significant reduction in expression at days 8 and 10 (MyoD, p=0.01) and 
days 6, 8 and 10 (Myf5, p<0.01) as shown in Figure 3.6. Myf6 (p=0.03) and myogenin 
(p=0.04) mRNA expression both increased in response to differentiation, however due 
to quite marked variability, the ~40-fold increase in Myf6 expression was only 
significant at day 6. Myogenin mRNA showed a marked (~6-fold) increase in 
expression which remained elevated above control at day 10. Again due to variability 
in expression, significant differences (p= 0.05) were only evident at day 8 (3 fold 
increase). Myogenin protein expression was not detectable in proliferating cells and 
increased maximally (p<0.01) at day 3 (Figure 3.6B).  
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Figure 3.5. Real-time PCR validation of the genes identified from the microarray 
analysis. Data is presented as arbitrary units normalized to the control value. Bars 
show the mean ± SEM of six replicate experiments.  
* Significantly different from control (p<0.05) 
** Significantly different from control (p<0.01) 
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Figure 3.6. Expression of the myogenic basic helix-loop-helix transcription factors. 
(A) mRNA expression of the MRFs over 10 days of differentiation. Data is presented as arbitrary 
units normalized to the control value. Bars show the mean ± SEM of six replicate experiments. 
(B) Western blot analysis of myogenin protein expression over 10 days of differentiation. A 
representative blot from one replicate experiment is shown above the histogram. The order of 
samples on the blot corresponds with the order of bars in the histogram below. The cell extracts 
were electrophoresed through a 12% SDS-polyacrylamide gel, transferred to nitrocellulose 
membranes and probed with the myogenin antibody (F5D). The average of three independent 
replicate experiments is presented. 
* Significantly different from control (p<0.05) 
** Significantly different from control (p<0.01) 
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IV. DISCUSSION 
Differentiation of skeletal muscle involves the withdrawal of myoblasts from the cell 
cycle and the subsequent expression of muscle-specific genes. We used an in vitro 
ter of genes which 
emonstrated marked up-regulation throughout the forced differentiation of the RMS 
 an acidic, nuclear protein which is highly conserved and ubiquitously 
xpressed in a wide variety of tissues. Despite the number of effects described for this 
protein, none are accepted as its physiological role and thus its function remains 
model of myogenesis and microarray technology to identify novel genes involved in 
time course of RMS proliferation arrest and progression towards terminal 
differentiation. RMS differentiation was induced by the addition of a phorbol ester and 
assessed by the appearance of myosin heavy chain, a widely used marker of 
differentiation. As expected, differentiation of the cells was accompanied by an 
increased expression of myosin heavy chain protein. Interestingly, the maximal rate of 
differentiation appeared evident following 6 days of treatment with TPA and 
subsequently declined. Aguanno (Aguanno et al. 1990) reported the presence of 
elongated and multinucleated myofibre-like structures in TPA-treated 
rhabdomyosarcoma cultures in addition to mononucleated and extremely elongated 
spindle cells, polygonal or star-shaped cells and small round cells. The small round 
cells were shown to rapidly proliferate and eventually reach confluence when the 
medium was replaced, even in the continued presence of TPA. The length of 
treatment in the present study necessitated the replacement of culture medium to 
maintain cell viability and is likely to have contributed to the increased percentage of 
mono-nucleated, undifferentiated cells observed and subsequent reduction in myosin 
heavy chain expression at 8 and 10 days post differentiation. Similarly, multinucleated 
cells may have detached during the extended culture times and possibly contributed to 
the reduction in myosin postive cells post 8 days of differentiation. 
 
Using microarray analysis of gene expression, we identified a clus
d
cells. In addition, a number of genes were dramatically reduced in their expression 
following differentiation. The majority of genes that showed increased expression were 
markers of terminal skeletal muscle differentiation such as myosin light chain, desmin 
and creatine kinase. Among the genes showing decreased expression were markers 
of cell proliferation, consistent with proliferation arrest, which is necessary for 
progression along the myogenic pathway. Of particular interest are two genes whose 
expression has not, to our knowledge, been investigated in RMS, including 
prothymosin alpha (PTMA), and translocase of inner mitochondrial membrane 10 
(Tim10). 
 
PTMA is
e
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elusive. Of its many reported functions, the relationship between PTMA and cellular 
proliferation and survival appears to be the mostly widely acknowledged. Expression 
of PTMA is generally correlated with cellular proliferation and its over-expression has 
been shown to stimulate cell division due to shortening of the G1 phase of the cell 
cycle (Wu et al. 1997b) as well as inhibit cell differentiation (Rodriguez et al. 1999). It 
was reported that terminal differentiation signals in HL-60 cells lead to a pronounced 
decrease in PTMA expression (Dosil et al. 1993), and a subsequent study confirmed 
that this decrease was related to the signal for the cessation of proliferation, rather 
than for the start of differentiation (Smith et al. 1993). Whilst PTMA appears to play a 
critical role in the process of proliferation and differentiation in a wide range of cells, 
the mechanism of action remains unclear. 
 
Due to its proliferative activity, PTMA has also been extensively studied in tumoral 
processes. PTMA expression is evident at higher concentrations in malignant tumours 
an normal or surrounding tissues (Tsitsiloni et al. 1993) and has been established as 
that 
cilitate importation through the outer (TOM translocase) and inner (TIM translocase) 
th
a marker for breast cancer (Dominguez et al. 1993; Tsitsilonis et al. 1998; Magdalena 
et al. 2000), hepatocarcinoma (Wu et al. 1997a) and lung cancer (Sasaki et al. 2001). 
Thus the possibility remains that PTMA might also be an effective marker of RMS, and 
as in the case of breast cancer, has the potential to be of prognostic value in 
determining metastatic capacity and also the risk of death (Tsitsilonis et al. 1998). 
 
Mitochondria import the vast majority of their proteins from the cytosol. To cope with 
the variety of these precursors, they have dedicated translocation machineries 
fa
membrane. The carrier import pathway also depends on the function of a soluble 70 
kDa complex made of Tim9 and Tim10 (the TIM10 complex). The passage of proteins 
across the intermembrane space is specifically mediated by the TIM10 complex which 
facilitates the transfer of carriers from the outer membrane to the outer surface of the 
inner membrane. This complex appears to be important as both the Tim9 and Tim10 
genes are essential in yeast (Koehler et al. 1998; Leuenberger et al. 1999; Tokatlidis 
and Schatz 1999). In the present study, the Tim10 mRNA expression was markedly 
reduced during differentiation of rhabdomyosarcoma cells. However, its role in this 
context is unclear. No studies have previously identified differential expression of the 
Tim10 gene in either the cell cycle or associated with tumoral processes. However, it 
remains a possibility that proliferation arrest may be associated with a reduced 
mitochondrial proliferation and therefore a reduced need for associated mitochondrial 
proteins. Regardless of the functions of this protein, the change in its expression is 
more likely to be a consequence of the differentiation stimulus, rather than as a critical 
regulator of the process.  
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In addition to the hypothesis generating approach of microarray, we also used a more 
informed approach to examine the expression of the myogenic regulatory factors 
RFs) during the time course of rhabdomyosarcoma differentiation. Previous studies 
te have examined the expression of all four of the basic 
elix-loop-helix factors over the time course of rhabdomyosarcoma differentiation. The 
ut also mapping the temporal pattern of their 
xpression throughout differentiation. These results again support the theory that the 
ray in detecting changes in gene expression in a biological system. The gene 
hanges observed over the differentiation time-course were appropriate and occurred 
(M
that have examined the MRF expression in rhabdomyosarcoma differentiation, have 
done so only at single time points (Bouche et al. 1993; Wasserman et al. 1996; Astolfi 
et al. 2001; Sirri et al. 2003) and did not observe any detectable level of Myf5 
expression (Bouche et al. 1993; Wasserman et al. 1996), contradicting the results 
presented here. It is possible however, due to its very limited expression, that the 
methodologies used in the previous studies were not sensitive enough to detect the 
lowly expressed transcript.  
 
Although the expression of the MRFs in rhabdomyosarcoma has been reported 
previously, no studies to da
h
expression of each of the MRFs observed reflects that previously described in normal 
myogenic differentiation (Megeney and Rudnicki 1995). MyoD and Myf5 were more 
highly expressed in proliferating cells and very early in the differentiated state, 
supporting their roles in the determination and/or maintenance of myogenic identity 
(Braun et al. 1992; Rudnicki et al. 1992), however their continued expression during 
myogenic differentiation may be required (Bergstrom and Tapscott 2001). Whereas, 
myogenin and Myf6 expression increased during differentiation, again consistent with 
their known roles in myogenic differentiation (Hasty et al. 1993; Sumariwalla and Klein 
2001) and fusion (Dedieu et al. 2002). 
 
The data presented here confirm and extend previous research by not only identifying 
the expression of the MRFs in RMS, b
e
suppression of differentiation in rhabdomyosarcoma cells is due to mechanisms that 
interfere with the activity of the MRFs, rather than with their expression (Bouche et al. 
1995). 
 
As a secondary aim, this study sought to test the sensitivity and reliability of the 
microar
c
in a chronologically appropriate manner. Furthermore, quantitative real-time PCR 
confirmed the results of the microarray thus ensuring confidence in the microarray as 
a robust, reliable and sensitive measure of global changes in gene expression.  
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The microarray data presented here identify new information related to the genetic 
regulation of myogenesis in differentiating human rhabdomyosarcoma cells. Our 
current understanding of the differentiation block evident in rhabdomyosarcomas 
however remains limited. We also examined the temporal pattern of MRF expression 
over the time-course rhabdomyosarcoma differentiation identifying a remarkably 
similar pattern of expression to that exhibited in normal myogenesis.  
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CHAPTER FOUR  
MYOGENIC AND ATROGENIC GENE EXPRESSION 
IN HUMAN SKELETAL MUSCLE FOLLOWING 
ACUTE RESISTANCE EXERCISE 
I. INTRODUCTION 
Skeletal muscle size is determined by the complex interplay between hypertrophic and 
atrophic stimuli ensuing remarkable adaptability to environmental challenges. Central 
to this adaptive process is the activation of satellite cells which are responsible for 
postnatal muscle growth. Increased loading, stretch, and muscular damage is 
accompanied by a myriad of growth signals that trigger normally mitotically quiescent 
satellite cells to re-enter the cell cycle and replicate (Rosenblatt et al. 1994; Kadi and 
Thornell 2000; Hill et al. 2003; Wozniak et al. 2003). The decision for the cell to divide 
occurs when a cell passes a restriction point late in the G1 phase of the cell cycle, 
after which it commits to the autonomous progression to divide. Critical to this G1 to S 
transition is the activity of a family of cyclin/cyclin-dependant kinases (Cdks) (eg. 
Cdk4, cyclin D1, cyclin E). Proliferation is also regulated by a number of Cdk-inhibitors 
(eg. p21cip, p27kip, p57kip), that inhibit the activity of the Cdks and thus promote cell 
cycle arrest and progression towards terminal differentiation.  
 
Whilst the activity of the Cdks and Cdk-inhibitors are important in the proliferative 
response in many cell types, the specification of the skeletal muscle phenotype is 
dependant on the activity of the basic-loop-helix family of MRFs. The MRFs comprise 
four members: MyoD, Myf5, myogenin and Myf6 (MRF4, Herculin) that bind to specific 
consensus sites that are functionally important in the transcription of muscle-specific 
genes. The critical role the MRFs play in muscle development (Braun et al. 1992; 
Rudnicki et al. 1992; Rudnicki et al. 1993; Ramakers et al. 2003) and their temporal 
expression during myogenic proliferation and differentiation has been extensively 
described (Montarras et al. 1991; Smith et al. 1994; Barjot et al. 1995). More recently, 
the role of the MRFs has been expanded to included the control of regenerating adult 
muscle (Cooper et al. 1999; Sakuma et al. 1999; Mendler et al. 2000; Launay et al. 
2001) as well as the adaptive response of skeletal muscle to hypertrophic stimuli 
(Lowe et al. 1998; Adams et al. 1999; Alway et al. 2001; Carson et al. 2002; Bickel et 
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al. 2003; Psilander et al. 2003; Willoughby and Rosene 2003; Bamman et al. 2004; 
Bickel et al. 2004).  
 
Since satellite cell regulation and specification of the muscle phenotype constitute 
critical components of skeletal muscle hypertrophy, several recent studies have begun 
to investigate the expression patterns of MRFs and cell cycle regulators in response to 
both acute resistance exercise (Haddad and Adams 2002; Willoughby and Nelson 
2002; Psilander et al. 2003; Bickel et al. 2004) and following resistance exercise 
training (Bamman et al. 2004) in human skeletal muscle. To our knowledge however, 
no study has systematically investigated the temporal expression of all members of 
the MRF family in conjunction with both stimulators and inhibitors of the satellite cell 
cycle in human skeletal muscle. Furthermore, it has yet to be established whether 
acute loading of muscle through resistance exercise is sufficient to activate the entire 
process of satellite cell activation and differentiation. Indeed, understanding of the 
coordinated regulation of the multiple signalling pathways and molecular responses 
currently recognized in hypertrophying skeletal muscle is limited. In the present study, 
the expression of markers of the cell cycle and MRFs following a single bout of 
resistance exercise was investigated.  
 
It has been established that many signalling pathways operate concurrently in skeletal 
muscle to elicit muscle adaptation. Although much interest has focused on the 
regulation of the anabolic response of skeletal muscle, the inhibition of the protein 
degradation pathways must also constitute an important part of the hypertrophy 
pathway. A secondary aim of the present study was to investigate the expression of 
recently identified down stream members of the protein degradation pathway following 
resistance exercise. It was hypothesised that a single bout of resistance exercise 
would increase the expression of members of the MRF and cell cycle regulator 
families whilst the expression of genes involved in skeletal muscle atrophy would be 
reduced. 
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II. METHODS 
A. Subjects 
Ten healthy male subjects volunteered to participate in this study. Informed written 
consent was obtained from each subject before participation in the study, after the 
nature, purpose and risks of the study were explained. Age, height and weight were 
on average 27.1 ± 2 years, 179.3 ± 1.6 cm, and 78.4 ± 2.7 kg (mean ± SEM). 
Concentric and eccentric maximal voluntary contraction of the quadriceps was 229.6 ± 
10 NM and 273.4 ± 9.5 NM, respectively. Exclusion criteria included resistance training 
within the past six months or previous history of a diagnosed condition or illness that 
would endanger the subjects during strenuous resistance exercise. All experimental 
procedures involved in this study were formally approved by the Deakin University 
Ethics Committee. 
B. Familiarisation 
 Each subject completed a familiarization session on a Cybex NORM dynamometer 
(Cybex International Inc. UK) to become familiar with the execution of the exercise. 
Isokinetic maximal voluntary contraction (MVC) strength was assessed during knee 
extension during the familiarization session. MVC was determined at 60°.sec-1 over 
five maximal leg extensions and the peak torque (Nm) for both concentric and 
eccentric contractions was recorded. Subjects were instructed to contract as hard as 
possible and were verbally encouraged throughout the test. Familiarization and 
strength testing was completed at least 7 days before the trial to prevent residual 
effects of the familiarization routine. 
C. Experimental Design 
Subjects arrived at the laboratory in the fasted state for a resting muscle biopsy. For 
the 24 h preceding, and the days of the trial, subjects were provided with and 
consumed a standard diet of 20% fat, 14% protein, 66% carbohydrate and abstained 
from alcohol, caffeine, tobacco and additional exercise. Macronutrient intake was 
assessed using FoodWorks 3.0 (Xyris Software, Australia). Following the resting 
biopsy, subjects completed an acute bout of concentric and eccentric isokinetic leg 
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extension exercise. All exercise was completed on the non-dominant limb using the 
Cybex NORM dynamometer at a constant speed of 60°.sec-1. Subjects completed 3 
sets of 12 repetitions of maximal singled-legged knee extension exercise with 2 
minutes rest between each set. The system provided visual graphical feedback for 
both subject and investigator. Subjects were instructed to contract as hard as possible 
and were verbally encouraged throughout each set. Further muscle samples from the 
recovering leg were obtained 30 min, 4h, and 24 h post exercise. 
D. Muscle Biopsy Procedure 
The vastus lateralis muscle of the non-dominant leg was sampled by percutaneous 
needle biopsy technique (Bergström 1962) modified to include suction (Evans et al. 
1982). Excised muscle tissue from each biopsy was immediately frozen and stored in 
liquid nitrogen for subsequent analysis. Sampling muscle by needle biopsy will 
inevitably damage tissue and stimulate muscle regeneration in the immediate area. To 
minimise the impact of muscle damage from previous biopsies site on the response of 
muscle to the exercise serial muscle biopsies were collected from separate incisions 
made at least 2cm from previous biopsy sites. Repeat biopsies have been shown 
previously to have a negliable effect on the MRF gene expression in human skeletal 
muscle (Psilander et al. 2003). Additionally, fibre type variability across the vastus 
lateralis muscle may impact on variations in gene expression observed. Care was 
taken to ensure that muscle biopsies were collected from a similar anatomical position 
for all subjects. Considerable inter-human variability evident in skeletal muscle gene 
expression precluded a comparison of intra-muscular variation with an untreated 
control population of subjects. 
E. Real-Time PCR Analysis 
1. RNA Extraction 
RNA was extracted from skeletal muscle samples (5-10mg) using the FastRNA™ Kit-
Green (BIO 101, Vista CA) protocol and reagents (Dana et al. 1995). RNA quality and 
concentration were determined by UV spectrometry. (Heλios, Unicam, Cambridge, 
U.K). RNA concentration was determined using the equation OD260 / 0.0625 µg/µl 
(Sambrook et al. 1989). RNA purity was determined by the equation OD260/OD280, 
with values required to be >1.7 to be accepted as non-contaminated. An aliquot of the 
RNA was stored at -80° C for subsequent reverse transcription. 
 61
2.  cDNA Synthesis 
cDNA synthesis was performed as described previously (Chapter 3, section II, part 
H.2) 
3. Primer Design 
Primer design was performed as previously described (Chapter 3, section II, part H.3) 
4. Real-time PCR Reaction 
Real-time PCR was performed using the GeneAmp® 5700 Sequence Detection 
System (Applied Biosystems, Foster City, CA). For the PCR step, reaction volumes of 
20µl contained SYBR Green 1 Buffer (Applied Biosystems), forward and reverse 
primers (see Table 4.1) and cDNA template (diluted 1:40). All samples were run in 
duplicate. Real-time PCR was run for 1 cycle (50ºC 2 min, 95ºC 10 min) followed by 
40 cycles (95ºC 15 s, 60ºC 60 s) and fluorescence was measured after each of the 
repetitive cycles. A melting point dissociation curve generated by the instrument was 
used to confirm that only a single product was amplified.  
5. PCR Efficiency 
RNA extracted from a single human muscle sample was used to examine the dynamic 
range of responses for a series of dilutions of cDNA generated from the RT step. 
Linear regression was used to analyse the response of CT vs. the logarithm of the 
cDNA concentration. Using the slopes of the lines, we calculated the efficiency (E) of 
target amplification with the equation E = (10-1/slope)– 1 (Table 4.1). 
6. PCR Analysis and Endogenous Control Selection 
Data was analysed using the comparative critical threshold (Ct) method where the 
amount of target normalised to the amount of the endogenous control is given by 2-∆Ct. 
β-actin has previously been identified as an appropriate endogenous control for 
resistance exercise studies (Mahoney et al. 2004) and as such was selected for the 
endogenous control for this study. The appropriateness of this gene as an 
endogenous control was confirmed by examining the 2-∆Ct normalised to control values 
(Figure 4.1). 
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Figure 4.1. Examination of the mRNA expression of the endogenous control β-
actin following an acute bout of resistance exercise. Statistical analysis revealed 
no change in the expression of this gene at any time point following the exercise 
intervention (p<0.05). Therefore, this was considered an appropriate endogenous 
control for this study.  
 
G. Statistical Analysis 
Statistical analysis was performed using GraphPad Prism 4.1 (GraphPad Software, 
San Diego, CA). Means were compared using a one-way ANOVA and any significant 
differences analysed using a Dunnet’s multiple comparison test. Data is presented as 
mean ± standard error of the mean (SEM). A probability level of <0.05 was adopted 
throughout to determine statistical significance unless otherwise stated. 
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Table 4.1. Real-Time PCR Primer Details. 
Gene 
GenBank 
Accession 
Number 
Forward Primer (5’ Æ 3’) Conc, µM Reverse Primer (5’ Æ 3’) 
Conc, 
µM 
Intron-
Exon 
Divide 
Amplicon 
Length 
PCR 
Efficiency 
Atrogin-1         NM_058229 CATCCTTATGTACACTGGTCCAAAGA 6 TCCGATACACCCACATGTTAATG 6 --- 74 0.8
β-Actin NM_001101        AAGCCACCCCACTTCTCTCTAA 2 AATGCTATCACCTCCCCTGTGT 2 --- 141 1.1
Cyclin D1 NM_053056 GCATGTTCGTGGCCTCTAAGA 2 CGGTGTAGATGCACAGCTTCTC 2 --- 69 1.2 
MuRF-1         NM_032588 GGCGTGGCTCTCATTCCTT 6 TCTCCAAGTTCTCCATGGGATT 6 --- 81 0.7
Myf5        NM_005593 TTCTACGACGGCTCCTGCATA 4 CCACTCGCGGCACAAACT 4 --- 67 1.2
Myf6        NM_002469 CACCCTGCGCGAAAG 2 CACAGTTCGCCGCTTCAGT 2 --- 70 1.1
MyoD         NM_002478 CCGCCTGAGCAAAGTAAATGA 4 GCAACCGCTGGTTTGGAT 4 --- 74 1.0
myogenin    NM_002479 GGTGCCCAGCGAATGC 2 TGATGCTGTCCACGATGGA 2 exon 2 & 3 155 0.9 
Myostatin    NM_005259 CCAGGAGAAGATGGGCTGAA 2 CAAGACCAAAATCCCTTCTGGAT 2 exon 2 & 3 82 0.8 
p21       NM_000389 GGCAGACCAGCATGACAGATTT 6 GGCGGATTAGGGCTTCCTCT 6 --- 73 0.9
p27       NM_004064 CGGTGGACCACGAAGAGTTAA 2 GGCTCGCCTCTTCCATGTC 2 --- 66 0.9
PCNA    NM_002592 CTAAAATGCGCCGGCAAT 2 GCTTCAAATACTAGCGCCAAGGT 2 exon 2 & 3 155 1.0 
 
Primer sequences were designed using Primer Express Version 2 software (Applied Biosystems) using sequences accessed through GenBank and checked for specificity using 
Nucleotide-Nucleotide Blast search (http://www.ncbi.nlm.gov/BLAST/). Exon information was obtained from the Ensembl Genome Database (http://www.ensembl.org/). The 
concentrations of forward and reverse primers are indicated along with the intron-exon divide the primers were designed around (if possible) and amplicon size in base pairs. 
MuRf-1, muscle ring finger protein 1; PCNA, proliferating cell nuclear antigen.
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III. RESULTS 
10 male subjects performed 3 sets of 12 maximal concentric and eccentric isokinetic 
exercises with 2 minutes rest between each set. Peak torque was 229.6 ± 10.1 Nm 
and 273.4 ± 9.5 Nm for the concentric and eccentric contractions respectively. To 
ensure that the subjects were contracting maximally over the three sets, both 
concentric and eccentric torque was recorded for each of the 12 contractions in all 
three sets. Figure 4.2 shows that there was no significant difference in either 
concentric or eccentric average torque over the three exercise sets. This indicates that 
the two minute rest between each set provided sufficient recovery to allow subjects to 
contract at or near maximal force throughout the exercise session. 
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Figure 4.2. Average concentric (white bars) and eccentric (black bars) torque 
across the three exercise sets. The data represented is the average of 12 
contractions from 10 subjects, ± SEM. 
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A. Cell Cycle Regulators 
The markers of cell proliferation, cyclin D1 and PCNA demonstrated no statistically 
significant change in their expression patterns however, the expression of both genes 
appeared to decrease somewhat, 30 min post exercise (Figure 4.3). p21, a Cdk 
inhibitor which blocks progression through the cell cycle, increased dramatically (8.5-
fold) at 4 hours and remained elevated (7.5-fold) at 24 hours post exercise (p<0.01). 
The expression of p27, however, another member of the Cdk inhibitor family, was not 
altered at any point following exercise. 
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Figure 4.3. The effects of a single of bout of heavy resistance exercise on the 
expression of cell cycle regulatory factors. Real-time PCR analysis was 
performed on Cyclin D1, PCNA, p21, and p27. Values are means ± SEM.  
**Significantly different from control (p<0.01) 
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B. Myogenic Regulatory Factors 
The single bout of resistance exercise induced a small but significant increase (1.8-
fold; p=0.01) in MyoD mRNA expression at 4 h although no change in the expression 
of Myf5 was observed (Figure 4.4). Myogenin mRNA expression increased 2-fold at 4 
hours following exercise (p<0.01) with no change in the expression of Myf6. 
 
 
Figure 4.4. The effects of a single of bout of heavy resistance exercise on the 
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expression of the Muscle Regulatory Factors. Real-time PCR analysis was 
performed on Myf5, MyoD, myogenin, and Myf6. Values are means ± SEM.  
*Significantly different from control (p<0.05) 
**Significantly different from control (p<0.01) 
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C. Myostatin 
In addition to examining the cell cycle regulators and MRFs, the expression of a 
powerful negative regulator of muscle growth, Myostatin, was investigated (Figure 
4.5). As expected, Myostatin showed a marked reduction in expression during the 
recovery from exercise with approximately a 2-fold reduction at 4 and 24 hours post 
exercise (p<0.01).  
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Figure 4.5. The effects of a single bout of heavy resistance exercise on the 
expression of myostatin mRNA. Values are means ± SEM. 
**Significantly different from control (p<0.01) 
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D. Protein Degradation Pathway 
 
Two ubiquitin ligases, atrogin-1 and muscle ring finger protein 1 (MuRF-1), whose 
expression is increases significantly during multiple models of muscle atrophy were 
also examined as potential negative regulators of muscle hypertrophy (Figure 4.6). 
Interestingly, MuRF-1 expression appeared to increase (2.4-fold) although not 
significantly (p=0.07) at 4 hours post exercise. Conversely, atrogin-1 expression 
appeared to decrease slightly at 4 hours post exercise, although again not 
significantly.  
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Figure 4.6. The effects of a single bout of heavy resistance exercise on the 
expression of atrogin-1 and MuRF-1 mRNA. Values are means ± SEM. No 
statistical significance was observed (p>0.05). 
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IV. DISCUSSION 
Whilst the central role that satellite cells play in skeletal muscle repair and adaptive 
hypertrophy has been well established, our understanding of the mechanisms 
necessary for, and regulating the satellite cell response is limited. In the present study, 
the aim was to investigate the expression of both activators and repressors of the cell 
cycle as well as the expression of critical drivers of the muscle phenotype, the MRFs, 
following a single bout of resistance exercise.  
A. Cell cycle regulators 
Crucial to the hypertrophic response is the progression of muscle precursor cells, or 
satellite cells through the cell cycle. Whilst it has been clearly established that satellite 
cells are activated in response to extensive damage to muscle cells (Vierck et al. 
2000) and following heavy resistance exercise training (Kadi and Thornell 2000), it 
remains unclear whether a single bout of resistance exercise is capable of stimulating 
the entire process of satellite cell activation and differentiation. Therefore the 
expression of two markers of cellular proliferation, PCNA (involved in DNA replication) 
and cyclin D1 was investigated. Somewhat surprisingly, neither PCNA nor cyclin D1 
expression increased following the resistance exercise bout. Whilst the expression of 
PCNA, to our knowledge, has not previously been investigated following resistance 
exercise, two previous studies (Haddad and Adams 2002; Bickel et al. 2004) found 
similar results for cyclin D following a single bout of resistance exercise. Interestingly, 
these studies demonstrated that two bouts of exercise seemed sufficient to elicit a 
significant increase in the expression of this gene. Collectively, these results seem to 
suggest that a single bout of resistance exercise is not sufficient to generate a 
measurable increase in the gene expressions of markers of satellite cell proliferation.  
 
Considering the lack of observed changes in markers of proliferation, it was surprising 
to observe a marked increase the Cdk inhibitor and mediator of cell cycle arrest, p21. 
Although a closely related Cdk-inhibitor family member, p27, showed no changes in 
expression following resistance exercise. In view of the very early induction of p21 
following the hypertrophic stimulus (4 hours), it seems unlikely that any activated and 
proliferating satellite cells (or indeed any other proliferating non-muscle cells) would 
have time to reach differentiation. 
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B. Myogenic Regulatory Factors 
The results of the present study demonstrated an up-regulation of MyoD and 
myogenin expression 4 hours following an acute bout of resistance exercise whilst no 
change in the expression of Myf5 and Myf6 was observed. These results support the 
results reported previously in human skeletal muscle following a single bout of 
resistance exercise (Willoughby and Nelson 2002; Bickel et al. 2003; Psilander et al. 
2003). However, the present study is the only study to date to examine the expression 
of all four members of the MRF family following a single bout of heavy resistance 
exercise.  
 
In addition to the up-regulation of muscle specific genes, the MRFs (in particular 
MyoD) interact with cell cycle regulators to promote cell cycle arrest and differentiation 
of myogenic cells. Previous studies have indicated that MyoD is capable of inducing 
the expression of p21 (Guo et al. 1995; Halevy et al. 1995; Parker et al. 1995) as well 
as the other Cdk inhibitors , p27 and p57 (Reynaud et al. 2000) during myogenesis. 
Although numerous studies have identified an up-regulation of p21 following 
resistance exercise (Carson et al. 2002; Bickel et al. 2003; Welle et al. 2004), its 
interaction with the MRFs in regulating this adaptive response has not been 
investigated. The results of the present study, with MyoD and p21 both up-regulated 4 
h post exercise might suggest cooperation between the Ckd inhibitors and MyoD in 
the differentiation signaling pathways in adult skeletal muscle. Similarly, myogenin 
mRNA expression, considered one of the earliest markers of differentiation and itself 
up-regulated by MyoD, was increased markedly at 4 h post exercise. As mentioned 
previously however, it seems highly unlikely that the observed increase in markers of 
satellite cell differentiation would be a result of satellite cell activation, proliferation, cell 
cycle arrest and differentiation within 4 hours of the exercise stimulus 
C. Possible Roles of p21, MyoD and Myogenin 
The most likely source of the increased expression of p21, myogenin and MyoD at 4 h 
post exercise is the mature myofibres. Previously, the expression of p21, MyoD and 
myogenin has been localized in mature myonuclei early after the initiation of an 
overload stimulus (Ishido et al. 2004b). However the function of these proteins in 
myonuclei of adult myofibres has not been elucidated. It has been clearly established 
that myogenin and MyoD regulate the expression of muscle specific genes such as 
CKM and MYL. Therefore, it is quiet likely that the increased expression of these 
mRNAs in the immediate recovery period following heavy resistance exercise is 
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contributing to the early repair and/or adaptive response of the myofibre such as 
increased expression of the contractile filaments and fibre-type transitions. In contrast, 
following the exercise stimulus satellite cells would become activated and then from 
approximately 24 h undergo DNA synthesis and cell division (proliferation). MyoD and 
Myogenin expression would subsequently increase from up to 3 days later regulating 
the differentiation, fusion and hypertrophic events (McGeachie and Grounds 1987).  
 
MyoD and p21 have also been considered as effectors of anti-apoptosis (Wang and 
Walsh 1996; Zhang et al. 1999; Ishido et al. 2004a). A number of studies have 
demonstrated that apoptosis can be induced in skeletal muscle during denervation, 
unloading and disease, suggesting that apoptosis may contribute to the loss of 
myonuclei and myofibre atrophy under these conditions (Allen et al. 1997; Allen et al. 
1999; Yoshimura and Harii 1999; Schmalbruch and Lewis 2000). Similarly, 
hypertrophic stimuli such as stretch may elicit apoptotic cell death (Cheng et al. 1995). 
p21 contributes to protection against apoptosis by dephosphorylating the 
retinoblastoma protein (Rb). Dephosphorylated Rb inhibits the activation of members 
of the E2F family of transcription factors, which are involved in the induction of 
apoptosis (Wang et al. 1997; Wang 1997). Furthermore, mice lacking the p21 gene fail 
to form myotubes and demonstrate increased apoptotic rates in myoblasts (Walsh 
1997; Zhang et al. 1999). Similarly, Rb deficient myotubes demonstrate increased 
rates of apoptosis (Zacksenhaus et al. 1996). Ishido (Ishido et al. 2004a) recently 
proposed that MyoD might contribute to protection against apoptosis by up-regulating 
the expression of p21 during denervation. A theory is proposed whereby MyoD up-
regulates the expression of p21 in myofibres early in the recovery from heavy 
resistance exercise to help protect against apoptotic cell death. 
D. Myostatin 
In addition to examining the expression of cell cycle regulatory factors and MRFs, we 
sought to examine the expression of a powerful negative regulator of skeletal muscle, 
myostatin. Myostatin (growth and differentiation factor 8) has demonstrated a 
remarkable capacity to regulate skeletal muscle growth such that animals exhibiting 
null mutations in the myostatin gene result in a dramatic hypermuscular phenotype 
(Grobet et al. 1997; Kambadur et al. 1997; McPherron et al. 1997; McPherron and Lee 
1997). Myostatin gene expression is suppressed in human muscle following 9 weeks 
of heavy resistance strength training, indicating that it is responsive to changes in the 
loading state of the muscle.  
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The results of the present study demonstrated that acute resistance exercise is indeed 
capable of a rapid and marked down-regulation of the myostatin gene. Myostatin 
appears to inhibit muscle hypertrophy via two independent pathways. Firstly, it inhibits 
the progression of myoblasts through the cell cycle via the up-regulation of p21 
(Thomas et al. 2000; McCroskery et al. 2003). Secondly, myostatin can also inhibit 
differentiation through the up-regulation of Smad3; Smad3 subsequently binds and 
represses the transcriptional activity of MyoD. As a result, the expression of several 
regulatory factors is reduced (myogenin, p21, Myf5, Rb), which results in improper cell 
cycle arrest and inhibition of myoblast differentiation (Allen and Boxhorn 1989; 
Langley et al. 2002; Rìos et al. 2002). Resistance exercise appears to regulate the 
transcriptional activity of myogenin such that its atrogenic effect is mitigated during 
recovery.  
E. Protein Degradation Pathway 
Several recent studies have indicated that muscle growth is not only reliant on 
anabolic processes but also on the suppression of protein breakdown (Sacheck et al. 
2004; Stitt et al. 2004). During atrophy, there is an increase in the amount of 
components of the ubiquitin-protein conjugates and increased transcription of 
components of the ubiquitin degradation pathway (Bodine et al. 2001a; Haddad et al. 
2003a; Haddad et al. 2003b). Two of the most sensitive markers of muscle atrophy 
are the mRNA expression of two muscle specific ubiquitin-ligases, atrogin-1 and 
muscle ring finger protein 1 (MuRF-1) (Sacheck et al. 2004). Rapid suppression of 
atrogin-1 and MuRF-1 mRNA has recently been demonstrated following a 
hypertrophic stimulus in vitro suggesting that inhibition of the protein degradation 
pathway is an important component of muscle growth (Sacheck et al. 2004).  
 
The significance of the inhibition of the protein degradation pathways in human 
skeletal muscle hypertrophy has not, to our knowledge, been investigated. 
Surprisingly, atrogin-1 expression demonstrated only a small non-significant reduction 
in expression, whilst MuRF-1 mRNA levels appeared to increase, although again not 
significantly. The lack of reduction in the expression of these genes observed in this 
study contrasts with previous in vitro work (Sacheck et al. 2004). The hypertrophic 
stimulus (IGF-1 stimulation of myogenic cells) employed by Sacheck et al. is likely to 
promote a greater hypertrophic response to that induced by a single bout of resistance 
exercise. Therefore a pronounced reduction in the expression of these genes might be 
observed following a more powerful, prolonged hypertrophic stimulus in vivo (e.g. 
resistance exercise training). 
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The activation and proliferation of satellite cells has been identified as a critical 
component of adaptive skeletal muscle hypertrophy. Despite recent advances in our 
understanding of the importance of satellite cells, many questions remain 
unanswered. The early induction of p21, MyoD and myogenin following resistance 
exercise likely preclude the involvement of satellite cells in the very early adaptive 
response to resistance exercise. Therefore, it is possible that the increased 
expression of these mRNAs in the immediate recovery period following heavy 
resistance exercise is contributing to the early repair and/or adaptive response of the 
myofibre.   
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CHAPTER FIVE 
IDENTIFICATION OF NOVEL GENES RESPONSIVE 
TO ACUTE RESISTANCE EXERCISE 
I. INTRODUCTION 
There is mounting evidence in support of the view that skeletal muscle hypertrophy 
results from the complex and coordinated interaction of numerous signalling 
pathways. Well characterised components integral to skeletal muscle adaptation 
include the IGF-1 mediated activation of the PI3K-Akt pathway, transcriptional activity 
of the members of the myogenic regulatory factors, numerous secreted peptide growth 
factors, and the regenerative potential of satellite cells. Whilst studies investigating 
isolated components or pathways have enhanced our current understanding of 
skeletal muscle hypertrophy, our knowledge of how all of these components react in 
concert to a common stimulus remains limited. Moreover, as it is estimated that 
approximately 40% of the 30,000 - 40,000 definitive genes in the human genome have 
undefined functions, it is likely that numerous genes integral in skeletal muscle 
hypertrophy are yet to be characterised (Blumenthal 2001). Receiving increasing 
focus has been the identification of novel genes that may play roles in the regulatory 
network through which muscle cells coordinate growth, adaptation and repair.  
 
Gene expression profiling technology permits the parallel assessment of expression 
levels of thousands of genes and may lead to a better understanding of the signalling 
pathways activated in skeletal muscle in response to a hypertrophic stimulus. A 
number of recent studies have all employed microarray technology to examine global 
gene expression in skeletal muscle following exercise. Carson (Carson et al. 2002) 
examined gene expression following synergist ablation-induced functional overload in 
rats whilst Chen (Chen et al. 2002) and Barash (Barash et al. 2003) examined the 
transcriptional response of muscle to eccentric contractions in rats and mice 
respectively. Jozsi (Jozsi et al. 2000) used filter arrays to examine both the influence 
of age and exercise on skeletal muscle expression profiles, Zambon (Zambon et al. 
2003) examined the effects of circadian rhythms and exercise on skeletal muscle gene 
expression and finally Chen (Chen et al. 2003) investigated the molecular response of 
human skeletal muscle to eccentric contractions. Whilst each study has provided 
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valuable progress towards the overall understanding of skeletal muscle adaptation to 
exercise, many questions remain unanswered. 
 
The primary purpose of the present study was to use microarray technology to study 
the transcriptional changes during the 24 hours following an acute bout of resistance 
exercise. Importantly, a time-course approach was chosen for this analysis in order to 
capture a more thorough picture of the molecular changes occurring at different times 
throughout the recovery period. Specifically the time-points selected provide a glimpse 
into the early responding and transient genes as well as genes with more prolonged or 
delayed responses to resistance exercise.  
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II. METHODS 
A. Subjects 
Ten healthy male subjects volunteered to participate in this study. Informed written 
consent was obtained from each subject before participation in the study, after the 
nature, purpose and risks of the study were explained. Age, height and weight were 
on average 27.1 ± 2 years, 179.3 ± 1.6 cm, and 78.4 ± 2.7 kg (means ± SE). 
Concentric and eccentric maximal voluntary contraction of the quadriceps was 229.6 ± 
10 Nm and 273.4 ± 9.5 Nm respectively. Exclusion criteria included resistance training 
within the past six months or previous history of a diagnosed condition or illness that 
would endanger the subjects during strenuous resistance exercise. All experimental 
procedures involved in this study were formally approved by the Deakin University 
Ethics Committee. 
B. Familiarisation 
 Familiarisation was conduced as described previously (Chapter 4, section II, part B). 
C. Experimental Design 
The experiment was conducted as described previously (Chapter 4, section II, part C). 
D. Muscle Biopsy Procedure 
The muscle biopsy was performed as previously described (Chapter 4, section II, part 
D). 
E. Microarray Production 
The skeletal muscle specific microarray was prepared as described previously 
(Chapter 2, section II, part A). 
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F. RNA Extraction 
Total RNA was extracted from skeletal muscle biopsy samples by a two-step 
procedure using Trizol Reagent followed by purification using RNeasy columns 
(Qiagen, Mannhiem, Germany) according to the manufactures instructions (Qiagen 
2001). Briefly, frozen muscle was homogenised using a rotor-stator homogenizer in an 
appropriate volume of Trizol. Chloroform was added to the solution, thoroughly mixed, 
incubated on ice for 5 mins followed by centrifugation at 4°C for 15 min. The upper 
aqueous layer was removed and mixed with an equal volume of 70% ethanol before 
being added to the RNeasy spin column. After washing the column, the RNA was 
eluted as described in the manufacture’s protocol. RNA quality and concentration was 
determined using the Agilent 2100 Bioanalyzer (Agilent Technologies, Inc., Palo Alto, 
CA) 
G. Indirect labelling of cDNA 
Fluorescently labelled cDNA was prepared from equal quantities of total RNA using an 
indirect labelling method as described previously (Chapter 2, section II, part C). The 
reference RNA used for this study was a commercially available human skeletal 
muscle RNA (Ambion, Austin, TX).  
H. Image Acquisition and Data Analysis 
Fluorescent images of the microarrays were acquired using the GenePix 4000B laser 
scanner (Axon Instruments, Inc., Union City, CA) and the images processed using 
Genepix Pro3 software (Axon Instuments). Data files were entered into Acuity 4.0 
software (Axon Instruments) where a global normalisation strategy was applied to 
normalise between arrays. Flagged spots and spots with less than 55% of feature 
pixels with intensities more than two standard deviations above the background pixel 
intensity were not retained for further analysis. Furthermore, genes had to be present 
in at least 70% of arrays to be considered in the analysis. Initially, self organising map 
clustering analysis was performed to provide an overall picture of the pattern of gene 
expression. Clustering is mainly applied to microarray data in order to reduce the 
dimensions of the data and to provide visualisations of the complex microarray 
experiment, but are also particularly useful if current knowledge of the transcriptional 
patterns of the biological system is limited (Hautaniemi et al. 2003). Importantly, once 
the data is grouped, the investigator needs to visually identify and interpret the results 
of the clustering. 
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Following clustering analysis, the expression of genes contained within individual 
clusters was examined more closely. Statistical analysis revealed genes 
demonstrating consistent and marked changes in each of the 10 subjects, over the 
time-course of recovery from exercise. Using the statistical analysis tools provided 
within the microarray analysis package Acuity 4.0, we calculated paired t-tests to 
explore the changes in each time-point compared to control. However in order to 
minimise the false discovery rate and lack of power for appropriate statistical analysis, 
we chose to confirm all discussed novel gene changes with quantitative real-time PCR 
and more stringent statistical analysis.  
I. Clone Identification 
Selected cDNA clones were grown overnight and plasmid isolation was conduction 
using the QIAprep Spin Miniprep Kit (Qiagen) according to the manufacturer’s 
instructions. Inserts were PCR amplified using 5’-amino modified vector specific 
primers. Products were visualized by agarose gel electrophoresis then excised and 
the sequence was determined using a BigDye Terminator Cycle Sequencing Ready 
Reaction Kit (Applied Biosystems). The resultant sequence was entered into BLAST 
(www.ncbi.nlm.nih.gov/BLAST/) to ascertain its homology to known gene sequences. 
J. Real-time PCR Analysis 
1. RNA Extraction 
RNA was extracted from skeletal muscle samples (5-10mg) as described previously 
(Chapter 4, section II, part E.1). 
2. cDNA Synthesis 
Reverse transcription was conduced as described previously (Chapter 3, section II, 
part H.2). 
3. Primer Design 
To perform PCR, specific primers were designed for all genes using Primer Express 
software (Applied Biosystems, Foster City, CA) as described previously (Chapter 3, 
section II, part H.3) See Table 5.1 for details.  
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4. Real-time PCR Reaction 
The real-time PCR reaction was conduced as previously described (Chapter 3, section 
II, part H.4). 
5. PCR Efficiency 
PCR efficiency was conducted as previously described (Chapter 3, section II, part 
H.5). See table 5.1 for details. 
6. PCR Analysis and Endogenous Control Selection 
PCR analysis and analysis of the endogenous control was conducted as previously 
described (Chapter 4, section II, part H.6). 
K. Statistical Analysis 
Statistical analysis was performed using GraphPad Prism 4.1 (GraphPad Software, 
San Diego, CA). Means were compared using a one-way ANOVA and any significant 
differences analysed using a Dunnet’s multiple comparison test. Data is presented as 
mean ± standard error of the mean (SEM). A probability level of <0.05 was adopted 
throughout to determine statistical significance unless otherwise stated. 
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Table 5.1. Real-Time PCR Primer Details. 
Gene 
GenBank 
Accession 
Number 
Forward Primer (5’ Æ 3’) Conc, µM Reverse Primer (5’ Æ 3’) 
Conc, 
µM 
Exon 
Divide 
Amplicon 
Length 
PCR 
Efficiency 
ASB5         AY057053 AAATGCAGTAACCTTAGACCATGTCA 2 ACATGCCACGTGATCTCCAA 2 --- 67 0.8
β-Actin NM_001101        AAGCCACCCCACTTCTCTCTAA 2 AATGCTATCACCTCCCCTGTGT 2 --- 141 1.1
FLJ38973         NM_153689 GAATGGTTGCAAGGGAGAAA 4 GCGTCATTTAGTGATGGTGGATAA 4 --- 87 1.1
MLP    NM_003476 TCAGTCTATGCTGCTGAGAAGGTT 2 GATGGCACAGCGGAAACAG 2  exon 4 & 5 72 0.8 
Myf5         NM_005593 TTCTACGACGGCTCCTGCATA 4 CCACTCGCGGCACAAACT 4 --- 67 1.2
Myf6         NM_002469 CACCCTGCGCGAAAG 2 CACAGTTCGCCGCTTCAGT 2 --- 70 1.1
MyoD         NM_002478 CCGCCTGAGCAAAGTAAATGA 4 GCAACCGCTGGTTTGGAT 4 --- 74 1.0
myogenin    NM_002479 GGTGCCCAGCGAATGC 2 TGATGCTGTCCACGATGGA 2  exon 2 & 3 155 0.9 
Myostatin    NM_005259 CCAGGAGAAGATGGGCTGAA 2 CAAGACCAAAATCCCTTCTGGAT 2 exon 2 & 3 82 0.8 
TTS2.2    XM_290535 CAGACGGCGAGAATGTCATTATAT 4 TGCAGACATTGGCCTGGA 4 exon 2 & 3 69 0.7 
TXNIP         NM_006472 AGATCAGGTCTAAGCAGAACA 4 TCAGATCTACCCAACTCATCTCAGA 4 --- 73 1.0
Primer sequences were designed using Primer Express Version 2 software (Applied Biosystems) using sequences accessed through GenBank and checked for specificity 
using Nucleotide-Nucleotide Blast search (http://www.ncbi.nlm.gov/BLAST/). Exon information was obtained from the Ensembl Genome Database (http://www.ensembl.org/). 
The concentrations of forward and reverse primers are indicated along with the intron-exon divide the primers were designed around (if possible) and amplicon size in base 
pairs. ASB5, ankyrin repeat and SOCs box-containing 5; MLP, muscle LIM protein; TXNIP, thioredoxin interacting protein; TTS2.2, transport secretion protein 2.2 
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III. RESULTS 
A. Microarray results 
Gene expression profiling analysis was performed using a customised human skeletal 
muscle cDNA microarray during the recovery from an acute bout of resistance 
exercise. Since the majority of the spots on the microarray were derived from a human 
skeletal muscle cDNA library, specifically designed for the analysis of gene expression 
in human skeletal muscle, it was not surprising to see that 7,229 elements out of the 
11,000 showed adequate expression levels, indicating a high degree of hybridisation 
to the array. Initially, self organising map clustering analysis was performed to provide 
an overall picture of the pattern of gene expression changes during the recovery from 
resistance exercise. Clustering in microarray experiments utilise algorithms that 
typically result in groups of genes whose member’s exhibit similar expression profiles. 
Thus clustering methods offer convenient ways to illustrate data. Figure 5.1 shows a 3 
× 2 self organising map whereby genes were grouped together based on similar 
patterns of expression. Cluster A contains genes showing a reduction in expression 
following resistance exercise, whilst clusters B and C contain genes with increased 
expression levels following exercise. Subsequently, the expression patterns in each of 
these clusters was examined more closely in order to isolate elements that  
demonstrated the most statistically significant and dramatic changes in expression 
and importantly, consistent patterns of expression across all subjects. 
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Figure 5.1. 3 × 2 self organising map representation of the patterns of gene expression observed following a single bout of endurance exercise. 
Subjects completed an acute bout of resistance exercise consisting of 3 sets of 12 repetitions of maximal leg extension. Biopsies were taken before 
exercise (pre), at 30 min, 4 h, and 24 h post exercise. Self organising map was used to group genes based on their expression profiles. Each gene 
element is represented vertically, and the time points are shown horizontally. The expression ratios for each gene at each time point are colour coded: 
red, increased expression compared to reference RNA; green reduced expression compared to reference RNA.  
The average results of ten subjects are presented. 
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1. Known skeletal muscle genes 
In addition to the unknown gene elements derived from the skeletal muscle cDNA 
library, 270 genes with known functional roles in skeletal muscle were selected for 
printing on to the microarray. Following hybridisation however, it appeared that only a 
fraction of the selected genes demonstrated adequate expression levels. The 
remainder of the known genes provided little or no expression data and were therefore 
unsuitable for further analysis. The reasons for the poor hybridisation levels in this 
subset of genes are unclear. The results of the remaining genes which demonstrated 
adequate expression must therefore be interpreted with a degree of caution. We 
identified 11 genes that demonstrated an increase in their mRNA expression following 
the acute bout of resistance exercise (Table 5.2). Whilst a further eight genes were 
identified as showing a reduction in expression following exercise (Table 5.3).  
 
Table 5.2.  List of genes with increased mRNA abundance in response to an acute 
bout of resistance exercise. The mRNA expression for each gene derived from the 
microarray analysis is presented as fold change from the resting (pre) value. 
FOLD CHANGE 
GENE NAME 
30 MINS 4 HOURS 24 HOURS 
Intracellular signalling    
CDC-like kinase 2 1.22 1.20 1.10 
Metabolism    
COX7c 1.24 1.38 1.12 
DLAT 1.50 -1.11 1.15 
GLUT4 -1.10 1.10 1.21 
PDK4 3.21 1.54 1.10 
Regulatory proteins    
Serpine1 2.03 1.81 2.29 
SNAP 29 -1.25 1.02 1.32 
Structural / contractile proteins    
Dystrophin 1.16 1.00 1.14 
Transcription    
PGC-1 1.00 1.34 1.08 
HSP27 1.43 1.51 1.56 
NFκB1 -1.14 1.27 1.32 
Abbreviations: COX7c, cytochrome c oxidase, subunits VIIc; DLAT, dihydrolipoamide S-
acetyltransferase;  PDK4, pyruvate dehydrogenase kinase, isoenzyme 4; SNAP 29, 
synaptosomal-associated protein, 29 kDa; PGC-1, peroxisome proliferators-activated 
receptor-gamma, coactivator 1; HSP27, heat shock 27-kDa protein; NFκB1, nuclear factor 
kappa-B, subunit 1 
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Table 5.3.  List of genes with decreased mRNA abundance in response to an acute 
bout of resistance exercise. The mRNA expression for each gene derived from the 
microarray analysis is presented as fold change from the resting (pre) value. 
FOLD CHANGE GENE NAME 
30 MINS 4 HOURS 24 HOURS 
Intracellular signalling    
PIK3R1 -1.43 -1.25 1.01 
STAT3 -1.52 -1.01 1.05 
Metabolism    
ATP5I -1.54 -1.04 -1.09 
Enolase 3 -1.10 -1.16 -1.28 
GOT2 -1.14 -1.22 -1.25 
UQCRC2 -1.49 -1.32 1.07 
Structural / contractile proteins    
Decorin -1.01 -1.19 -1.61 
α-actinin 1 -1.05 -1.19 -1.43 
Abbreviations: PIK3R1, phosphatidylinositol 3-kinase, regulatory 1; STAT3, signal 
transducer and activator of transcription 3; ATP5I, ATP synthase, H+ transporting, 
mitochondrial F0 complex, subunit E; GOT2, glutamate oxaloacetate transaminase, 
mitochondrial; UQCRC2, ubiquinol-cytochrome c reductase core protein II.  
 
 
2. Unknown cDNA clones 
 
Due to the nature of the array construction, all cDNAs spotted from the cDNA library 
are unknown until sequencing analysis is performed. As it is impractical to sequence 
all differentially expressed genes, a subset of these genes were selected for 
sequencing. Only genes showing consistent expression across the majority of the ten 
subjects, and showing the greatest statistically significant fold change from the control 
biopsy were selected for sequencing. In order to obtain a good cross section of both 
early and late responding genes, elements were selected that showed differential 
expression at each, but not necessarily all time-points. In total, 19 elements were 
sequenced, with 15 individual genes identified as shown in Table 5.4. 
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Table 5.4. List of genes identified using microarray analysis with increased mRNA 
abundance in response to an acute bout of resistance exercise. The mRNA 
expression for each gene derived from the microarray analysis is presented as fold 
change from the resting (pre) value. 
FOLD CHANGE 
GENE ID GENE NAME 
30 MINS 4 HOURS 24 HOURS 
M02e13 Crystallin, alpha B 1.32 1.12 -1.10 
M07d10 Leiomodin 2 (cardiac) 1.24 1.79 1.76 
M11h23 HNRPH1 1.10 1.09 1.30 
M13d6 Synaptopodin 2 1.26 -1.25 1.02 
M13e13 TXNIP 1.72 -1.69 -1.16 
M17j10 MLP -1.10 1.75 2.39 
M17j8 MLP 1.15 1.41 1.81 
M20a22 ASB5 -1.33 2.95 1.80 
M20p18 Filamin C, gamma 1.09 1.58 2.16 
M20k22 NADH dehydrogenase 1 β 1.05 1.31 1.51 
M21h1 TXNIP 1.68 -2.38 -1.43 
M23a7 LRP16 protein 1.34 1.25 1.21 
M23m3 Troponin I 2.25 -1.79 -1.11 
M23n22 RNA binding motif protein 8A 1.03 1.70 1.94 
M12i11 MLP 1.13 1.47 1.74 
M24n10 FLJ38973 1.62 2.18 1.69 
M28p16 HSP27 1.39 1.71 1.80 
M29p15 α-tropomyosin -1.02 1.25 0.87 
M31n6 COX6B 1.00 1.30 1.18 
M32i7 PDK4 1.80 1.37 -1.05 
M34j8 TTS2.2 -1.06 1.21 -1.05 
M46d2 ASB5 1.16 2.41 1.92 
M52i5 HSP40 1.11 1.91 1.83 
Abreviations: HNRPH1, Heterogeneous nuclear ribonucleoproteins H1; TXNIP, thioredoxin 
interacting protein; MLP, muscle LIM protein; ASB5, ankyrin repeat and SOCS box-
containing 5; HSP27, heat shock 27-KD protein; COX6B, cytochrome c oxidase subunit VIb; 
PDK4, pyruvate dehydrogenase kinase; TTS2.2, transport secretion protein 2.2; HSP40 
heat-shock 40-kDa protein 1.  
 
 
Of the 15 genes identified, 5 were selected for further analysis. The genes selected, 
ankyrin repeat and SOCS box-containing 5 (ASB5), thioredoxin interacting protein 
(TXNIP), muscle LIM protein (MLP), unknown protein FLJ38973 and transport-
secretion protein 2.2 (TTS2.2) all showed marked changes in expression and 
represented potentially interesting candidates for roles in the adaptive response to 
resistance exercise. Extensive bioinformatical analysis was performed on the selected 
genes to identify the gene sequence, transcript structure, amino acid profile in addition 
to known or predicted functions of the protein. The databases searched for this 
analysis included, Ensemble (http://www.ensembl.org/), GeneCards 
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(http://bioinfo.weizmann.ac.il/cards/index.shtml) and the Entrez suit of databases 
(http://www.ncbi.nlm.nih.gov/Entrez/). Information on each of the selected genes was 
readily available from these databases and is presented in Appendices A-D.  
 
Further analysis and confirmation of the microarray data was performed using 
quantitative real-time PCR on ASB5, TXNIP, MLP, FLJ38973 and TTS2.2 (Figure 5.2). 
The results of the real-time PCR analysis generally supported the microarray results 
with one exception, TTS2.2. FJL38973 gene expression increased markedly (~2-fold) 
although not significantly at 4 hours post exercise. ASB5 mRNA expression increased 
significantly at 4 hours (~3-fold increase, p<0.01) which remained elevated at 24hours 
(~2.3-fold). MLP expression markedly increased (~4-fold increase, p<0.01) 24 hours 
following the exercise bout. Whilst TXNIP showed a marked (~10-fold increase, 
p<0.01) albeit transient increase at 30 minutes followed by a rapid return to resting 
levels by 4 hours. 
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Figure 5.2. Real-time PCR results for selected genes. Subjects completed an 
acute bout of resistance exercise consisting of 3 sets of 12 repetitions of maximal 
leg extension. Biopsies were taken before exercise (pre), at 30 min, 4 h, and 24 h 
post exercise. Bars represent mean ± SEM, average of 10 subjects.  
* Significantly different from control, p<0.05 
** Significantly different from control, p<0.01 
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IV. DISCUSSION 
Gene expression profiling analysis was performed using a customised human skeletal 
muscle cDNA microarray during the recovery from an acute bout of resistance 
exercise. Muscle biopsies were taken from the vastus lateralis muscle before, 30 min, 
4 h and 24 h after the exercise bout. An examination of the transcriptional events over 
the time-course of 24 hours was employed to monitor both early and transient 
responses to the exercise as well as delayed or sustained gene changes. Thus the 
chances of identifying novel genes with important roles in the response to resistance 
exercise was far greater than by simply examining a single time point post exercise. In 
addition to the examination of potentially novel genes, a selection of genes with known 
or potentially interesting roles in skeletal muscle was included in the development of 
the microarray.  
 
Expression analysis of these known genes revealed 11 up-regulated genes. Of note 
was the increase in PDK4, previously recognised for its rapid increase during and after 
more prolonged endurance type exercise (Pilegaard et al. 2000; Hildebrandt et al. 
2003; Pilegaard and Neufer 2004). As well as the increase in expression of HSP27 
and NFκB1, two genes that have previously been implicated in mediating cellular 
stress responses (Kumar and Boriek 2003; Thompson et al. 2003). In contrast, nine 
genes demonstrated slight decreases in expression following the resistance exercise 
bout. Surprisingly, the magnitude of gene changes, were on the whole, somewhat 
smaller than expected although consistent with the degree of change in general that 
has been observed previously using microarray following acute resistance exercise 
(Zambon et al. 2003).  
 
The second aspect to this study involved the examination of the expression patterns of 
genes derived from a human skeletal muscle cDNA library. A subset of genes 
demonstrating markedly increased expression following the resistance exercise bout 
was selected for sequencing and further analysis. Whilst only genes showing 
increased expression were sequenced for this analysis, it is anticipated that similar 
analysis will be conducted for genes exhibiting down-regulation expression. In total, 19 
cDNA clones were sequenced with 15 individual genes identified following sequencing 
and bioinformatics analysis. Importantly, two of these genes, PDK4 and HSP27 were 
also identified as showing increased expression in the analysis of the known skeletal 
muscle genes. In addition to HSP27, the expressions of two further heat shock 
proteins (HSP40 and alpha-2-B crystallin) were also shown to increase following 
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resistance exercise. The increased expression of these proteins has been linked to 
the facilitation of muscle repair and remodelling following damaging exercise as well 
as providing considerable protection against subsequent periods of resistance type 
exercise (Neufer et al. 1998; Thompson et al. 2001; McArdle et al. 2002; Thompson et 
al. 2003).  
 
From the 15 genes identified, five genes were selected for further analysis based on: 
(1) the statistically significant degree of change demonstrated by the microarray 
expression analysis, (2) their unique nature, and/or (3) their known or potentially 
important role in skeletal muscle. The genes selected were TTS2.2, hypothetical 
protein FLJ38973, ASB5, MLP, and TXNIP. Real-time PCR validation confirmed the 
expression of all but TTS2.2 which showed no change in expression following 
exercise and was subsequently excluded from further analysis. The reasons for the 
incongruent results from the two analytical techniques are unclear however it may 
reflect inadvertent measurement of the expression of a closely related unidentified 
gene or perhaps differential exon usage of the gene itself.  
 
MLP (also referred to as CRP3) was originally discovered in denervated skeletal 
muscle and identified as a positive regulator of the myogenic program in myogenic 
cells (Arber et al. 1994). MLP belongs to the LIM superfamily of proteins and consists 
of two tandem LIM motifs each followed by a glycine-rich region that serve as points of 
interaction with other proteins (Arber et al. 1994; Bach 2000). Detected exclusively in 
skeletal and cardiac muscle, MLP has been shown to be up-regulated in fast muscle 
by enhanced contractile activity (Schneider et al. 1999) as well as during the transition 
to slower phenotypes (Willmann et al. 2001) in rats and mice respectively. 
Furthermore, MLP transcripts have been shown to be induced during C2C12 myocyte 
differentiation (Arber et al. 1994; Shen et al. 2003) as well as being up-regulated 
during the recovery from eccentric contraction in the tibialis anterior muscles of mice 
(Barash et al. 2003).  
 
To our knowledge this is the first study to measure the up-regulation of MLP in human 
skeletal muscle following an acute bout of resistance exercise. Whilst the exact 
function of MLP in muscle adaptive response to contractile activity is not discernable 
from this study, mice homozygous null for MLP exhibit highly disorganised cytoskeletal 
architecture and decreased cell-cell interactions (Arber et al. 1997) suggesting critical 
roles in the development of muscle structure and function. Further to this MLP has 
been observed to interact with the structural proteins β1-spectrin, telethonin and α-
actinin suggesting that it may be involved in facilitating the assembly or stabilization of 
the myofibril apparatus (Flick and Konieczny 2000) in addition to a potential role in the 
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mechanical stretch sensor machinery (Knoll et al. 2002). The understanding of the 
mechanistic actions of MLP is further confounded however by its dual sub-cellular 
localization, initially expressed exclusively in the nucleus early in muscle differentiation 
and later translocating to the cytoplasm (Arber et al. 1994). Interestingly, nuclear MLP 
appears to positively regulate myogenesis through the interaction with the myogenic 
transcription factors, MyoD, Myf6 and myogenin (Kong et al. 1997). Collectively these 
data seem to suggest multiple complementary roles for MLP in sensing mechanical 
stretch, regulating the subsequent transcriptional response and ultimately facilitating 
the assembly or stabilization of the contractile apparatus. Thus it appears that in 
response to a stimulus like resistance exercise, MLP plays a critical and coordinated 
role in the repair and adaptation of skeletal muscle.  
 
Thioredoxin-interacting protein (TXNIP), also known as vitamin-D3 up-regulating 
protein-1 or thioredoxin-binding protein-2, is the endogenous inhibitor of thioredoxin, a 
major regulator of cellular redox state. Several recent studies, through examination of 
the TXNIP-null mouse, have established a causal relationship between the loss of 
TXNIP and disregulated carbohydrate and lipid metabolism (Donnelly et al. 2004; Hui 
et al. 2004; Van Greevenbroek et al. 2004). Furthermore, TXNIP has been described 
as a stress responsive gene that regulates cardiac hypertrophy and cardiomyocyte 
viability through interaction with thioredoxin. In contrast to the present study however, 
expression of TXNIP was rapidly suppressed by biomechanical strain in 
cardiomyocytes (Wang et al. 2002) and by transverse aortic constriction in vivo 
(Yoshioka et al. 2004). Importantly, pathological cardiac hypertrophy is characterized 
by diminished contractility and ultimately congestive heart failure, whilst skeletal 
muscle hypertrophy is characterized by enhanced muscle contractility and strength 
gains. Although cardiac and skeletal muscle hypertrophy share elements of common 
signalling pathways (Molkentin and Olson 1996), it is likely that there exist numerous 
divergent regulatory mechanisms providing a potential explanation for these 
paradoxical results.  
 
Whilst the mechanisms regulating TXNIP expression or the significance of its 
observed increase in response to exercise cannot be elucidated from this study, its 
marked, early induction is of interest. TXNIP is readily inducible by various stress 
stimuli including H202, TGF-β and heat shock (Junn et al. 2000). We have 
demonstrated here that an acute bout of resistance exercise is sufficient to increase 
the expression of several markers of cellular stress (HSP27, HSP40, alpha-2-B 
crystallin). As such, it is interesting to speculate that the very rapid and transient 
increase in TXNIP might constitute an early signalling response to the stress imposed 
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by the exercise. The exact function of TXNIP in skeletal muscle and its role in the 
response to resistance exercise however requires further investigation. 
 
Ankyrin repeat and SOCS box-containing 5 (ASB5) is a member of the asb family, 
which is characterized by a non-conserved N-terminus, a various number of ankyrin 
repeats as well as a C-terminal SOCS box (Kile et al. 2000). To date only one study 
has investigated the expression of ASB5 which observed its up-regulation in growing 
collateral arteries following femoral ligation (Boengler et al. 2003). The authors noted 
an increased expression of ASB5 in both endothelial and smooth muscle cells which 
proliferate rapidly during collateral artery growth. Interestingly, these studies indicated 
that ASB5 is expressed predominately in skeletal muscle and to a lesser extent in 
cardiac muscle (Kile et al. 2000; Boengler et al. 2003). Moreover, ASB5 proteins have 
been localized in some satellite cells whilst mature myocytes themselves do not 
appear to express this protein (Boengler et al. 2003). These data, combined with the 
marked up-regulation in skeletal muscle presented here, suggest a role for ASB5 in 
the recovery and adaptation from resistance exercise. Since ASB5 has been shown to 
be up-regulated in actively proliferating cells, we speculate that this protein might 
constitute a novel molecule involved in the proliferation of satellite cells in response to 
a hypertrophic stimulus. Similarly, since skeletal muscle biopsies contain a mixture of 
cells types (e.g. myofibers, satellite cells, fibroblasts, endothelial cells, smooth muscle 
cells, and nerve cells), the increase in ASB5 might not reflect changes in muscle cells 
at all. Capillary proliferation is an important feature of skeletal muscle hypertrophy 
(Hather et al. 1991; McCall et al. 1996; Kadi et al. 1999; Chen et al. 2003; Degens et 
al. 2003a; Degens et al. 2003b). Moreover, elevated markers of capillarisation 
including vascular endothelia growth factor (VEGF) mRNA and protein expression are 
evident following compensatory hypertrophy before increased capillary growth is 
evident (Takahashi et al. 2002; Degens et al. 2003b). Since ASB5 expression has 
been identified during arteriogenesis, it is plausible that the increased ASB5 
expression observed in the present study might be associated with capillary growth 
rather than a muscle specific adaptation. Therefore it would be of interest to further 
examine importance of ASB5 during the response of skeletal muscle to a hypertrophic 
stimulus, both within muscle cells and surrounding supportive structures.  
 
The hypothetical protein FLJ38973, because of its novel character, represented a 
potentially interesting gene to investigate further. FLJ38973 was originally identified 
during a large-scale screen of ESTs for the purpose of identifying the full-open reading 
frame cDNA sequence for each human and mouse gene (Mammalian Gene Collection 
Program Team et al. 2002). Whilst no subsequent study has investigated FLJ38973, 
bioinformatics analysis using AceView (http://www.aceview.org/) revealed that it is 
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located on chromosome 2 and produces, by alternative splicing, 2 different transcripts 
(aDec03, bDec03) together encoding 2 different protein isoforms. PSORT II analysis 
(http://psort.nibb.ac.jp), trained on yeast data, predicts that the subcellular location of 
this protein is most likely in the nucleus (43%) or in the mitochondria (43%). Less likely 
possibilities are in the cytoplasm (13%). We report here, for the first time that the 
hypothetical protein FLJ38973, is found in skeletal muscle and that its mRNA levels 
increase following a bout of resistance exercise in human skeletal muscle. Much work 
however is necessary to fully describe the functional role of this protein.  
 
In conclusion, this experiment used microarray technology to examine the 
transcriptional response of human skeletal muscle to a single bout of resistance 
exercise. The analysis uncovered four interesting genes that have not previously been 
examined in this context. The role of these genes in the biological response of muscle 
to hypertrophic stimuli such as resistance exercise remains to be determined. 
However, their identification constitutes a valuable contribution to our understanding of 
the molecular responses of skeletal muscle following resistance exercise. 
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CHAPTER SIX 
EXPRESSION OF NOVEL GENES DURING THE 
DIFFERENTIATION OF HUMAN PRIMARY 
SKELETAL MUSCLE CELLS IN CULTURE 
I. INTRODUCTION 
Strenuous, growth-inducing exercise is associated with changes in numerous 
variables including growth factors, cytokines, cellular damage, sarcoplasmic calcium 
concentrations and energy demand. Alterations in any one or more of these factors is 
capable of stimulating signal transduction pathways that ultimately regulate the 
transcription of genes differentially expressed during muscle hypertrophy (Rennie et 
al. 2004). Insulin-like growth factor (IGF-1) is released during skeletal muscle stretch 
and overload, and is a potent regulator of muscular growth and repair (Frost and Lang 
2003). The most pronounced examples of the anabolic effect of IGF-1 on muscle 
growth comes from studies of transgenic animals whereby localised over-expression 
of IGF-1 results in a dramatic increase in skeletal muscle mass (Coleman et al. 1995; 
Musarò et al. 2001). 
 
Much of our understanding of the signalling mechanisms mediating IGF-1 induced 
hypertrophy, and indeed hypertrophy in general have come from the study of myoblast 
proliferation and differentiation in culture. The process of muscle hypertrophy has 
been described as a recapitulation of the stages of embryonic muscle development 
with the proliferation, differentiation and fusion of muscle specific stem cells (satellite 
cells) integral to both (Grounds 1991; Chambers and McDermott 1996; Grounds et al. 
2002). IGFs are unique among growth factors in that they are capable of stimulating 
both proliferation and differentiation of muscle cells in culture. Initially, IGF-1 
stimulates proliferation via inhibition of the growth suppressor retinoblastoma (Rb) 
protein, and up-regulation of the mRNA expression of proliferative factors including 
proliferating cell nuclear antigen (PCNA) and cyclin-dependant protein 1 (cyclin D1) 
whilst simultaneously inhibiting the expression of myogenin (Rosenthal and Chen 
1995). Following an unknown differentiation signal however, IGF-1 stimulates the 
expression of MyoD which in turn up-regulates the expression of the cyclin-dependent 
kinase inhibitor p21, ultimately resulting in cell cycle arrest, expression of myogenin 
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and progression towards terminal differentiation (Lawlor and Rotwein 2000; Xu and 
Wu 2000).  
 
Central to the terminal differentiation of myoblasts, which is characterised by cell cycle 
arrest, expression of muscle specific proteins, formation and maturation of myofibres, 
is the expression of the MRFs. The examination of the developmental sequence of 
myogenesis has clearly established the temporal pattern of MRF expression and 
action. As such the expression of the MRFs along with other muscle specific genes 
provides valuable molecular markers for the entire process of muscle development.  
 
Both primary skeletal muscle cell cultures and established muscle cell lines have 
become important tools as model systems for skeletal muscle development. The 
dividing myoblasts provided by these systems provide great flexibility in studies of 
myogenesis in that they remain as activity proliferating cells until growth factors 
provided in the medium are withdrawn. Following the reduction of growth factors 
below a critical threshold, myoblasts readily cease proliferating and progress towards 
terminal differentiation with the expression of muscle specific genes and proteins and 
finally fuse with adjacent myoblasts to become syncytial myotubes. Thus these 
cultures are readily manipulated allowing the examination of distinct aspects of muscle 
development.  
 
Many studies have been carried out on the growth and differentiation of muscle cells 
however the vast majority use immortalised rat and mouse muscle cell lines. Although 
these studies have highlighted the critical role of IGF-1 in the control of proliferation 
and differentiation, these muscle cell lines differ in which IGF binding proteins they 
express (James et al. 1993; McCusker and Clemmons 1998; Crown et al. 2000) and 
are not identical in their responses to IGFs (Florini et al. 1991). The great advantage 
of primary skeletal muscle cell cultures, readily obtainable from adult human muscle 
biopsies, is that they provide a more physiologically relevant in vitro model of the 
human skeletal muscle phenotype.  
 
Previous studies in this thesis have identified a number of genes that show increased 
expression in skeletal muscle following an acute bout of resistance exercise. Three of 
these genes: thioredoxin-interacting protein (TXNIP), ankyrin repeat and SOCS box-
containing 5 (ASB5), and unknown protein FLJ38973, have not been previously 
investigated in skeletal muscle and as such provide unique targets for further 
investigation into the molecular regulation of hypertrophy. The fourth gene, muscle 
LIM protein (MLP), has previously been implicated in skeletal muscle hypertrophy 
however the exact functions of this protein in muscle are not completely understood. 
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In an effort to understand the functional roles of these genes in skeletal muscle a 
human primary skeletal muscle cell culture model was employed to examine the 
expression of the genes during the proliferation, cell cycle arrest and differentiation. 
Since IGF-1 is a potent stimulator of muscle hypertrophy, satellite cells in culture were 
stimulated to differentiate with serum withdrawal, and serum withdrawal combined with 
exogenous IGF-1 administration. 
 
 In this study the aim was to identify whether the expression of these genes were (1) 
activated at any time during proliferation, cell cycle arrest or differentiation or (2) 
activated by the additional mitogenic and myogenic stimulation provided by 
exogenous IGF-1. It was hypothesised that the expression of ASB5, TXNIP, MLP, 
FLJ38973 and the MRFs would be altered during the differentiation of human 
myoblasts in culture.  
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II. METHODS 
A. Materials 
All media and supplements were purchased from (Gibco, Invitrogen Corporation, 
Carlsbad, CA) unless otherwise stated. Primary skeletal muscle growth medium 
consisted of minimum essential medium (MEM)-alpha modification with 50 IU/ml 
penicillin, 5 µg/ml streptomycin and 10% FBS. Differentiation medium consisted of 
MEM-alpha modification with 50 IU/ml penicillin, 5 µg/ml streptomycin and 2% horse 
serum to reduce proliferative growth factors. The IGF-1 analogue LongTMR3IGF-1 was 
purchased from GroPep, (Adelaide, SA). LongTMR3IGF-1 is a variant of human IGF-I 
that contains an amino terminal extension peptide as well as glutamate-3 replaced by 
arginine, exhibits very weak binding to IGF-binding proteins and has been shown to 
exhibit greater biological activity than natural IGF-1 (Francis et al. 1992; Tomas et al. 
1993).  
B. Subjects 
Human primary skeletal muscle cells were obtained from the vastus lateralis muscle of 
8 healthy volunteers (6 males and 2 females, average age 25.1 ± 1.3 years). Informed 
written consent was obtained from each subject before participation in the study, after 
the nature, purpose and risks of the study were explained. All experimental 
procedures involved in this study were formally approved by the Deakin University 
Ethics Committee. 
C. Human primary skeletal muscle cell cultures 
Skeletal muscle samples were excised using the percutaneous needle biopsy 
technique (Bergström 1962) modified to include suction (Evans et al. 1982). Human 
primary skeletal muscle cells were cultured according to the technique of Gaster 
(Gaster et al. 2001). The excised muscle was immersed and extensively washed in 
ice-cold Hams F-10 medium before being minced in 0.5% Trypsin/EDTA. Minced 
tissue was then digested in 0.5% Trypsin/EDTA at room temperature with agitation for 
20 minutes to release the myoblasts. The supernatant containing the myoblasts was 
then collected and the process repeated a further two times to break down any 
remaining tissue. FBS was subsequently added to the supernatant to a final 
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concentration of 10%. The supernatant was filtered through a 100µm filter to remove 
any connective tissue and then spun for 7 minutes at 1600rpm to collect the cells. The 
resulting cell pellet was resuspended in α-MEM medium. The cells were then seeded 
on to an uncoated flask and incubated at 37°C for 25 minutes to induce fibroblast 
attachment, leaving myoblasts suspended in the medium. The medium was aspirated 
and seeded on to an extra-cellular matrix-coated (Sigma, St Louis, MO) flask. The 
resulting primary cell cultures were maintained in α-MEM medium containing 10% 
FBS in humidified air at 37°C and 5% CO2. 
D. Experimental conditions 
Primary skeletal myoblasts were plated onto plates coated with ECM containing 
laminin and entactin derived from Engelbroh-Holm Swarm murine sarcoma cells. In 
each experiment, the cells were initially plated in α-MEM medium containing 10% FBS 
until 80% confluency was attained. The plating medium was then removed, the cells 
were washed twice with PBS and the standard differentiation medium (DM) (α-MEM 
containing 2% horse serum) or IGF-1 treated medium (DM+IGF-1) (α-MEM containing 
2% horse serum plus 30ng/ml LongTMR3IGF-1) was added. Medium was changed 
every 48h throughout the 72 differentiation time-course. Following 2 washes with PBS, 
cells were extracted at 12h, 24h, 48h and 72h following the addition of the 
differentiation medium. The control for each condition consisted of actively 
proliferating cells grown in the maintenance medium and extracted immediately before 
the addition of the differentiation medium (0h).  
E. Immunocytochemistry 
The differentiation potential of our skeletal muscle cell cultures was initially determined 
using immunocytochemical staining of myosin heavy chain MHC. MHC expression 
was evaluated on cells grown on cover slips in the proliferative state and following 7 
days of differentiation in DM. The cells were fixed in cold 100% methanol at -20°C for 
10min. Non-specific binding sites were blocked with 1% BSA in PBS followed by 
incubation in the primary antibody reactive to skeletal myosin heavy chain (MY-32, 
Zymed, San Francisco, CA). Subsequently, the cells were incubated with the 
fluorescent secondary antibody, anti-mouse AlexaFluor 488 (Molecular Probes, 
Oregon, USA). Nuclei were stained by incubating the cells in the DNA binding dye 
Bisbenzimide Hoechst 33285 (Sigma). Immunostained cells were visualised with an 
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Olympus IX70 fluorescent microscope (Olympus, Australia) and digital images 
collected (Spot RT slider camera: Image-Pro® Plus Software).  
F. Creatine kinase activity 
The creatine kinase (CK) activity, an established marker of myoblast differentiation 
(Gaster et al. 2001), was determined in cell culture lysates. Cells were resuspended in 
lysis buffer (50mM Tris, pH7.6, 250mM NaCl, 5mM EDTA, 0.1% IGEPAL, Complete 
protease inhibitor cocktail) and passed through a syringe. The cell extracts were 
centrifuged to pellet cell debris and supernatants and analysed for total protein (BCA 
protein assay kit, Pierce, Rockford, IL). CK activity in aliquots of the supernatant was 
determined with a commercial assay kit (Randox Laboratories Ltd. Crumlin, UK) and 
automated clinical analyser (RX Daytona, Randox).  
G. Western blot analysis 
100 µg of denatured total proteins (extracted as described above) from each sample 
were separated by electrophoresis on a 6% (MHC) SDS-polyacrylamide gel and 
transferred to nitrocellulose membrane by electroblotting.  Membranes were blocked 
for 2 h with 5% skim milk in Tris-buffered saline (50 mM Tris-HCl, 750 mM NaCl, 
0.25% Tween), and were incubated overnight at 4oC with a polyclonal anti-MHC (MY-
32, Zymed, San Francisco, CA). Membranes were washed (4 x 5 min), followed by a 
60 min incubation with anti-rabbit IgG conjugated to horse-radish peroxidase (1 in 
10,000 dilution) (Santa Cruz Biotechnology, Santa Cruz, CA), then washed again. 
Immunoreactive bands were detected using enhanced chemiluminescence (Western 
Lightning Chemiluminescent Reagent, Perkin-Elmer, Boston, MA). An internal control 
was used in each gel to normalize for variation in signal observed across the 
membranes.  
H. Real-time PCR analysis 
1. RNA Extraction 
RNA was extracted as previously described (Chapter 3, section II, part D). 
2. cDNA Synthesis 
The cDNA synthesis reaction was conducted as previously described (Chapter 3, 
section II, part H.2). 
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3. Primer Design 
Primers were designed as previously described (Chapter 3, section II, part H.3). See 
Table 6.1 for details. 
4. Real-time PCR reaction 
PCR was performed as previously described (Chapter 3, section II, part H.4). 
5. PCR Efficiency 
For each gene, the PCR efficiency of the primer pairs was determined as previously 
described (Chapter 3, section II, part H.5). See Table 6.1 for details 
I. Statistical Analysis 
Statistical analyses were performed using GraphPad Prism 4.1. Two-way ANOVAs 
with repeated measures were performed to examine differences in both treatment and 
time. Significant main effects were explored using Bonforoni post hoc tests. Data is 
presented as mean ± standard error of the mean (SEM). A probability level of <0.05 
was adopted throughout to determine statistical significance unless otherwise stated. 
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Table 6.1. Real-Time PCR Primer Details. 
Gene 
GenBank 
Accession 
Number 
Forward Primer (5’-3’) Conc, µM Reverse Primer (5’-3’) 
Conc, 
µM 
Exon 
Divide 
Amplico
n Size, 
PCR 
Efficiency 
ASB5        AY057053 AAATGCAGTAACCTTAGACCATGTCA 2 ACATGCCACGTGATCTCCAA 2 --- 67 0.8
FLJ38973         NM_153689 GAATGGTTGCAAGGGAGAAA 4 GCGTCATTTAGTGATGGTGGATAA 4 --- 87 1.1
MHC I NM_000257 TGAAAGTGGGCAATGAGTACG 2 TCCAGTTGAACATCCTCTCATACA 2 exon 10 & 11 105 0.8 
MHC IIx NM_005963.2 GACTGATCGGGAGAATCAGTCTATC 2 TCCCCAGTAACTGCAATTGTTG 2 exon 3, 4, 5 & 6 111  0.7
MLP   NM_003476 TCAGTCTATGCTGCTGAGAAGGTT 2 GATGGCACAGCGGAAACAG 2 exon 4 & 5 72 0.8 
Myf5        NM_005593 TTCTACGACGGCTCCTGCATA 4 CCACTCGCGGCACAAACT 4 --- 67 1.2
Myf6        NM_002469 CACCCTGCGCGAAAG 2 CACAGTTCGCCGCTTCAGT 2 --- 70 1.1
MyoD        NM_002478 CCGCCTGAGCAAAGTAAATGA 4 GCAACCGCTGGTTTGGAT 4 --- 74 1.0
myogenin    NM_002479 GGTGCCCAGCGAATGC 2 TGATGCTGTCCACGATGGA 2 exon 2 & 3 155 0.9 
Myostatin    NM_005259 CCAGGAGAAGATGGGCTGAA 2 CAAGACCAAAATCCCTTCTGGAT 2 exon 2 & 3 82 0.8 
p21       NM_000389 GGCAGACCAGCATGACAGATTT 6 GGCGGATTAGGGCTTCCTCT 6 --- 73 0.7
PCNA   NM_182649.1 CTAAAATGCGCCGGCAAT 2 GCTTCAAATACTAGCGCCAAGGT 2 exon 2 & 3 155 1.0 
TXNIP        NM_006472 AGATCAGGTCTAAGCAGAACA 4 TCAGATCTACCCAACTCATCTCAGA 4 --- 73 1.0
 
Primer sequences were designed using Primer Express Version 2 software (Applied Biosystems) using sequences accessed through GenBank and checked for specificity 
using Nucleotide-Nucleotide Blast search (http://www.ncbi.nlm.gov/BLAST/). Exon information was obtained from the Ensembl Genome Database (http://www.ensembl.org/). 
The concentrations of forward and reverse primers are indicated along with the intron-exon divide the primers were designed around (if possible) and amplicon size in base 
pairs. ASB5, ankyrin repeat and SOCs box-containing 5; MLP, muscle LIM protein; TXNIP, thioredoxin interacting protein; MHC I, myosin heavy chain I, MHC IIx, myosin 
heavy chain IIx; PCNA, proliferating cell nuclear antigen.   
 101
III. RESULTS 
In an effort to improve the understanding of the functional roles of several novel 
resistance exercise responsive genes a human primary skeletal muscle cell culture 
model was employed to examine the expression of the genes during the proliferation, 
cell cycle arrest and differentiation. Human primary skeletal muscle cell cultures were 
established from vastus lateralis muscles from 8 healthy young male and female 
volunteers. These cell lines were maintained in a proliferating state in medium 
containing 10% foetal bovine serum and all experiments were performed between the 
2nd and 6th passages. Cells were stimulated to differentiate with serum withdrawal, and 
serum withdrawal combined with over-expression of exogenous IGF-1 (R3IGF-1). 
Since IGF-1 is a potent stimulator of muscle hypertrophy we sought to identify whether 
the expression of our novel genes were (1) activated at any time during proliferation, 
cell cycle arrest or differentiation or (2) activated by the additional mitogenic and 
myogenic stimulation provided by R3IGF-1.  
A. Characterisation of human skeletal muscle cell cultures 
Initially, the capacity of the human skeletal muscle cells lines to differentiate was 
examined using classical serum withdrawal induced differentiation. Cells actively 
proliferating in high serum media and cells exposed to low serum conditions were 
grown for up to 6 days on glass cover slips for immunocytochemical analysis of MHC 
protein expression. MHC expression is a widely used marker of differentiation in 
skeletal muscle cell cultures. No MHC expression was evident in proliferating cells 
(Figure 6.1, A), whereas by 7 days, extensive MHC expression was apparent with 
multi-nucleation and myotube formation evident (Figure 6.1, B).  
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B 
 
 
 
Figure 6.1. Differentiation of primary human skeletal muscle cell lines. The 
differentiation potential of our cell lines was examined using 
immunocytochemical staining of MHC protein in proliferating cells (A) and 
following 7 days of serum withdrawal mediated differentiation (B). Cells were 
reacted to the MHC antibody MY-35 (green). Nuclei were counterstained using 
the DNA binding dye Bisbenzimide Hoechst 33285 (blue). Bar represents 
100µm. 
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B. Assessment of Proliferation and Differentiation 
To examine the relative effectiveness of our treatments on myogenesis, well 
established markers of progression through the cell cycle and myoblast differentiation 
were examined using real-time PCR (Figure 6.2). The expression of PCNA, necessary 
for cell cycle progression, was examined to assess cell proliferation. As expected, 
differentiation stimulated a reduction in the expression of PCNA for both the IGF-1 
treated and untreated differentiating cells (significant main effect of time, p<0.01). No 
statistically significant difference was observed between treatments; however, 
DM+IGF-1 treatment appeared to initially increase the expression of PCNA (~1.4-fold) 
12 h after the initiation of differentiation. The expression of p21, a prominent regulator 
of and molecular marker of cell cycle arrest, demonstrated a significant main effect of 
time (p<0.01); however no differences in expression were observed between DM and 
DM+IGF-1 treatment groups. Myostatin, a powerful negative regulator of muscle 
growth, has been shown to regulate cell cycle arrest through p21 (McCroskery et al. 
2003). Differentiation appeared to decrease the expression of myostatin (main effect 
of time, p<0.01); although the decrease observed in the IGF-1 treated group failed to 
reach statistical significance. No differences between treatment groups were 
observed. In addition to the analysis of cell cycle regulators, we sought to examine the 
expression of several established markers of myogenic differentiation. As expected, 
the expression of myosin heavy chain type IIx (MHC IIx) was markedly increased by 
DM (~35-fold) and DM+IGF-1 (~27-fold) however no differences between treatment 
groups were observed (main effect of time, p<0.01). Conversely, the expression of the 
slow MHC isoform (MHC I) displayed marked differences between DM and DM+IGF-1 
treatment groups. DM treatment alone significantly increased MHC I expression (~12-
fold) whilst DM+IGF-1 treatment resulted in a comparably modest (~3-fold) and 
insignificant increase in MHC I expression. Furthermore, significant main effects of 
time were observed for CKM mRNA and activity, during DM and DM+IGF-1 
treatments; however no differences between treatment groups were observed.  
 
To further confirm effectiveness of differentiation stimuli, we examined both the 
expression of a muscle specific protein (MHC) as well as the activity of CMK. CKM 
activity increased following 48 h and remained elevated 72 h post differentiation 
(Figure 6.3). Finally, MHC protein expression was assessed to confirm the attainment 
of the differentiated state (Figure 6.4). Consistent with CKM activity, no difference in 
MHC protein expression was observed between treatment groups, although MHC 
protein expression increased over the time-course of differentiation (Figure 6.4).  
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Figure 6.2. mRNA expression analysis of markers of proliferation (PCNA), cell 
cycle arrest (p21, Myostatin) and differentiation (MHC IIx, MHC I, CKM) during 
serum withdrawal (DM; solid bars) or serum withdrawal combined with 30ng/ml 
R3IGF-1 (DM+IGF-1;white bars). Each bar represents the mean ± SEM of eight 
independent, replicate experiments.  
* Significantly different from control (p<0.05) 
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Figure 6.3. CK activity increases with time in differentiating conditions. Human 
primary skeletal myoblasts were differentiated with serum withdrawal (DM) or 
serum withdrawal combined with 30ng/ml R3IGF-1 (DM+IGF-1). CK assay was 
performed on cell lysates and is expressed as mU/mg of total protein 
normalised to the 0h time-point. The average of eight independent primary cell 
cultures is presented, ± SEM.  
* Significantly different from control. 
 106
 
 
 
 
 
 
 
 
0 h 12 h 24 h 48 h 72 h
0
5000
10000
15000
20000
25000
30000
35000
Hours post differentiation
Ar
bi
tra
ry
 U
ni
ts
DM
DM+IGF-1
A
B
DM+IGF-1 
DM 
Figure 6.4.  Western blot analysis of MHC protein expression over time in 
differentiating conditions. The cell extracts were electrophoresed through a 6% 
SDS-polyacrylamide gel, transferred to nitrocellulose membranes and reacted 
to the myosin antibody (MY-35). A: MHC expression analysed using 
densitometry and expressed as arbitrary density units. The average of four 
independent primary cell culture experiments is presented B: Representative 
blots from DM and DM+IGF-1 treated cells. 
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C. Myogenic regulatory factor expression 
Since the temporal expression of the MRF transcription factors is critical to the 
appropriate development of the muscle phenotype, the expression of these factors 
was examined during the 72 h differentiation treatments (Figure 6.5). MyoD 
expression decreased significantly 72 h following DM and DM+IGF-1 treatments 
(p<0.05) however there were no differences in expression between treatments. In 
contrast, Myf5 showed no significants main effects of time or treatment; however a 
moderate decrease seemed evident at 48 h and 72 h post differentiation. Myogenin, 
considered the one of the earliest indicators of differentiation, demonstrated a 
dramatic increase at 24 h post differentiation which was sustained out to 72 h. Again, 
no differences were observed between groups. Myf6 expression demonstrated a 
significant main effect of time (p<0.01), with no significant difference evident between 
treatment groups. Myf6 expression was decreased by approximately 3-fold at both 48 
h and 72 h in the DM treatment group. The expression of Myf6 was reduced by 
approximately 4-fold at 48 h and 72 h in the DM+IGF-1 treatment group.  
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Figure 6.5. mRNA expression analysis of the myogenic regulatory factors 
(MyoD, Myf5, myogenin, Myf6) during serum withdrawal (DM; solid bars) or 
serum withdrawal combined with 30ng/ml R3IGF-1 (DM+IGF-1;white bars). 
Each bar represents the mean ± SEM of eight independent, replicate 
experiments.  
* Significantly different from control (p<0.05) 
** Significantly different from control (p<0.01) 
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D. Expression of novel resistance exercise responsive genes 
Once the temporal patterns of expression of markers of cell cycle and myogenic 
events that characterise the myogenic differentiation were established, we examined 
the expression of the novel genes previously identified as being responsive to 
resistance exercise (Figure 6.6). The expression of FLJ38973, ASB5 did not change 
with either the DM or DM+IGF-1 treatments, whilst MLP expression appeared to 
increase slightly, although not significantly different during differentiation. A significant 
main effect of time (p<0.05) was observed for TXNIP expression with early induction 
evident from 12 h post exercise, sustained out to 72 h. No differences between 
treatment groups were observed for any of these genes. 
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Figure 6.6. mRNA expression analysis of the FLJ 38973, ASB5, MLP, and 
TXNIP during serum withdrawal (DM; solid bars) or serum withdrawal 
combined with 30ng/ml R3IGF-1 (DM+IGF-1;white bars). Each bar represents 
the mean ± SEM of eight independent, replicate experiments.  
** Significantly different from control (p<0.01) 
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IV. DISCUSSION 
Muscle differentiation is a multi-step process involving permanent cell cycle arrest, 
expression of muscle specific genes and proteins, and fusion of myoblasts to form 
multi-nucleated myotubes. Previous work has clearly delineated the sequential 
expression of numerous molecular markers of muscle differentiation. Using human 
primary skeletal muscle cell cultures derived from the vastus lateralis muscle of 
healthy volunteers, and the established knowledge of the temporal patterns of 
myogenesis, the expression patterns of several novel myogenic genes were 
investigated.  
A. R3IGF-1 mediated differentiation 
The differentiation of skeletal myogenic cells in culture is classically induced by serum 
deprivation. In an attempt to augment an in vitro hypertrophic response, the standard 
differentiation stimulus of serum withdrawal was combined with the added 
hypertrophic stimulus of exogenous IGF-1. The IGF-1 analogue we selected, 
LongTMR3IGF-1 is a variant of human IGF-I that contains an amino terminal extension 
peptide as well as glutamate-3 replaced by arginine. This form of IGF-1, exhibits very 
weak binding to IGF-binding proteins and has been shown to exhibit greater biological 
activity than natural IGF-1 (Francis et al. 1992; Tomas et al. 1993). Since IGF-1 has 
been reported to stimulate both the proliferation and differentiation of muscle cells in 
culture, several molecular markers were selected to compare the mitogenic and 
myogenic effects of DM+IGF-1 and DM alone on our human primary skeletal muscle 
cell cultures. Somewhat surprisingly, no obvious differences in the expressions of any 
of the chosen markers were observed between the two differentiation stimuli, with the 
possible exception of PCNA and MHC I. PCNA is a widely used marker of proliferating 
myoblasts with increased expression in the G1 phase of the cell cycle, peak during S 
phase, and decline during G2 (Bravo and Macdonald-Bravo 1987; Mesires and Doumit 
2002). The moderate increase observed in PCNA expression at 12 hours post 
differentiation in the DM+IGF-1 group might indicate increased proliferative activity in 
these cells.  
 
Despite this minor difference, DM+IGF-1 appeared to have very little if any effect on 
the differentiation potential of the human skeletal muscle cell cultures above DM 
alone. Although unexpected, the lack of an obvious increase in the differentiation 
potential of IGF-1 treated myoblasts might be explained by endogenous IGF-1 
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production. After serum withdrawal, spontaneous IGF-1 peptide production is 
observed in muscle cells (Tollefsen et al. 1989a; Tollefsen et al. 1989b; Rosenthal et 
al. 1991). Therefore, exogenous IGF-1 in the DM+IGF-1 treated cells may have had 
no added effect on differentiation than the endogenous IGF-1 produced following 
serum deprivation in the DM cells. Alternatively, the concentrations of IGF-1 used in 
this study (30ng/ml) may not have been sufficient or indeed too high to augment 
differentiation in human primary myoblasts. However, at least one previous study has 
demonstrated increased differentiation in primary human myoblasts with 30ng/ml 
R3IGF-1 (Foulstone et al. 2003). Comparisons between IGF-1 stimulated 
differentiation and differentiation (induced by serum withdrawal) in this study were only 
examined at 7 days post differentiation. Thus the possibility remains that the type 
points selected in the present study were too short to see any marked increase in IGF-
1 stimulated differentiation.  
B. Cell cycle regulator and MRF expression during differentiation  
Despite the equivocal effects of the IGF-1 treatment, serum withdrawal alone was 
sufficient to promote a marked differentiation response in our human skeletal muscle 
cell cultures. The expression patterns of the cell cycle regulators and MRF were 
initially examined to establish the temporal pattern of myogenesis exhibited in the 
human primary skeletal muscle cultures. It was anticipated that this would allow the 
association of observed changes in the expression of novel genes with specific stages 
of the differentiation program.  
 
The decision of myoblasts to proliferate or exit the cell cycle and progress towards 
skeletal muscle differentiation is determined in late G1 of the cell cycle and is 
governed by the activity of G1 cyclins/Cdk complexes (Pardee 1989). The cyclin / Cdk 
complexes cyclin D/Cdk4 and cyclin E / Cdk2, cooperate to control the G1 to S 
transition through the phosphorylation and inactivation of retinoblastoma protein (Rb). 
The commitment of myogenic cells into skeletal muscle differentiation requires prior 
irreversible cell cycle arrest and inactivation of cell cycle activators by cell cycle 
inhibitors (such as Rb p21, p27 and p57). Central to this process are the MRFs which 
are involved not only in the expression of muscle specific genes, but also cooperate 
with cell cycle regulators in mediating the transition from the proliferative stage. 
Previous studies have indicated the MyoD is capable of inducing the expression of 
p21 (Guo et al. 1995; Halevy et al. 1995; Parker et al. 1995) as well as other Cdk 
inhibitors , p27, p57 (Reynaud et al. 2000) and Rb (Martelli et al. 1994) during 
myogenesis. The time window for cells to exit the cell cycle and into differentiation is in 
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G1, when MyoD expression is maximal and Myf5 expression is lowest (Kitzmann et al. 
1998; Kitzmann and Fernandez 2001). In the present study, MyoD expression was 
maximal at 0 h and 12 h post differentiation, followed by a small increase in p21 
expression. p21 works redundantly with p57 (Zhang et al. 1999) by blocking 
progression through the cell cycle by binding to PCNA (to inhibit DNA synthesis) as 
well as the G1 phase cyclin/Cdk complexes to prevent their enzymatic activity 
(Boulaire et al. 2000). As expected, PCNA expression was markedly reduced by 24 h 
post differentiation, despite only minor changes in the expression of p21. Although p57 
expression was not measured in this study, it is possible that increased p57 
expression might account for the attenuated expression of p21. The expression of 
myogenin, considered one of the earliest markers of differentiation, was increase at 12 
h with expression peaking at 48 h and 72 h. Myogenin expression preceded the 
expression and activity of markers of terminal myoblast differentiation MHC and CKM. 
Myf6 expression, consistent with its suggested role at the latest stages of myogenesis, 
possibly during myobirillogenesis (Rudnicki and Jaenisch 1995) was down-regulated 
throughout the 72 h differentiation time-course.  
 
Collectively, these observations suggested that our model exhibited the molecular 
markers of muscle differentiation in a chronologically appropriate manner. Importantly, 
the establishment of the temporal pattern of myogenesis in this model would allow the 
association of observed changes in the expression of novel genes with specific stages 
of the differentiation program. As discussed in chapter 5, the genes examined in this 
study were all observed to be up-regulated in the vastus lateralis during the 24 h 
recovery from a single bout of resistance exercise. The genes investigated were 
muscle LIM protein (MLP), thioredoxin interacting protein (TXNIP), ankyrin repeat and 
SOCS box-containing 5 (ASB5), and hypothetical protein FLJ38973.  
C. Examination of the Expression Patterns of Novel Myogenic 
Genes 
MLP was originally discovered in denervated skeletal muscle and has shown an 
enriched pattern of expression in striated muscle tissue (Arber et al. 1994). Several 
previous studies have identified important roles for MLP in myogenesis and in the 
promotion of myogenic differentiation (Arber et al. 1994; Arber et al. 1997; Louis et al. 
1997; Shen et al. 2003). More specifically, the actions of MLP have been described 
late in differentiation potentially facilitating the assembly or stabilization of the 
myofibrillar apparatus by interacting with the structural proteins β1-spectrin, telethonin 
and α-actinin (Louis et al. 1997; Stronach et al. 1999; Flick and Konieczny 2000) The 
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results of the present study show MLP slightly increased at 72 h, however, as 
described previously, MLP expression is likely to peak later in differentiation (i.e. after 
6 days (Shen et al. 2003)), outside the time-frame of this study.  
 
TXNIP, is a ubiquitous protein that binds with high affinity to thioredoxin and has been 
implicated the maintenance of cellular redox state and insulin secretion (Hui et al. 
2004), development of hepatic steatosis (Donnelly et al. 2004; Van Greevenbroek et 
al. 2004), among others (Ikarashi et al. 2002; Yoshioka et al. 2004). In chapter 5, 
TXNIP expression was shown to be rapidly and transiently increased in skeletal 
muscle following a resistance exercise bout; providing the first evidence of a role for 
TXNIP in skeletal muscle. Interestingly, in the present study following the 
differentiation signal, TXNIP expression was rapidly increased and remained elevated 
throughout the differentiation time-course. The expression of TXNIP was the earliest 
induction of any of our markers of the myogenic program, which might suggest a very 
early role in the transduction of the differentiation stimulus. Similarly, TXNIP 
expression was markedly expressed very early (30 min) following the resistance 
exercise bout, supporting a potential role as an immediate responsive gene. Previous 
research has identified elevated levels of TNXIP expression in terminally differentiated 
epithelial cells of the human gastrointestinal tract (Takahashi et al. 2003) as well as 
reduced TXNIP expression in gastrointestinal cancers, characterized increases in their 
proliferative potential (Ikarashi et al. 2002). Collectively, these results suggest a 
potentially vital role for TXNIP in cellular differentiation. Whilst a role in differentiation 
remains speculative at this stage, it would be interesting to investigate the forced 
inhibition of TXNIP on the capacity of myobasts to attain the differentiated phenotype. 
 
Conversely, the expression of ASB5 and hypothetical protein FLJ38973 demonstrated 
no altered expression patterns during primary myoblast differentiation. Very little is 
known about the functions of ASB5, one study has identified increased expression of 
this gene in growing collateral arteries following femoral ligation (Boengler et al. 2003). 
The authors noted an increased expression of ASB5 in both endothelial and smooth 
muscle cells which proliferate rapidly during collateral artery growth. Thus the 
possibility remains that ASB5 might exert its function on actively proliferating cells, 
despite no reduction in its expression post differentiation. Alternatively, it is intriguing 
to speculate that the expression of ASB5 might respond exclusively to the damage, 
contraction, or stretch imposed by resistance exercise. In support of this, the 
expression of ASB5 has been localized in some satellite cells whilst mature myocytes 
themselves do not appear to express this protein (Boengler et al. 2003). Thus the 
possibility still remains that ASB5 might constitute a novel molecule involved in 
proliferative response of satellite cells in response resistance exercise. Equally, 
 115
nothing is known of the functions of the unknown protein FLJ38973 and the results of 
this study provide little answers as to its role during skeletal myogenesis.  
 
Skeletal muscle differentiation is a highly complex and coordinated process requiring 
the prior irreversible cell cycle arrest, before terminal differentiation, the expression of 
muscle specific genes and ultimately the formation of multinucleated myotubes. Here, 
the expression of novel myogenic genes in the context of the expression of known 
regulators and markers of skeletal myogenesis during the forced differentiation of 
human primary skeletal muscle cell cultures was investigated. Whilst the exact 
functions of these genes in skeletal muscle remains to be determined, these data 
provide additional insights into their regulation during myogenesis, and go some way 
to potentially identifying their mechanisms of action.  
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CHAPTER SEVEN 
EXPRESSION OF THE NOVEL GENES 
FOLLOWING AN ACUTE BOUT OF ENDURANCE 
EXERCISE 
I. INTRODUCTION 
Skeletal muscle is an extremely dynamic tissue, which possesses the ability to adapt 
to a variety of physiological stimuli resulting in improved muscular capacity, 
specifically adapted to its functional demands. The plasticity of muscle is illustrated by 
the diverse phenotypic profiles of muscle evident following different exercise training 
regimes. For example, endurance training improves the metabolic properties of 
muscles, including an increase in number and size of mitochondria, switches in 
muscle fibre types from fast to slow isoforms, as well as the activity of enzymes 
related to fat and carbohydrate oxidation. Conversely, resistance training results in 
greater accumulation of contractile proteins, increased myofibre cross-sectional area, 
increased numbers of myonuclei and a shift in fibre type from slow to fast isoforms. 
Despite a great understanding of the specific phenotypic adaptations to endurance 
and resistance exercise. The knowledge surrounding the regulatory mechanisms 
governing the highly specified cellular level changes is limited. Through the use of 
molecular biology tools, we are starting to identify specific molecules and signalling 
pathways, which together result in the appropriate adaptation of skeletal muscle. For 
example, increases in the expression of genes related to fat and carbohydrate 
oxidation have been observed following both acute and chronic endurance exercise 
(i.e. GLUT4, PDK4) (Pilegaard et al. 2000; Hildebrandt et al. 2003; Pilegaard and 
Neufer 2004). Whereas resistance exercise has been shown to promote the 
expression of genes associated with muscle regeneration and development (i.e. 
MyoD, myogenin) (Willoughby and Nelson 2002; Bickel et al. 2003; Psilander et al. 
2003).  
 
In chapter 5, the identification of a number of genes that show increased expression in 
skeletal muscle following an acute bout of resistance exercise was described. Three of 
these genes: thioredoxin-interacting protein (TXNIP), ankyrin repeat and SOCS box-
containing 5 (ASB5), and unknown protein FLJ38973, have not previously investigated 
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in skeletal muscle and as such provide unique targets for further investigation into the 
molecular regulation of hypertrophy. The fourth gene, muscle LIM protein (MLP), has 
previously been implicated in skeletal muscle hypertrophy however its mechanisms of 
action remain equivocal.  
 
In chapter 6, the expression of these genes was investigated during the differentiation 
of human primary myoblasts. The results of this study showed that ASB5 and 
FLJ38973 mRNA was not altered at any time during proliferation arrest or 
differentiation. Conversely, the expression of MLP tended to increase and TXNIP 
mRNA increased rapidly and markedly following the initiation of differentiation. Whilst, 
these results suggested potential roles for TXNIP and MLP in the differentiation of 
skeletal muscle satellite cells during hypertrophy, it provided no clues as to the 
potential importance of the increased expression of ASB5 and FLJ38973 in skeletal 
muscle. Furthermore, we were no closer to determining if the responses of these 
genes were a unique response to resistance exercise or if they were responsive to 
skeletal muscle contraction or exercise in general. Therefore, in the present study the 
expression of resistance exercise responsive genes following a single bout of 
endurance exercise was investigated.  
 
Additionally, the expression of the muscle regulatory factors (MRFs) was examined. 
Whilst the majority of studies to date have examined the expression of the MRFs in 
the context of resistance exercise, there is some suggestion that the MRFs might have 
the capacity to mediate muscle metabolic and contractile properties, not only towards 
phenotypes suited to resistance exercise, but also towards a more oxidative 
phenotype such as that observed following endurance training (Hughes et al. 1993; 
Bottinelli et al. 1994; Hughes et al. 1997; Hughes et al. 1999; Kadi et al. 2004a; Siu et 
al. 2004). Since these studies had focused on MyoD and myogenin, the expression of 
all four MRFs was investigated following an acute bout of endurance exercise. It was 
hypothesised that the expression of ASB5, TXNIP, MLP, FLJ38973 and the MRFs 
would not be altered following a single bout of endurance exercise. 
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II. METHODS 
A. Subjects 
Eight healthy, habitually active but non-endurance trained male subjects volunteered 
to participate in this study. Age, height and weight were on average 26.1 ± 1.6 years, 
183.2 ± 2.5 cm, and 77.1 ± 2.9 kg (mean ± SEM). Peak oxygen uptake (VO2 peak) 
determined by an incremental bicycle test was 47.5 ± 2 ml.kg-1.min-1. Exclusion 
criteria included endurance training status as evidence by a VO2 peak greater than 55 
ml.kg-1.min-1 or previous history of a diagnosed condition or illness that would 
endanger the subjects during strenuous endurance exercise. Informed written consent 
was obtained from each subject before participation in the study, after the nature, 
purpose and risks of the study were explained. All experimental procedures involved 
in this study were formally approved by the Deakin University Ethics Committee. 
B. VO2 Peak 
All subjects completed a VO2 peak test on an electromagnetically braked cycle 
ergometer (Lode, Groninegen, The Netherlands) with an incremental protocol and 
subjects pedalling at a self selected rate. Respiratory gasses were collected and 
analysed using Vista TurboFit software (Vacumetrics Inc. Ventura, CA) connected to 
Applied Electrochemistry Technologies oxygen (Model S-34) and carbon dioxide 
(Model CD-3A) analysers (Pittsburg, Pennsylvania). The gas analysers were 
calibrated prior to each test against commercially prepared (BOC, Australia) alpha 
rated gases of known concentrations. 
C. Experimental Design 
Subjects arrived at the laboratory in the fasted state for a resting muscle biopsy. For 
the 24 h preceding, and the days of the trial, subjects were provided with and 
consumed a standard diet of 20% fat, 14% protein, 66% carbohydrate and abstained 
from alcohol, caffeine, tobacco and additional exercise. Macronutrient intake was 
assessed using FoodWorks 3.0). Following the resting biopsy, subjects began cycling 
at a power output requiring approximately 70% peak oxygen consumption (average 
across all subjects throughout the exercise was 71.2 ± 2.1%). The exercise bout 
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lasted 60 min and subjects were permitted to consume water ad libitum. Further 
muscle samples were obtained 30 min after the exercise bout, 4 hours after the 
exercise bout and again 24 hours after the exercise bout. 
D. Muscle Biopsy Procedure 
The vastus lateralis muscle of the non-dominant leg was sampled by percutaneous 
needle biopsy technique as described previously (Chapter 4, section II, part D). 
E. Real-Time PCR Analysis 
1. RNA Extraction 
The RNA extraction was performed as described previously (Chapter 4, section II, part 
E.1). 
2. Reverse Transcription  
The cDNA synthesis reaction was performed as described previously (Chapter 3, 
section II, part H.2) 
3. Primer Design 
PCR primers were designed as described previously (Chapter 3, section II, part H.3). 
PCR primer sequences are presented in Table 7.1. 
4. Real-time PCR reaction 
The real-time PCR reaction was performed as previously described (Chapter 3, 
section II, part H.4). 
5. PCR Efficiency  
Linearity of PCR primers was performed as described previously (Chapter 3, section 
II, part H.5), see Table 7.1 for details. 
6. PCR Analysis and Endogenous Control Selection  
Data was analysed using the comparative critical threshold (Ct) method where the 
amount of target normalised to the amount of the endogenous control is given by 2-∆Ct. 
β-actin has previously been identified as an appropriate endogenous control for 
endurance exercise studies (Mahoney et al. 2004) and as such was selected for the 
endogenous control for this study. The appropriateness of this gene as an 
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endogenous control was examined by using the 2-∆Ct normalised to control values 
(Figure 7.1A). However, this analysis revealed significant changes in the expression of 
this gene and as such was deemed to be an inappropriate endogenous control to use 
for this study. Subsequently, cyclophilin was investigated as an endogenous control 
(Figure 7.1B). No significant change in its expression following endurance exercise 
was observed and therefore was selected as the endogenous control for this study. 
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Figure 7.1. Examination of the mRNA expression of the endogenous control β-
actin (A) and cyclophilin (B) following an acute bout of resistance exercise. , The 
expression of the endogenous control in a given sample was calculated by 
subtracting the CT of each sample from the CT of the corresponding pre or control 
value. The relative expression of the gene of interest normalised to control was 
calculated using the expression 2-∆CT. Statistical analysis revealed no change in 
the expression of this gene at any time point following the exercise intervention. 
Therefore, this was considered an appropriate endogenous control for this study. 
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F. Statistical Analysis 
Statistical analysis was performed using GraphPad Prism 4.1 (GraphPad Software, 
San Diego, CA). Means were compared using a one-way ANOVA and any significant 
differences analysed using a Dunnet’s multiple comparison test. Data is presented as 
mean ± standard error of the mean (SEM). A probability level of <0.05 was adopted 
throughout to determine statistical significance unless otherwise stated. 
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Table 7.1. Real-Time PCR Primer Details. 
 
Gene 
GenBank 
Accession 
Number 
Forward Primer (5’ Æ 3’) Conc, µM Reverse Primer (5’ Æ 3’) 
Conc, 
µM 
Exon 
Divide 
Amplicon 
Length 
PCR 
Efficiency 
ASB5         AY057053 AAATGCAGTAACCTTAGACCATGTCA 2 ACATGCCACGTGATCTCCAA 2 --- 67 0.8
β-Actin NM_001101        AAGCCACCCCACTTCTCTCTAA 2 AATGCTATCACCTCCCCTGTGT 2 --- 141 1.1
Cyclophilin    NM_021130 CATCTGCACTGCCAAGACTGA 4 TTCATGCCTTCTTTCACTTTGC 4 exon 4 & 5 80 0.9 
FLJ38973         NM_153689 GAATGGTTGCAAGGGAGAAA 4 GCGTCATTTAGTGATGGTGGATAA 4 --- 87 1.1
MLP   NM_003476 TCAGTCTATGCTGCTGAGAAGGTT 2 GATGGCACAGCGGAAACAG 2 exon 4 & 5 72 0.8 
Myf5        NM_005593 TTCTACGACGGCTCCTGCATA 4 CCACTCGCGGCACAAACT 4 --- 67 1.2
Myf6        NM_002469 CACCCTGCGCGAAAG 2 CACAGTTCGCCGCTTCAGT 2 --- 70 1.1
MyoD         NM_002478 CCGCCTGAGCAAAGTAAATGA 4 GCAACCGCTGGTTTGGAT 4 --- 74 1.0
myogenin    NM_002479 GGTGCCCAGCGAATGC 2 TGATGCTGTCCACGATGGA 2 exon 2 & 3 155 0.9 
PDK4         NM_002612 ATGGATAATTCCCGGAATGCT 2 ACTTGGCATACAGACGAGAAATTG 2 --- 93 0.9
TXNIP         NM_006472 AGATCAGGTCTAAGCAGAACA 4 TCAGATCTACCCAACTCATCTCAGA 4 --- 73 1.0
 
Primer sequences were designed using Primer Express Version 2 software (Applied Biosystems) using sequences accessed through GenBank and checked for specificity using 
Nucleotide-Nucleotide Blast search (http://www.ncbi.nlm.gov/BLAST/). Exon information was obtained from the Ensembl Genome Database (http://www.ensembl.org/). The 
concentrations of forward and reverse primers are indicated along with the intron-exon divide the primers were designed around (if possible) and amplicon size in base pairs. 
ASB5, ankyrin repeat and SOCs box-containing 5; MLP, muscle LIM protein; PDK4, pyruvate dehydrogenase kinase 4; thioredoxin interacting protein. 
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III. RESULTS  
The expressions of the resistance exercise responsive genes were examined 
following a single bout of endurance exercise (Figure 7.2). Interestingly, the 
expressions of TXNIP, MLP and FLJ38973 were not altered at any time-point post 
exercise. Conversely, the expression of ASB5 was rapidly increased (p<0.05) by 
approximately 2-fold, 30 min following the cessation of exercise before returning to 
resting levels by 4 h.  
 
Additionally, the expression of the muscle regulatory factors was investigated (Figure 
7.3). Myf5 expression appeared to increase by approximately 2-fold at 30 min 
however considerable between-subject variability was evident and this increase failed 
to reach significance. MyoD and Myf6 expression was not altered at any point 
following endurance exercise. Myogenin expression appeared to increase at 24 h, 
although again this failed to reach significance.  
 
Finally, the expression of PDK4, previously shown to be up-regulated following 
endurance exercise (Pilegaard et al. 2000; Hildebrandt et al. 2003; Pilegaard and 
Neufer 2004), was examined to ensure the exercise bout in conducted this study was 
sufficient to elicit expected increases in gene expression (Figure 7.4). As expected, 
PDK expression significantly increased by approximately 10-fold 4 h following the 
endurance exercise bout.  
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Figure 7.2. The effects of a single of bout of endurance exercise on the expression of 
resistance exercise sensitive genes. Real-time PCR analysis was performed on 
TXNIP, MLP, ASB5 and FLJ38973. Values are means ± SEM of 8 subjects.  
*Significantly different from control (p<0.05) 
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igure 7.3. The effects of a single of bout of endurance exercise on the expression of 
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F
the Muscle Regulatory Factors. Real-time PCR analysis was performed on Myf5, 
MyoD, myogenin, and Myf6. Values are means ± SEM of 8 subjects. No significantly 
different changes in gene expression were observed (p>0.05). 
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Figure 7.4. The effects of a single bout of endurance exercise on the expression of 
PDK4. Values are means ± SEM of 8 subjects.  
**Significantly different from control, p<0.01 
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IV. DISCUSSION 
Following a single bout of resistance exercise, microarray technology was used to 
identify genes whose expression changed markedly, and therefore had the potential to 
play important roles in the repair and adaptation of skeletal muscle. Since very little is 
known about the functions of these genes (TXNIP, ASB5, MLP and FLJ 39873) in 
muscle, this study aimed to determine whether these changes were specific to 
resistance type exercise, or a common response to muscle contraction.  
 
Previously in chapter 5 it was demonstrated that ASB5 gene expression increased 
markedly 4 and 24 h following a single bout of resistance exercise. Interestingly, ASB5 
expression also increased in the present study, 30 min following a single bout of 
endurance exercise. The expression of ASB5 had been shown to be significantly 
increased in endothelial and smooth muscle cells during arteriogenesis. Since 
increased capillarisation is an adaptive response to both endurance and resistance 
type exercise. It seems that the likely explanation for the increased expression of 
ASB5 mRNA following both of these types of exercise is as an adaptive response to 
an increased need for capillaries within the muscle. In support of this, increased 
VEGF, a very early marker of arteriogenesis, is evident following both endurance and 
resistance exercise well before capillarisation itself is likely to have occurred 
(Gustafsson et al. 1999; Takahashi et al. 2002; Degens et al. 2003b). Thus, it appears 
likely that ASB5 is a novel molecule implicated in the initiation of arteriogenesis, 
although its mechanisms of action remain to be determined. 
 
The lack of increased expression of TXNIP, MLP and FLJ38973 following endurance 
exercise seem to suggest a reliance on conditions specifically imposed on the muscle 
during resistance type exercise for their transcriptional activation. Numerous divergent 
signals unique to each type of exercise might be responsible for the different 
molecular responses of, and ultimately, phenotypic endpoint of resistance versus 
endurance type training. Potential regulators of early gene expression in muscle 
include, but are not limited to: exercise induced myotrauma, energy demands, 
intracellular calcium, growth factors, and mechanical stretch. Different exercise 
paradigms have the obvious potential to alter many different signalling pathways 
within muscle ultimately resulting in the unique patterns of gene expression and 
muscular adaptation. Thus TXNIP, MLP and FLJ38973 might constitute critical early 
molecular adaptations within skeletal muscle with the potential, following training, to 
promote muscle hypertrophy. 
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Several studies have suggested that MRFs may be involved in determining structural 
and metabolic characteristics of postmitotic skeletal muscles (Hughes et al. 1993; 
Bottinelli et al. 1994; Hughes et al. 1997; Adams et al. 1999; Allen et al. 2001). 
Specifically, these studies have suggested that myogenin expression is associated 
with the slow myosin heavy chain expression and increased oxidative capacity, 
whereas MyoD is related to the expression of the fast isoforms and a shift towards 
greater glycolytic activity. This is the first study to investigate the gene expression of 
all members of the MRF family following a single bout of endurance exercise. Whilst 
no significant change was evident in any of the MRFs, Myf5 express tended to 
increase however considerable variability was evident between subjects likely 
contributing to the lack of statistical power. Conversely, in a previous study (see 
chapter 4) utilizing identical time-points post exercise, marked increases in both MyoD 
and myogenin were evident following a single bout of resistance exercise. The results 
of this study seem to suggest that immediate changes in the gene expressions of the 
MRFs are not critical adaptations to endurance exercise.  
 
Previous studies have demonstrated increased nuclear localization of myogenin 
following a single bout of exercise (Kadi et al. 2004a) and increased myogenin mRNA 
and protein levels following 8 weeks of endurance exercise (Siu et al. 2004). Despite 
the lack of increase in myogenin mRNA expression in the present study it is possible 
that the cellular localisation of myogenin protein might be adequate in mediating the 
short term adaptation of muscle following endurance exercise. Whereas repeated 
bouts of exercise might be necessary for increased myogenin gene and protein 
expression. Importantly, current understanding of the genes whose trans-activation is 
directly regulated by members of the MRF family is limited. Further examinations into 
to specific gene targets of each MRF will further clarify the divergent functions of these 
critical regulators of muscle development. 
 
Resistance and endurance exercise results in the activation of numerous divergent 
signalling pathways that ultimately result in the unique expression of muscle specific 
proteins and development of a phenotypic profile highly suited to its functional 
demands. In this study, the expressions of resistance exercise sensitive genes was 
further characterised by examining their expression following endurance exercise. 
Furthermore, we have examined the primary regulators of the muscle phenotype, the 
MRFs following endurance exercise. These data provide further evidence of the 
unique molecular mechanisms that regulate the exercise-induced adaptations of 
skeletal muscle.  
 129
CHAPTER EIGHT 
GENERAL DISCUSSION & FUTURE DIRECTIONS 
I. INTRODUCTION 
Skeletal muscle confers numerous vital functions including locomotion and postural 
behaviour, strength, breathing and metabolism. Unfortunately, diseases of skeletal 
muscle such as age related sarcopenia, muscular dystrophies, cancer cachexia, 
disuse atrophy and other wasting disorders (e.g. AIDS) can lead to considerable 
morbidity, loss of functional capacity and in the worst cases, lethality. Understanding 
the mechanisms regulating skeletal muscle mass is therefore of great importance. 
Both in the development of therapeutic strategies that may alleviate some of the 
pathological conditions associated with diseases of muscle. But also in the 
development of preventative measures that might assist in the maintenance of muscle 
mass to arrest the currently inevitable muscle atrophy associated with ageing.  
 
The specific aims of this thesis were: 
 
• To develop and test a human skeletal muscle specific cDNA microarray for 
global transcriptional profiling and the identification of novel gene transcripts. 
 
• To further enhance current understanding of the process of myogenesis by 
examining the expression profile of rhabdomyosarcoma cells undergoing forced 
differentiation using the human skeletal muscle specific microarray.  
 
• To further test the sensitivity and reliability of the microarray in identifying 
changes in gene expression in a biological system. Thus ensuring reliable and 
reproducible would be attainable from the microarray in subsequent studies 
using less readily available human skeletal muscle samples.  
 
• To investigate the expression of myogenic and atrogenic genes in human 
skeletal muscle following an acute bout of resistance exercise. 
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• To use the human skeletal muscle specific microarray to study the time-course 
of transcriptional changes and identify novel genes expressed following an 
acute bout of resistance exercise. 
 
• To identify whether the expression of the novel genes identified in chapter 5 
were (1) activated at any time during proliferation, cell cycle arrest or 
differentiation or (2) activated by the additional mitogenic and myogenic 
stimulation provided by exogenous IGF-1 peptide supplementation.   
 
• To examine whether the novel genes identified in chapter 5 were a unique 
response to resistance exercise or if they were responsive to skeletal muscle 
contraction or exercise in general.   
 
 
II. SUMMARY OF MAJOR FINDINGS 
 
The broad aim of this thesis was to further understand the mechanisms of hypertrophy 
by identifying novel genes involved in resistance exercise induced increases in 
skeletal muscle mass. In chapter 2, the development of a human skeletal muscle 
specific microarray was discussed. Approximately 11,000 cDNA clones derived from a 
normalised human skeletal muscle cDNA library were arrayed onto the microarray 
along with 270 genes with known functional roles in skeletal muscle. It was 
demonstrated that the expression profiling data derived from the microarray was 
accurate, reliable and would allow expression analysis and identification of novel 
genes in a range of different experimental systems. The results presented 
demonstrate the robustness of the microarray in producing accurate and reliable data. 
In chapter 3, the human muscle specific microarray was used to profile the temporal 
expression of genes during the differentiation of a model of skeletal muscle 
myogenesis, rhabdomyosarcoma cells. It was demonstrated that, despite aberrant 
differentiation in vivo, during forced differentiation, rhabdomyosarcoma cells exhibit a 
pattern of gene expression consistent with that observed during normal myogenesis. 
Furthermore, two genes (PTMA and Tim10) were identified as being markedly down-
regulated during rhabdomyosarcoma differentiation. This was the first study to 
investigate the expression of these genes in rhabdomyosarcoma.  
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The activation and proliferation of satellite cells has been identified as a critical 
component of adaptive skeletal muscle hypertrophy. In chapter 4, the expression of 
several cell cycle regulatory factors was examined following a single bout of 
resistance exercise. It was identified that, whilst markers of cell proliferation were not 
altered within the 24 h following an acute exercise bout, a marker of cell cycle 
withdrawal, p21 was markedly and rapidly induced by 4 h post exercise. Similarly, the 
expression of two members of the MRF family, MyoD and myogenin were also rapidly 
induced by 4 h. The time-course of these changes however, likely preclude the 
involvement of satellite cells in these gene responses. It was proposed that MyoD and 
p21 act within the myonuclei of mature myofibres to reduce apoptotic cell death. In 
addition, the expression of several negative regulators of skeletal muscle hypertrophy, 
myostatin and the atrophy related genes, MURF-1 and atrogin-1 was investigated. To 
date, this is the first study to examine the expression of these genes following a single 
bout of resistance exercise in human subjects.  
 
In chapter 5, the human skeletal muscle microarray was used to identify novel genes 
involved in the early recovery from resistance exercise. Four genes (hypothetical 
protein FLJ38973, ASB5, MLP, and TXNIP) demonstrating marked increases in 
expression following resistance exercise were identified and had not previously been 
investigated in this context. To further understand the functions of these genes in 
skeletal muscle, a human primary skeletal muscle cell culture model was employed to 
examine the expression of the genes during proliferation, cell cycle arrest and 
differentiation. No change in expression was observed for MLP, ASB5 and FLJ38973 
throughout the time-course of differentiation. Conversely, TXNIP expression was 
rapidly increased and remained elevated throughout the 72 h of differentiation. Finally, 
the expression of these novel genes was examined following a single bout of 
endurance exercise to determine if the responses observed in chapter 5 were a 
unique response to resistance exercise or if they were responsive to skeletal muscle 
contraction or exercise in general. The expressions of TXNIP, MLP and FLJ38973 
were not altered by the endurance exercise protocol, whilst ASB5 expression 
increased at 30 min post exercise.  
 
The results of this thesis describe the identification of four genes whose expression 
had not previously been examined in skeletal muscle in response to an acute bout of 
resistance exercise; consequently increasing the overall body of knowledge regarding 
the transcriptional activity following a single bout of resistance exercise. Additionally, 
the potential functions of these genes in the early adaptive response to resistance 
exercise was further characterised by examining their expressions during myogenic 
differentiation as well as during the recovery from a single bout of endurance exercise. 
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Collectively, the results described in this thesis, in part, describe the potential 
functional roles of these genes in skeletal muscle.  
A. ASB5 
ASB5 was originally detected in endothelial and smooth muscle cells proliferating 
rapidly during collateral artery growth following femoral ligation (Boengler et al. 2003). 
In this thesis, ASB5 was observed to be up-regulated following both resistance and 
endurance exercise bouts, however no change in ASB5 expression was demonstrated 
during the differentiation of human primary skeletal muscle cells in culture. From these 
and previous studies, it seems that the likely functions of the observed increases in 
ASB5 mRNA following endurance and resistance exercise is as an adaptive response 
to an increased need for capillaries within the muscle. The exact functional role of the 
ASB5 protein in these processes however remains unknown.  
B. TXNIP  
TXNIP, is a ubiquitous protein that binds with high affinity to thioredoxin and has been 
implicated the maintenance of cellular redox state and insulin secretion (Hui et al. 
2004), development of hepatic steatosis (Donnelly et al. 2004; Van Greevenbroek et 
al. 2004), among others (Ikarashi et al. 2002; Yoshioka et al. 2004). In this thesis, 
TXNIP expression was shown to be markedly, and transiently up-regulated 30 min 
following a single bout of resistance exercise, whilst no change was observed 
following endurance exercise. Interestingly, it was also demonstrated that TXNIP 
mRNA was markedly induced during differentiation. Several possible functions for 
TXNIP in skeletal muscle can be hypothesized from the results presented here. Firstly,  
The lack of induction following endurance exercise seems to suggest a reliance on 
conditions specifically imposed on the muscle during resistance type exercise for its 
transcriptional activation. Secondly, increased TXNIP expression during differentiation 
in vitro might suggest a potential role in the differentiation of satellite cells in vivo. 
However, the very early (30 min) and transient nature (return to resting levels by 4 h) 
of TXNIP expression following resistance exercise would likely preclude a role for 
TXNIP in satellite cell differentiation within this time frame. It is possible therefore, that 
TXNIP might be acting within the myonuclei to exert its functions on the 
adapting/repairing myofibre. Importantly, considerable work is necessary to further 
delineate its functions within skeletal muscle.  
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C. MLP 
MLP was originally discovered in denervated skeletal muscle and identified as a 
positive regulator of the myogenic program in myogenic cells (Arber et al. 1994). In 
this thesis, it was demonstrated for the first time that MLP transcriptional expression is 
increased by resistance exercise whilst not being altered following endurance 
exercise. Numerous functions have been attributed to MLP in skeletal muscle 
including facilitating the assembly or stabilization of the myofibril apparatus (Flick and 
Konieczny 2000) contributing to the mechanical stretch sensor machinery (Knoll et al. 
2002), and regulating myogenesis through the interaction with the myogenic 
transcription factors, MyoD, Myf6 and myogenin (Kong et al. 1997). Collectively these 
data seem to suggest multiple complementary roles for MLP in sensing mechanical 
stretch, regulating the subsequent transcriptional response and ultimately facilitating 
the assembly or stabilization of the contractile apparatus. Thus it appears that in 
response to a stimulus like resistance exercise, MLP plays a critical and coordinated 
role in the repair and adaptation of skeletal muscle.  
D. Hypothetical Protein FLJ38973  
The hypothetical protein FLJ38973 was originally identified during a large-scale 
screen of ESTs for the purpose of identifying the full-open reading frame cDNA 
sequence for each human and mouse gene (Mammalian Gene Collection Program 
Team et al. 2002). Whilst no subsequent study has investigated FLJ38973, 
bioinformatics analysis using revealed that it is located on chromosome 2 and 
produces, by alternative splicing, 2 different transcripts (aDec03, bDec03) together 
encoding 2 different protein isoforms. In the thesis, FLJ38973 mRNA was 
demonstrated to be up-regulated following an acute bout of resistance exercise, whilst 
no changes in expression were observed during differentiation or following a single 
bout of endurance exercise. This is the first collection of studies to investigate this 
gene and provides valuable data on its possible functions in vivo. Considerable work 
is necessary to further characterise the tissue distribution, cellular localisation, and 
most important, biological functions of the protein(s) encoded by this gene.  
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III. FUTURE DIRECTIONS 
This thesis describes the identification and characterisation of four novel genes whose 
expression was increased during the early recovery from a single bout of resistance 
exercise in human vastus lateralis muscle. Subsequently, the expression patterns of 
these genes was investigated during the differentiation of primary human skeletal 
muscle cells in culture as well as following a single bout of endurance exercise. Whilst 
these studies go some way towards characterising the functions of these genes, 
considerable work is necessary to delineate their biological functions in skeletal 
muscle. In this section, details of future studies designed to advance current 
understanding of functions of these gene products will be discussed.  
 
Throughout this thesis, each study focused not only on the identification of novel 
genes, but also on understanding further the importance of the myogenic pathways in 
the development of skeletal muscle hypertrophy. Despite the recent advances in the 
understanding of the molecular regulation of skeletal muscle hypertrophy, 
considerable gaps remain. Further research required to advance knowledge in this 
area will be discussed.  
A. Functional analysis of novel gene targets using gene 
knockdown and over-expression techniques 
1. Background 
In chapter 5, the identification of several novel resistance exercise responsive genes 
was discussed. Subsequently, the potential functions of these genes were examined 
during myogenic differentiation in culture (chapter 6) and following a single bout of 
endurance exercise (chapter 7). Whilst these studies provided considerable 
information on the transcriptional regulation of these genes, very little is currently 
known about their functions within skeletal muscle. Targeted gene knockdown and 
over-expression techniques are effective ways of analysing the functions of genes in 
vitro.  
2. Aims 
(i) To investigate the functions of selected genes by examining the 
phenotypic changes induced by targeted knockdown in myogenic 
cells in culture. 
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(ii) To investigate the functions of selected genes by examining the 
phenotypic changes induced by targeted over-expression in myogenic 
cells in culture. 
 
 
3. Key Methods 
3.1 RNA Interference 
RNAi has been widely adopted as the simplest and most effective method of 
suppressing a gene’s product resulting in null or hypomorphic phenotypes. 
Subsequently, the biological effects of knocking down a target gene can be examined 
and functions of a gene inferred. In mammalian cells, RNAi is typically induced by the 
introduction of small inhibitory RNAs (siRNA) (specifically designed to target the gene 
of interest whilst minimizing the effects on non-target genes) into the cell culture 
system (Sago et al. 2004). 
 
Following siRNA synthesis, delivery of the siRNA into the cell system is usually 
accomplished via transfection with a lipid- or amine-based reagent. Delivery into 
primary cells, however, can be problematic, if not impossible, using standard 
transfection methodologies. In these cases, electroporation using a specialized, 
gentle-on-cells buffer and optimized pulsing conditions generally results in very 
efficient siRNA delivery without compromising cell viability. Following transfection, the 
effectiveness of the siRNA in inducing knockdown of its intended target needs to be 
assessed. siRNAs exert their effects at the mRNA level,  therefore, quantitative real-
time PCR analysis would be required for siRNA validation and transfection 
optimization purposes. Subsequently, the effect of the targeted knock-down of the 
gene can be assayed using standard functional, morphological and phenotypical 
measures. For example, targeted gene knockdown of IL-6 in muscle cells has been 
used previously to examine its effect on myogenic differentiation (Baeza-Raja and 
Munoz-Canoves 2004).   
 
3.2 Over-expression studies 
Over-expression techniques involve the forced expression of a specific gene and 
subsequent examination of biological changes induced by the gene product. Standard 
techniques are available for cloning of the selected gene into an expression plasmid 
and the transient transfection of the target gene into the cell line of interest. Classical 
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transfection technologies that are widely used include the DEAE-dextran method, the 
calcium phosphate method, electroporation, and liposome mediated transfection.  
 
Following verification and optimisation of the transfection techniques, standard 
functional, morphological and phonotypical measures would be employed to examine 
the effect of the forced over-expression of the gene. For example, over-expression 
studies have been effectively employed to examine the effect of integrin binding 
proteins on muscle differentiation (Li et al. 1999) and the effect of Chemokine-like 
factors on myoblast proliferation (Xia et al. 2002).  
4. Significance 
The genes identified in this thesis are all likely to be involved in the repair or 
adaptation of muscle. Therefore measures of proliferation (e.g. PCNA mRNA, DNA 
content), differentiation (e.g. creatine kinase activity, MHC protein content) and 
myofibre size (hypertrophy) would all be appropriate end-point measures to assess 
possible functions of each target gene in vitro. For example, the knock-down of a gene 
exhibiting markedly reduced creatine kinase activity and MHC expression would likely 
play a critical role in myogenic differentiation. Similarly, dramatic increases in the rate 
of proliferation following the over-expression of a particular gene would likely indicate 
a role in the cellular proliferation. Therefore these studies would be valuable in further 
examining the functions of these genes in skeletal muscle.  
 
B. Examination of cellular localisation and tissue distribution of 
selected novel genes 
1. Background 
Microarray analysis and gene expression analysis in general are valuable measures of 
the regulation of biological processes. However, mRNA expression patterns are by 
themselves insufficient for the quantitative description of a biologically active product. 
Further examination of the functions of the novel resistance exercise sensitive genes 
would be advanced by the examination of the cellular localisation and tissue 
distribution of the proteins encoded by each gene. Whilst commercially produced 
antibodies may be available for some of the proteins of interest, others may need to 
be custom produced. The development of a polyclonal antibody to target the protein 
encoded by the gene of interest would provide numerous avenues for further 
investigation into its functions.  
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2. Aims 
(i) To investigate the cellular localisation of selected novel proteins in 
skeletal muscle using confocal microscopy. 
(ii) To investigate the tissue distribution of selected novel genes using 
western blot analysis 
 
3. Key Methods 
 
3.1 Fluorescence Microscopy 
Specific primary antibodies could be used to examine the cellular localisation (if not 
already known) of the novel skeletal muscle sensitive proteins. Furthermore, 
immunohistochemical techniques could be used to track the cellular localisation of 
these proteins in mounted muscle tissue following, for example, a single bout of 
resistance exercise. Similarly, immunocytochemical techniques might be used to 
examine the possible changes in cellular localisation during proliferation and 
differentiation of satellite cells in culture.  
 
3.2 Western Blot Analysis 
The development of specific primary antibodies or the use of commercially available 
antibodies specific to the protein of interest would provide an opportunity to compare 
the expression of the selected protein across many different tissues. Analysis of the 
protein expression in many tissues would be carried out using standard western 
analysis techniques. 
 
4. Significance 
These analysis strategies would further advance current understanding of the potential 
functions and mechanisms of actions of the proteins encoded by these novel genes. 
For example tissue distribution analysis might reveal that a particular protein is 
expressed exclusively in skeletal muscle or alternatively is enriched in skeletal and 
cardiac muscles tissues whilst demonstrating minimal expression in other tissues. 
Such a protein would be of particular interest as a potentially critical mediator of the 
skeletal muscle phenotype.  
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C. Effects of resistance exercise training on the expression of 
selected novel resistance exercise responsive genes 
1. Background 
The novel resistance exercise sensitive genes discussed in this thesis were identified 
following a single bout of resistance exercise. However a single bout of resistance 
exercise is unlikely to confer marked phenotypic or functional changes within the 
skeletal musculature. Therefore it would be of interest to examine the effects of a 
resistance exercise training protocol, of sufficient intensity and duration to induce 
marked increases in muscle hypertrophy and strength, on the expression of these 
previously identified genes.  
2. Aims 
(i) To examine the mRNA expression of novel resistance exercise 
sensitive genes following 12 weeks of high intensity resistance 
exercise training. 
(ii) To examine the protein expression of novel resistance exercise 
sensitive genes following 12 weeks of high intensity resistance 
exercise training. 
3. Key Methods 
Approximately 10 young male subjects would be recruited to undergo a 12 week 
heavy resistance exercise training protocol. Vastus lateralis muscle biopsies would be 
collected before exercise and following a single bout of resistance exercise. Following 
the 12 weeks of training, subsequent biopsies would be collected at rest and again 
following a single bout of exercise. 
 
RNA and protein would be extracted from the muscle biopsies and analysed to 
measure RNA and protein expression for each of the novel resistance exercise 
sensitive genes. 
4. Significance 
The study would provide further valuable data on both the transcriptional regulation of 
these genes as well as the translational regulation of the proteins following a single 
bout of resistance exercise. The great advantage of this study design would however, 
be to examine the effect of training on the expression of these genes and proteins. If 
these genes are indeed important regulatory components of the hypertrophic 
response, a marked increase in their expression would be likely following the intensive 
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training regime. Thus valuable data collected from this study would further current 
understanding of the molecular regulation of skeletal muscle hypertrophy.  
D. Identification of novel genes demonstrating decreased 
expression following acute resistance exercise 
1. Background 
In chapter 5, a human skeletal muscle specific microarray was used to examine the 
global transcriptional response of skeletal muscle to a single bout of resistance 
exercise. 7,229 elements out of the 11,000 spotted onto the microarray showed 
adequate expression levels, with 3112 elements demonstrating increased expression 
following resistance exercise whilst 1436 elements decreased in expression. 
Considerable time and cost involved in sequencing gene elements prevented the 
analysis of all differentially expressed elements so a subset of these genes were 
selected for sequencing and further analysis. Only genes demonstrating increased 
expression were selected for this analysis. Genes showing reduced expression 
however are likely to constitute and equally important biological adaptation following 
resistance exercise.  
2. Aims 
(i) To examine the collected microarray data to identify novel genes 
down-regulated following a single bout of resistance exercise in 
human subjects. 
3. Key Methods 
3.1 Microarray data analysis 
Further detailed analysis of the collected microarray data would be required to isolate 
elements demonstrating marked and consistently reduced expression following a 
single bout of resistance exercise. A subset of these elements will be selected for 
further analysis. 
3.2 Sequencing 
Sequencing analysis would be performed on the selected clones as previously 
described.  
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3.3 Bioinformatics analysis  
Extensive bioinformatical analysis will be performed on the selected genes to identify 
the gene sequence, transcript structure, amino acid profile in addition to known or 
predicted functions of the protein.  
3.4 Real-Time PCR  
Real-Time PCR analysis would be performed to validate the results of the microarray. 
4. Significance 
Several proteins (most notably myostatin) have recently been identified as powerful 
negative regulators of skeletal muscle mass. Further analysis of the microarray data 
collected for this thesis has the potential to isolate further novel genes with critical 
biological roles in skeletal muscle.  
E. Examination of alternate pathways potentially involved in 
skeletal muscle hypertrophy  
1. Background 
Considerable recent research into the molecular mechanisms regulating skeletal 
muscle mass has greatly enhanced the current understanding of this complex 
process. In this thesis, several novel resistance exercise responsive genes have been 
identified that might constitute important components of early adaptive response to 
resistance exercise. Furthermore, a number of genes with identified roles in 
myogenesis were examined to investigate potential roles in the early adaptive 
response to resistance exercise. Despite these recent breakthroughs, a substantial 
amount of work is required to further unlock the complex regulatory mechanisms 
mediating skeletal muscle hypertrophy. For example, the mechanism(s) by which 
skeletal muscle senses skeletal muscle contraction and transduces this information 
into downstream cellular level responses remains unknown. Similarly, it is unclear how 
satellite cells and mature myofibres act cooperatively to mediate myofibre adaptation 
and hypertrophy. It is likely that there are numerous as yet uncharacterised pathways 
that might contribute to skeletal muscle hypertrophy however further research is 
necessary to investigate these questions further. 
2. Suggested targets for further investigation 
Recent research has demonstrated that the Notch signalling pathway is a key 
determinant of muscle regeneration. Importantly, components of the Notch signalling 
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mechanism are impaired with age, contributing to the reduced regenerative potential 
evident in elderly muscle (Conboy et al. 2003). It is unclear whether this pathway plays 
an important role in the regeneration of human skeletal muscle nor whether it might 
contribute to skeletal muscle adaptation and hypertrophy. Therefore, this pathway 
constitutes a potentially interesting target for further investigation. 
 
Much of our understanding of the biology of skeletal muscle has come from the study 
of embryonic muscle development. The processes of muscle regeneration and 
adaptation has been described as a recapitulation of the stages of embryonic muscle 
development and subsequently may share parallel morphological steps (Grounds 
1991; Chambers and McDermott 1996). These initial stages of myogenesis are 
regulated by positive and negative signals, including Wnt, bone morphogenetic protein 
and sonic hedgehog family members. Therefore, these myogenic regulators would 
provide interesting candidates as potential mediators skeletal muscle adaptation.  
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IV. CONCLUSIONS 
In summary, the findings of this thesis are as follows: 
 
1. The mRNA expression of two genes, PTMA and Tim10 were identified as 
being down-regulated following forced myogenic differentiation of 
rhabdomyosarcoma cells.  
 
2. The temporal pattern of the MRF expression over the time-course 
rhabdomyosarcoma differentiation was identified as exhibiting a remarkably 
similar pattern of expression to that exhibited in normal myogenesis. 
 
3. A single bout of resistance exercise was shown to be sufficient to increase the 
expression of the MRF member’s myogenin and MyoD but not Myf5 and Myf6. 
The cell cycle regulator p21 was demonstrated to increase following 
resistance exercise whilst no change was observed for PTMA, cyclin D1 and 
p27. Myostatin mRNA expression was shown to be significantly reduced 
following acute resistance exercise. 
 
4. Four novel genes (ASB5, TXNIP, MLP, FLJ38973) were identified as being 
increased following an acute bout of resistance exercise. These genes have 
not previously been implicated in the early molecular response of skeletal 
muscle to resistance exercise in humans. 
 
5. The expression of TXNIP was demonstrated to be increased during the 
differentiation of human primary skeletal muscle cell culture. ASB5, MLP and 
FLJ38973 expression was not altered during differentiation. 
 
6. The expression of ASB5 was increased following a single bout of endurance 
exercise. The expression of MLP, TXNIP and FLJ38973 was not altered by 
this exercise protocol. Similarly, the expression of the MRFs was not altered 
by a single bout of endurance exercise. 
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APPENDIX A 
ANKYRIN REPEAT AND SOCS BOX-CONTAINING PROTEIN5 
Official Gene Name: Ankyrin repeat and SOCS box-containing protein 5 
Official Gene Symbol: ASB5 
Alternative symbols: None 
Chromosomal Location: 4q34.2 
Gene Size: 55.4 kb 
Number of Exons: 7 
mRNA Length: 8613 bases 
Open Reading Frame Length: 987 bases (329 amino acids) 
Protein pI/Mw: 6.34 / 36340.85 
Transcript Structure:  
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cDNA and amino acid sequence:  
 
ACCAGCTGATATTTTCTTTCCTCAGGACCAGCTGTTCAGGAGCATCCCGGACGAGAGCCA 
GGCACATTTGAGACTTGGATCCAACTAAAGACCGCCGCAGATTCTTCTGCAGCAATGTCG 
                                                       M  S 
GTGTTAGAAGAAAATCGGCCGTTTGCTCAACAATTATCCAATGTCTACTTTACAATACTT 
 V  L  E  E  N  R  P  F  A  Q  Q  L  S  N  V  Y  F  T  I  L 
TCGCTGTTCTGTTTTAAGCTTTTTGTGAAAATCAGCCTTGCCATCCTCAGTCATTTCTAC 
 S  L  F  C  F  K  L  F  V  K  I  S  L  A  I  L  S  H  F  Y 
ATAGTGAAAGGCAACCGCAAGGAAGCGGCAAGGATAGCAGCTGAATTTTATGGAGTAACC 
 I  V  K  G  N  R  K  E  A  A  R  I  A  A  E  F  Y  G  V  T 
CAAGGACAAGGTTCCTGGGCAGATCGATCACCACTACATGAAGCAGCAAGTCAAGGTCGC 
 Q  G  Q  G  S  W  A  D  R  S  P  L  H  E  A  A  S  Q  G  R 
CTTCTTGCTCTGAGAACATTATTATCACAGGGTTATAATGTAAATGCAGTAACCTTAGAC 
  L  L  A  L R  T  L  L  S  Q  G  Y  N  V  N  A  V  T  L  D 
CATGTCACCCCATTGCACGAAGCCTGCCTTGGAGATCACGTGGCATGTGCCAGAACTCTG 
 H  V  T  P  L  H  E  A  C  L  G  D  H  V  A  C  A  R  T  L 
CTGGAAGCAGGAGCTAATGTAAATGCAATCACGATAGATGGCGTGACTCCGTTATTCAAC 
 L  E  A  G  A  N  V  N  A  I  T  I  D  G  V  T  P  L  F  N  
GCATGCTCCCAAGGCAGTCCAAGCTGTGCAGAGCTGCTTCTGGAGTATGGTGCCAAAGCC 
 A  C  S  Q  G  S  P  S  C  A  E  L  L  L  E  Y  G  A  K  A 
CAGCTGGAGTCATGTCTTCCATCCCCAACGCATGAGGCCGCCAGTAAAGGTCACCATGAA 
 Q  L  E  S  C  L  P  S  P  T  H  E  A  A  S  K  G  H  H  E 
TGTCTTGACATCCTGATATCCTGGGGCATAGATGTTGACCAAGAAATTCCTCATTTGGGA 
 C  L  D  I  L  I  S  W  G  I  D  V  D  Q  E  I  P  H  L  G  
ACTCCTCTCTATGTAGCTTGTATGTCACAGCAATTCCATTGCATCTGGAAGCTTCTTTAT 
 T  P  L  Y  V  A  C  M  S  Q  Q  F  H  C  I  W  K  L  L  Y  
GCTGGTGCTGACGTACAGAAAGGCAAATATTGGGATACTCCATTACATGCTGCTGCTCAA 
 A  G  A  D  V  Q  K  G  K  Y  W  D  T  P  L  H  A  A  A  Q  
CAATCCAGCACAGAAATTGTAAACTTACTGCTAGAATTTGGAGCAGATATCAATGCCAAA 
 Q  S  S  T  E  I  V  N  L  L  L  E  F  G  A  D  I  N  A  K  
AATACAGAGCTTCTGCGACCTATAGATGTAGCTACGTCTAGCAGTATGGTGGAAAGGATA 
 N  T  E  L  L  R  P  I  D  V  A  T  S  S  S  M  V  E  R  I 
TTGCTTCAACATGAAGCTACCCCAAGCTCTCTTTACCAACTTTGCCGACTCTGTATCCGA 
 L  L  Q  H  E  A  T  P  S  S  L  Y  Q  L  C  R  L  C  I  R 
AGCTACATAGGAAAACCAAGATTGCACCTTATCCCACAACTCCAGCTGCCAACGTTACTG 
 S  Y  I  G  K  P  R  L  H  L  I  P  Q  L  Q  L  P  T  L  L 
AAGAATTTCTTACAGTATCGATAAAACAGTAAAGTAATTCTAAATACCTTGAAAATCAAA 
 K  N  F  L  Q  Y  R  * 
ATTTCTATTTCTTTTGCTTAAGGAATAGTTCATATAAAAATATGCTAAAGATAGGATAAA 
AGTGAGTGTGAGATCACCCAGGGAAGCAGTAAAATATCAATTTTCATTTTAAGTGTATTA 
GTACTATTGTTTTATCATTTATGCTGTCTTTGGATTATAGCATATTTATAATATCTATTT 
TTTGTTATTTCAATATACCCTCCTGTTTATTCAGGAAAAAATAATAAAGTCACTATCTTA 
TGTTTTCTTTTGGATTGGAAAGAAATAAAGCTCCTAGTAAAGTTATTCATATTATATTTA 
AAAAGGTCTATGTTCTTCAACTAATGGGTTAACTTTTTAATTTTGGCTATTGTAATTGGC 
TAACTTGTTACTGATATTGACATAAAATATGAATATGGCTTAGCAAAGAGCAACTAATAT 
GTTTTCTGAAACCAGGATGATGCTCATTCAGGAAATCCACTATGTTGAATGTCCACTGGT 
CATTAGAATGAACACTTCATAAAGATAAATTGCCCCCCTCTCCCCCACTTACCCCTGGCA 
AAGGACTCACAAGTCACTTCTCTTCTCCATAGTACATGGACTTGTTACAGAAAAGTGATA 
GGATGAAAGGTCAATACTGCCCTCTCACCCTGAGATATTTAGAACATTACACACCTTCTA 
AGGCTATGTTAAGACTGCCTCCTTCTCAGGAGTAGCCCCTGATGATCTCTTATCAAGGCG 
GTTATATGCATATTACTCCAGCCTTCTTCCATTTCAGAAATTGTCAATAGCTAGTGATAC 
TTGGACTTAAGAAAATGAACTATATATCTAATTAACAAACAGGCCCTGGATCATATTCCG 
GGGATCATCACATCAGTCCAAGGATATAAAAAAATGGAAGATTAAAAACTCAAATTGTGG 
AGTTTTTAAAGAGTGGGTGCCACTTAACACATTGGAGACCTTAAAAAATGTATATAGAGA 
ACTTAATCGCACTGTTTCTAATTCTTTTTACACAAAACAAGGGCTTAGAGTATACTGTAT 
TTGCAAGTAATAGCAAGAGAGTATTGTATAAAAGAAGATATTACTAAGCTAGTCCTCTGC 
AAGGGTAAATACTACGTTTATTCTCTTCAGCTTTAACTATACTTGAGTGCAATAAAAAAC 
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TTAATAAAATTTTATGCCTGTTTTGTAATTCAGGGCCTATTATGATTTTAGAAATAAGAT 
AATCAACGTACAACTCTTTGTAAAACAAAAGCAACTTTGGGTGAGTTTTATAGATTTATT 
AAATTTTGATAAAGTAAATATTTTGACCACTATTTTCAACAACCCAGGGCTTATTTTCTT 
CTGACTTCTTGGCTAACTTCCAGACTATGGGAAAATAAATTATGATTGTATGTGACCCCC 
AGATCACTAAGCTTGCATTTTGGCAGAAAGAAAAAAAATCAGTTGTGATTTAAAACGTTT 
GTTGAGATTTTCAAACATAGAAATAAAGCTGTAGCATATTCACTAAACAATGTTTTATAT 
GAGGATAGGGACCTTTAAATATGTGTTTTATAGAATATCTCACACATTTGTAATGGATAA 
CGTGCATTAAAATGGAGTTCTTATTATAGAATAACCTGGTTAAACAGATATTAAAGCTGC 
TTTTGGGTAAAACAGGTTTCCACCAGTATTTTCCCTGAGCTAGAGGAGAAGTCTTAGATT 
TTAAGAGTAATACAACCCATCTATCTTATTAGTCTTGTGCCAATAAGAGAAGTAAATATC 
AAACATTAAAATGGTCACTTTACAATTTCAGTATGTCTGTACCTTGTATCTTAGCTTGAG 
TATGATTGTCTTATCAAAGTAGTGTTCTAACTTTAATGTATTGTATGTTTGTTATTATAT 
TAAAGTGTGATTATTATTCATTGG 
 
 
The coding sequence of the ASB5 cDNA and its deduced amino acid 
translation (in black). Exons are represented in alternating blue and red text, 
whilst non-coding regions are highlighted in yellow. The stop codon (TGA) is 
shown as an asterisk (*). 
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APPENDIX B 
THIOREDOXIN INTERACTING PROTEIN 
Official Gene Name: Thioredoxin interacting protein 
Official Gene Symbol: TXNIP 
Alternative Gene Names: THIF, VDUP1, HHCPA78, EST01027 
Chromosomal Location: 1q21.2 
Gene Size: 3.9 kb 
Number of Exons: 8 
mRNA Length: 8820 bases 
Open Reading Frame Length: 1173 bases (391 amino acids) 
Protein pI/Mw: 7.46 / 43689.39 
Transcript Structure:  
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cDNA and amino acid sequence: 
 
GCTTAGTGTAACCAGCGGCGTATATTTTTTAGGCGCCTTTTCGAAAACCTAGTAGTTAAT 
ATTCATTTGTTTAAATCTTATTTTATTTTTAAGCTCAAACTGCTTAAGAATACCTTAATT 
CCTTAAAGTGAAATAATTTTTTGCAAAGGGGTTTCCTCGATTTGGAGCTTTTTTTTTCTT 
CCACCGTCATTTCTAACTCTTAAAACCAACTCAGTTCCATC 
ATGGTGATGTTCAAGAAGATCAAGTCTTTTGAGGTGGTCTTTAACGACCCTGAAAAGGTG 
 M  V  M  F  K  K  I  K  S  F  E  V  V  F  N  D  P  E  K  V   
TACGGCAGTGGCGAGAAGGTGGCTGGCCGGGTGATAGTGGAGGTGTGTGAAGTTACTCGT 
 Y  G  S  G  E  K  V  A  G  R  V  I  V  E  V  C  E  V  T  R   
GTCAAAGCCGTTAGGATCCTGGCTTGCGGAGTGGCTAAAGTGCTTTGGATGCAGGGATCC 
 V  K  A  V  R  I  L  A  C  G  V  A  K  V  L  W  M  Q  G  S 
CAGCAGTGCAAACAGACTTCGGAGTACCTGCGCTATGAAGACACGCTTCTTCTGGAAGAC 
 Q  Q  C  K  Q  T  S  E  Y  L  R  Y  E  D  T  L  L  L  E  D 
CAGCCAACAGGTGAGAATGAGATGGTGATCATGAGACCTGGAAACAAATATGAGTACAAG 
 Q  P  T  G  E  N  E  M  V  I  M  R  P  G  N  K  Y  E  Y  K 
TTCGGCTTTGAGCTTCCTCAGGGGCCTCTGGGAACATCCTTCAAAGGAAAATATGGGTGT 
 F  G  F  E  L  P  Q  G  P  L  G  T  S  F  K  G  K  Y  G  C 
GTAGACTACTGGGTGAAGGCTTTTCTTGACCGCCCGAGCCAGCCAACTCAAGAGACAAAG 
 V  D  Y  W  V  K  A  F  L  D  R  P  S  Q  P  T  Q  E  T  K  
AAAAACTTTGAAGTAGTGGATCTGGTGGATGTCAATACCCCTGATTTAATGGCACCTGTG 
 K  N  F  E  V  V  D  L  V  D  V  N  T  P  D  L  M  A  P  V 
TCTGCTAAAAAAGAAAAGAAAGTTTCCTGCATGTTCATTCCTGATGGGCGGGTGTCTGTC 
 S  A  K  K  E  K  K  V  S  C  M  F  I  P  D  G  R  V  S  V 
TCTGCTCGAATTGACAGAAAAGGATTCTGTGAAGGTGATGAGATTTCCATCCATGCTGAC 
 S  A  R  I  D  R  K  G  F  C  E  G  D  E  I  S  I  H  A  D 
TTTGAGAATACATGTTCCCGAATTGTGGTCCCCAAAGCTGCCATTGTGGCCCGCCACACT 
 F  E  N  T  C  S  R  I  V  V  P  K  A  A  I  V  A  R  H  T 
TACCTTGCCAATGGCCAGACCAAGGTGCTGACTCAGAAGTTGTCATCAGTCAGAGGCAAT 
 Y  L  A  N  G  Q  T  K  V  L  T  Q  K  L  S  S  V  R  G  N 
CATATTATCTCAGGGACATGCGCATCATGGCGTGGCAAGAGCCTTCGGGTTCAGAAGATC 
 H  I  I  S  G  T  C  A  S  W  R  G  K  S  L  R  V  Q  K  I  
AGGCCTTCTATCCTGGGCTGCAACATCCTTCGAGTTGAATATTCCTTACTGATCTATGTT 
 R  P  S  I  L  G  C  N  I  L  R  V  E  Y  S  L  L  I  Y  V 
AGCGTTCCTGGATCCAAGAAGGTCATCCTTGACCTGCCCCTGGTAATTGGCAGCAGATCA 
 S  V  P  G  S  K  K  V  I  L  D  L  P  L  V  I  G  S  R  S 
GGTCTAAGCAGCAGAACATCCAGCATGGCCAGCCGAACCAGCTCTGAGATGAGTTGGGTA 
 G  L  S  S  R  T  S  S  M  A  S  R  T  S  S  E  M  S  W  V 
GATCTGAACATCCCTGATACCCCAGAAGCTCCTCCCTGCTATATGGATGTCATTCCTGAA 
 D  L  N  I  P  D  T  P  E  A  P  P  C  Y  M  D  V  I  P  E 
GATCACCGATTGGAGAGCCCAACCACTCCTCTGCTAGATGACATGGATGGCTCTCAAGAC 
 D  H  R  L  E  S  P  T  T  P  L  L  D  D  M  D  G  S  Q  D 
AGCCCTATCTTTATGTATGCCCCTGAGTTCAAGTTCATGCCACCACCGACTTATACTGAG 
 S  P  I  F  M  Y  A  P  E  F  K  F  M  P  P  P  T  Y  T  E  
GTGGATCCCTGCATCCTCAACAACAATGTGCAGTGAGCATGTGGAAGAAAAGAAGCAGCT 
 V  D  P  C  I  L  N  N  N  V  Q  * 
TTACCTACTTGTTTCTTTTTGTCTCTCTTCCTGGACACTCACTTTTTCAGAGACTCAACA 
GTCTCTGCAATGGAGTGTGGGTCCACCTTAGCCTCTGACTTCCTAATGTAGGAGGTGGTC 
AGCAGGCAATCTCCTGGGCCTTAAAGGATGCGGACTCATCCTCAGCCAGCGCCCATGTTG 
TGATACAGGGGTGTTTGTTGGATGGGTTTAAAAATAACTAGAAAAACTCAGGCCCATCCA 
TTTTCTCAGATCTCCTTGAAAATTGAGGCCTTTTCGATAGTTTCGGGTCAGGTAAAAATG 
GCCTCCTGGCGTAAGCTTTTCAAGGTTTTTTGGAGGCTTTTTGTAAATTGTGATAGGAAC 
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TTTGGACCTTGAACTTATGTATCATGTGGAGAAGAGCCAATTTAACAAACTAGGAAGATG 
AAAAGGGAAATTGTGGCCAAAACTTTGGGAAAAGGAGGTTCTTAAAATCAGTGTTTCCCC 
TTTGTGCACTTGTAGAAAAAAAAGAAAAACCTTCTAGAGCTGATTTGATGGACAATGGAG 
AGAGCTTTCCCTGTGATTATAAAAAAGGAAGCTAGCTGCTCTACGGTCATCTTTGCTTAA 
GAGTATACTTTAACCTGGCTTTTAAAGCAGTAGTAACTGCCCCACCAAAGGTCTTAAAAG 
CCATTTTTGGAGCCTATTGCACTGTGTTCTCCTACTGCAAATATTTTCATATGGGAGGAT 
GGTTTTCTCTTCATGTAAGTCCTTGGAATTGATTCTAAGGTGATGTTCTTAGCACTTTAA 
TTCCTGTCAAATTTTTTGTTCTCCCCTTCTGCCATCTTAAATGTAAGCTGAAACTGGTCT 
ACTGTGTCTCTAGGGTTAAGCCAAAAGACAAAAAAAATTTTACTACTTTTGAGATTGCCC 
CAATGTACAGAATTATATAATTCTAACGCTTAAATCATGTGAAAGGGTTGCTGCTGTCAG 
CCTTGCCCACTGTGACTTCAAACCCAAGGAGGAACTCTTGATCAAGATGCCGAACCCTGT 
GTTCAGAACCTCCAAATACTGCCATGAGAAACTAGAGGGCAGGTCTTCATAAAAGCCCTT 
TGAACCCCCTTCCTGCCCTGTGTTAGGAGATAGGGATATTGGCCCCTCACTGCAGCTGCC 
AGCACTTGGTCAGTCACTCTCAGCCATAGCACTTTGTTCACTGTCCTGTGTCAGAGCACT 
GAGCTCCACCCTTTTCTGAGAGTTATTACAGCCAGAAAGTGTGGGCTGAAGATGGTTGGT 
TTCATGTTTTTGTATTATG 
 
The coding sequence of the TXNIP cDNA and its deduced amino acid 
translation (in black). Exons are represented in alternating blue and red text, 
whilst non-coding regions are highlighted in yellow. The stop codon (TGA) is 
shown as an asterisk (*). 
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APPENDIX C 
MUSCLE LIM PROTEIN  
Official Gene Name: Cysteine and glycine rich protein 3 
Official Gene Symbol: CRP3 
Alternate Gene Names: Muscle LIM Protein (MLP), cardiac LIM protein (CLP), 
LMO4, CMD1M 
Chromosomal Location: 11p15.1 
Gene Size: 10.1 kb 
Number of Exons: 5 
mRNA Length: 5693 bases 
Open Reading Frame Length: 582 bases (194 amino acids) 
Protein pI/Mw: 8.89 / 20968.89 
Transcript Structure: 
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cDNA and amino acid sequence: 
 
 
CCCTTCCCCCAGCAGGCCAAGGCTGGTGACAGCCTTCATATATTTAAAGAGGACAAGAGC 
CCCTCAGACTCAGTTGAGCTGAACGGAGTCCACACAGGCAGACTTGACCTTGACCAGATA 
GTCTTCAAGATGCCAAACTGGGGCGGAGGCGCAAAATGTGGAGCCTGTGAAAAGACCGTC 
          M  P  N  W  G  G  G  A  K  C  G  A  C  E  K  T  V 
TACCATGCAGAAGAAATCCAGTGCAATGGAAGGAGTTTCCACAAGACGTGTTTCCACTGC 
 Y  H  A  E  E  I  Q  C  N  G  R  S  F  H  K  T  C  F  H  C  
ATGGCCTGCAGGAAGGCTCTTGACAGCACGACAGTCGCGGCTCATGAGTCGGAGATCTAC 
 M  A  C  R  K  A  L  D  S  T  T  V  A  A  H  E  S  E  I  Y  
TGCAAGGTGTGCTATGGGCGCAGATATGGCCCCAAAGGGATCGGGTATGGACAAGGCGCT 
 C  K  V  C  Y  G  R  R  Y  G  P  K  G  I  G  Y  G  Q  G  A 
GGCTGTCTCAGCACAGACACGGGCGAGCATCTCGGCCTGCAGTTCCAACAGTCCCCAAAG 
 G  C  L  S  T  D  T  G  E  H  L  G  L  Q  F  Q  Q  S  P  K 
CCGGCACGCTCAGTTACCACCAGCAACCCTTCCAAATTCACTGCGAAGTTTGGAGAGTCC 
 P  A  R  S  V  T  T  S  N  P  S  K  F  T  A  K  F  G  E  S 
GAGAAGTGCCCTCGATGTGGCAAGTCAGTCTATGCTGCTGAGAAGGTTATGGGAGGTGGC 
 E  K  C  P  R  C  G  K  S  V  Y  A  A  E  K  V  M  G  G  G 
AAGCCTTGGCACAAGACCTGTTTCCGCTGTGCCATCTGTGGGAAGAGTCTGGAGTCCACA 
 K  P  W  H  K  T  C  F  R  C  A  I  C  G  K  S  L  E  S  T 
AATGTCACTGACAAAGATGGGGAACTTTATTGCAAAGTTTGCTATGCCAAAAATTTTGGC 
 N  V  T  D  K  D  G  E  L  Y  C  K  V  C  Y  A  K  N  F  G  
CCCACGGGTATTGGGTTTGGAGGCCTTACACAACAAGTGGAAAAGAAAGAATGAAGAGGT 
 P  T  G  I  G  F  G  G  L  T  Q  Q  V  E  K  K  E  * 
GCGCCGTTTCTCAGATTTTTTGCGAGCCTAAAACACTTGCCAAGTAATCCTGCACAGATC 
GATACCTTTCCCCAAATAGCCTCTCCTTTGTAGTCGTACATTATGTGTTTCTCCTCAGAA 
GTGATCAGGTCTTTACTGAATGTTAGAAGAGGCCTTTGGAAGAAAATTATGTAAAGTTTA 
ATCTATAACAAATGCTTTATTATTTATAATGCTTGGAATGGGAGAGGCAATAAATAAATG 
TTTTAGTGCTATCTTGTATGGCTCTAGATCTTTTCTTTGAGATAGAAATTTTCAAAAACA 
TAAAGCTAGTTCAAAAAACGAGTTGCAGAGCATATAATAAATTTGGATGTCAACTGAGAA 
AGGAGTGAGAAGGAAGAAACAATGCGCAAAGGAAAGCAGTCTTTCAGAATCTGTCAGCCA 
AGTGTCTTTCTAGTTACTGCTAATGGAGAAGAAAACAGGGGGTCTGGGAGAAAATAGAGA 
ACATGATAGCAAAATCTAAAAGGAAAATCAAAACTAATAAAATTGCTGAAGAGTTGATCC 
CTTTGTCCTATCGTGGGGCTTTGTAATGTTACACATCTCGTGAAAACTCAGAAATGACAA 
TAAAGCGTGGCATTTGCCTCTGTATTATAAATG 
 
The coding sequence of the MLP cDNA and its deduced amino acid translation 
(in black). Exons are represented in alternating blue and red text, whilst non-
coding regions are highlighted in yellow. The stop codon (TGA) is shown as an 
asterisk (*). 
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APPENDIX D 
HYPOTHETICAL PROTEIN FLJ38973
Official Gene Name: Hypothetical Protein FLJ38973 
Official gene symbol: FLJ38973 
Alternative symbols: None 
Gene Product: hypothetical protein FLJ38973 
Chromosomal Location: 2q33.1 
Gene Size: 17.0 kb 
Number of Exons: 2 
mRNA length: 8021 bases 
Open Reading Frame Length: 807 bases (269 amino acids) 
Protein pI/Mw: 8.65 / 30918.17 
Transcript Structure:  
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cDNA and amino acid sequence: 
 
 
GCCTCAGCGCCGGCTCCCGGCCGGGCCGCGGCCGCCGACCGTTGAGCCGCCGGCTGAGCC 
GCCTGCTGAAGTCCCTCCCTCAGGAACCCCTCCGCCACCCTCCACCTCCGAACCGCTCTC 
GCGGCGGCGACCC 
ATGTGGGGGTTCAGGCTCCTGCGGTCGCCGCCGTTGCTGCTCCTGCTGCCGCAGCTCGGA 
 M  W  G  F  R  L  L  R  S  P  P  L  L  L  L  L  P  Q  L  G 
ATCGGAAACGCCTCGTCCTGCTCTCAGGCCAGAACCATGAACCCGGGCGGCAGCGGCGGC 
 I  G  N  A  S  S  C  S  Q  A  R  T  M  N  P  G  G  S  G  G 
GCGCGATGCTCCCTCTCGGCCGAGGTGCGCCGCCGTCAGTGCCTGCAGCTTTCCACCGTG 
 A  R  C  S  L  S  A  E  V  R  R  R  Q  C  L  Q  L  S  T  V 
CCTGGAGCCGATCCGCAGCGCAGCAACGAATTGCTCCTGTTGGCGGCGGCCGGGGAGGGA 
 P  G  A  D  P  Q  R  S  N  E  L  L  L  L  A  A  A  G  E  G 
CTGGAGCGGCAGGACCTCCCCGGGGACCCAGCGAAGGAGGAGCCGCAGCCGCCGCCCCAG 
 L  E  R  Q  D  L  P  G  D  P  A  K  E  E  P  Q  P  P  P  Q 
CATCACGTCCTCTATTTCCCTGGGGATGTGCAGAATTACCATGAAATTATGACTCGTCAT 
 H  H  V  L  Y  F  P  G  D  V  Q  N  Y  H  E  I  M  T  R  H 
CCTGAGAATTATCAATGGGAAAACTGGAGTCTAGAAAATGTTGCTACCATTTTAGCCCAC 
 P  E  N  Y  Q  W  E  N  W  S  L  E  N  V  A  T  I  L  A  H 
CGGTTCCCCAATAGTTATATTTGGGTGATAAAATGTTCCCGAATGCATTTGCACAAATTC 
 R  F  P  N  S  Y  I  W  V  I  K  C  S  R  M  H  L  H  K  F 
AGCTGCTATGACAATTTTGTGAAAAGTAACATGTTTGGTGCCCCAGAACACAATACTGAC 
 S  C  Y  D  N  F  V  K  S  N  M  F  G  A  P  E  H  N  T  D 
TTTGGAGCTTTTAAGCACCTTTATATGTTATTAGTTAATGCTTTTAATTTAAGTCAGAAT 
 F  G  A  F  K  H  L  Y  M  L  L  V  N  A  F  N  L  S  Q  N 
AGTTTATCAAAGAAAAGTTTGAATGTTTGGAATAAGGACTCCATAGCATCTAACTGTAGA 
 S  L  S  K  K  S  L  N  V  W  N  K  D  S  I  A  S  N  C  R 
TCCAGTCCTTCTCATACTACGAATGGTTGCCAGGGAGAAAAAGTGAGGACCTGTGAAAAA 
 S  S  P  S  H  T  T  N  G  C  Q  G  E  K  V  R  T  C  E  K 
TCTGATGAGTCTGCCATGAGTTTTTATCCACCATCACTAAATGACGCATCTTTTACTTTG 
 S  D  E  S  A  M  S  F  Y  P  P  S  L  N  D  A  S  F  T  L  
ATTGGATTCAGTAAAGGTTGTGTTGTTTTGAATCAGTTGCTTTTTGAATTGAAAGAAGCC 
 I  G  F  S  K  G  C  V  V  L  N  Q  L  L  F  E  L  K  E  A 
AAGAAAGACAAGAACATAGATGCTTTTATCAAAAGCATAAGAACAATGTATTGGCTGGAT 
 K  K  D  K  N  I  D  A  F  I  K  S  I  R  T  M  Y  W  L  D 
GGTGGTCATTCTGGAGGAAGCAATACTTGGGTTACTTATCCAGAAGTCTTGAAAGAATTT 
 G  G  H  S  G  G  S  N  T  W  V  T  Y  P  E  V  L  K  E  F   
GCACAAACAGGAATTATCGTTCACACTCATGTAACACCTTACCAAGTACGTGATCCAATG 
 A  Q  T  G  I  I  V  H  T  H  V  T  P  Y  Q  V  R  D  P  M   
AGATCTTGGATTGGAAAGGAGCACAAGAAATTTGTTCAGATACTTGGGGATCTTGGTATG 
 R  S  W  I  G  K  E  H  K  K  F  V  Q  I  L  G  D  L  G  M 
CAGGTGACTAGCCAAATTCATTTTACAAAGGAAGCTCCTTCCATAGAGAATCACTTCAGG 
 Q  V  T  S  Q  I  H  F  T  K  E  A  P  S  I  E  N  H  F  R 
GTTCATGAAGTATTTTGAGATTACAGGTATATTAATGAACTTGTTCAGTGGAAGAACATA 
 V  H  E  V  F  * 
AGCACTTTTGAGTGTTATAAATTCAGATAATGGGATGTAATTCATAGCTGCATTGTCAGT 
TTTGGGGTATGGGGGGAAGCACACATTCCTAAAATGTGAGTGTAATGTGCAATAGTATTT 
TTTGCTTGTGAATGTGAGCAGTTATTAATTTGGATTGAGTTAGAATTAGTTAATTTGAAA 
TCTAACAAGGTGGTTTGTAATAATGCTGAGGAGATATAAGACCCTTAAAATGAAAGTTAC 
AACATTGTTCTTATAAAAGGTAACTAAAATTGTTACTGTTGGAAATAACTGATTTTCTGA 
GTAATGTTTTAAACTAATTTGGTGACATTTTAACAGTAATTAGCTATTTTGAGTGGAAAT 
ATTTTCATTTCTCTTCAAACAAAAGCAAAGGTACGATGCTGTTTTCTATCATTTTGGAAT 
AACTGCACCCTGCCTTTTGTGTTTTTGTAAACTCCTTGACTCATTCTTTCATGTGTCACC 
 177
AAGTACTTTTCTCATGAGAGTCAACATATATTTGTTTCCAAATGTCCACAAGTGTACAAT 
AGTGTAAAGGTGGTTTTTAAAAACATAGCCAGGTGTGGTGGCACGTGCCTTTAGTTCCAG 
CTACTCAGGAGGCTAAGGCAGGAGGATTGCTTGAGCCCAGGCTGTGTGGTTCACCATAAT 
TGTGTTTGTGACTAGCTACTGCACTCCAACCTGGGCAACATAGTGGGACTTCATCTCTAA 
AACAAAACAAAACAAAATTACACTTAAGCACTATTGTTTAATTTTTAATTGTCAGTTTAT 
CATTATTTTGGGTAAGACATTCTGGGGTTTCTTGAATCTTGTCCAAAAACCAGTTGTTTT 
GGAAAATTGCTTTAAATTGAGCATATTTATGTATATTGGATAAAAATGTACTACAGAGCA 
AATTTCAAATTTTTCATTATATCAGTCTTTTTGAAAGGATCAACTTGGATAAAATAAATA 
TATAATGCTCTATTTGTTAGAGCTCTATTAAAAAGGAAACAGATTCCATAGATCTAAGTC 
AATGTTTCTCCAGAAGCATGATTTTGTCTGCCAAAAGAAAATAGCTCTCTTTGGCCAAAA 
TGCAAAATTACATTGCTATAAGAAAAGTTACAAGGGAAAGTTTGAAGACACAAATGATTT 
AATTTTGGCTCAAAAACTGAATTTGCTTAACACTGCTACATAATTTGGGTGAAGTTTCCT 
TCTGCCCGTTTTTCTTGACCTAGATAAATACACTTTGAGAAATCCAGATCTAATAAATGT 
CAACCAACATTGACATTGTAATTGGGTGATTACAATAAAAGGTGAGCAGTTTGTTGTTTA 
TTAATAATTAGCTTTTGCAGGTAATGAAATAGCAGGGAAGTAACATGCTGCTTTAGGACT 
AAAAAAAAAAAAAAAAAAAAGACACTGAAGCTTAATACCTTAATGACCCAGAAGACCTAG 
ATTTATAAAGCCATATAGAATAAAAATGTTAATTTCTTGGTTTCTTCCCAGAATTATATT 
TTAATGACTCCATAAATACATTCCAAATATTCAGAGATTCATGAGAAAGGATTCTTAACA 
AATGTTTAAAAATAACATTTCTTTTTGGTGTTTTAACACTTAATTTTATAAACTGCAGAA 
CAGCATCTCTAAATGGCTTTTTTTTTTTTTTTAAAGACAAAGTAGTATTATGTTGCTTCA 
GTTTCTTTAAATACCTCGTTTCTTTTGAGACCAAAAATTCCCATCAAGGAAATAAATCAG 
CCTGATTTTAACATTTTACATATTACATTGCCTTTAAGCACTATGATTGGATGGCTTTTT 
TTCTATTTGTTTAATAATCCTTGGCTAAATTCACATGTATCTAAAGGAAAATAGCTGAGT 
TACTGAATTCTATAAGGGGAAGAAAAAGCATTTATTTTCACATGATTAACTGAAATGGAA 
AAGTAAGACATTTAGCAGAATAATTCATTTAAAAATAATTTTAAAAAATCAGACATATTT 
AAAAATCTAGGTTGTCTATCCAGTATGTGAATGCTTAATTATAATTGTTACATGTTGAAT 
GGGTATTAAGAGTAAGTCACCAGGTACACAAAACTGCCATCATAGCAAAATGAGACAGTG 
TTGAAAAGACAAAATATTTTCTGGAATGAAAATATATTCAAGTTGATCCATATTCAGATG 
TTTTCTGTTTAATACTTCAGATTGGTCCTTTGTCCACATTTGTTTAAAACTTATTGTAAT 
GTTAATTTACACTTTTGGATTGTGCCTTTGTCATGAGTTGAGAAAAGTAGTCCTACAAAT 
AATGTGAAAGTTGTTACCACCACAGCATGAATGTATAATTGTATTAAAATTGATCATCCA 
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The coding sequence of the FLJ38973 cDNA and its deduced amino acid 
translation (in black). Exons are represented in alternating blue and red text, 
whilst non-coding regions are highlighted in yellow. The stop codon (TGA) is 
shown as an asterisk (*). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
